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1.1. Overview 
 
Since Wöhler’s synthesis of Urea in 1828 which is also the “official” birth of organic 
chemistry, the formation of C-C bonds has become the most important mission in this field of 
science. Kolbe was the first chemist achieving this goal, when he synthesized acetic acid in 
1845.1 Only three years later, Frankland2 managed to produce the first organometallic reagent, 
diethyl zinc by the reaction of zinc dust with ethyl iodide. This breaktrough discovery would 
emerge to the most powerful tool to form C-C and C-Heteroatom bonds during the next 150 
years. Today one can hardly speak about modern organic chemistry without mentioning the 
milestones set by Grignard, Wittig or Grubbs, for instance.3 In the last 25 years of the 20th 
century, organic chemistry was characterized by the assembly of complex framworks.1,3 Like 
a perpetuum mobile, this work was influenced by the development of new synthetic methods 
and influenced itself the evolution of new techniques often implementing organometallic 
reagents or catalysts. The new reagents should fulfill demands which are at first glance 
contrary: they are asked to be highly reactive, highly selective and highly tolerant towards 
sensitive functionalities and also be as environmetally friendly as possible and – of course – 
economically at the same time.4 The still ongoing development ensures that nearly every 
metal in the periodic table can be used for either the preparation of (new) organometallic 
reagents or in catalytic processes. 
The origin of the variety in the properties of organometallics can be explained by the 
difference in the polarity of the carbon-metal bond. Very polar bonds as they are found in 
organolithium reagents ensure high reactivity towards electrophiles even at low temperatures. 
At the same time this ionic character of the formed intermediates is the reason for the limited 
tolerance towards sensitive functional groups. Reagents with a more covalent character of the 
carbon-metal bond can be found in organozinc or organotin reagents. These compositions 
offer a wider range of tolerance towards susceptible groups. However, these molecules are 
often characterized by a lack of reactivity towards electrophiles. This gap can be brigded by 
transmetalation (Sn or B → Li) or the use of transition-metals as catalysts (Pd, Co, Ni, Cu). 
Organomagnesium and organocopper compounds play a special role in this context. Showing 
a good reactivity when intercepted with electrophiles, they possess at the same time, a 
                                                 
1
 K. C. Nicolaou, P. G. Bulger, D. Sarlah, Angew. Chem. Int. Ed. 2005, 44, 4442.  
2
 a) E. Frankland, Liebigs Ann. Chem. 1848-9, 71, 171; b) E. Frankland, J. Chem. Soc. 1848-9, 2, 263.  
3
 K. C. Nicolaou, P. G. Bulger, D. Sarlah, Angew. Chem. Int. Ed. 2005, 44, 4490. 
4
 a) B. M. Trost, Angew. Chem. Int. Ed. 1995, 34, 259; b) C.-J. Li, B. M. Trost, Proc. Nat. Acad. Sci. 2008, 105, 
13197. 
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remarkable tolerance of a broad range of functional groups. They can also be easily 
transmetalated to access other organometallic reagents. Therefore, these reagents represent 
formidable and flexible tools for organic synthesis.5 Grignard reagents are often found in total 
syntheses, even embedded in process chemistry, as for example in the synthesis of a Farnesyl 
Transferase Inhibitor 1 by Pfizer, where a heteroaryl magnesium reagent 2 adds to the ketone 
3 leading to the alcohol 4 (Scheme 1).6 
 
 
Scheme 1:  Grignard reagent in the Synthesis of a Farnesyl Transferase Inhibitor. 
 
An example for the use of organocopper reagents in total synthesis is shown in Scheme 2. The 
assembly of the D ring in the complex natural product Brevetoxin B is supported by the use of 
the copper reagent 5, which is brought onto the EFG ring system 6 leading to the substructural 
unit 7 in good yield. The residue of 5 is used in the following steps to construct the D ring of 
Brevetoxin B (8).7 
 
 
 
 
 
 
 
 
 
 
                                                 
5
 a) A. Boudier, L. O. Bromm, M. Lotz, P. Knochel, Angew. Chem. Int. Ed. 2000, 39, 4415; b) Handbook of 
Functionalized Organometallics (Ed.: P. Knochel), Wiley-VCH, Weinheim, 2005. 
6
 B. M. Andresen, M. Couturier, B. Cronin, M. D’Occhio, M. D. Ewing, M. Guinn, J. M. Hawkins, V. J. Jasys, S. 
D. LaGreca, J. P. Lyssikatos, G. Moraski, K. Ng, J. W. Raggon, A. M. Stewart, D. L. Tickner, J. L. Tucker, F. J. 
Urban, E. Vasquez, L. Wei, Org. Process Res. Dev. 2004, 8, 643.  
7
 K. C. Nicolaou, E. A. Theodorakis, F. P. J. T Rutjes, M. Sato, J. Tiebes, X. Y. Xiao, C. K. Hwang, M. E. 
Duggan, Z. Yang, E. A. Couladouros, F. Sato, F. Shin, H. M. He, T. Bleckman, J. Am. Chem. Soc. 1995, 117, 
10239.  
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Scheme 2: Organocopper compounds in the synthesis of Brevetoxin B. 
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1.2. Preparation and Use of Organomagnesium  and 
Organocopper Compounds 
 
1.3. Introduction 
 
A C-H or a C-X/LG (LG: leaving group e.g. OTs, OTf, X: halogen e.g. Cl, Br, I) bond in 
organic chemistry can basically be activated in catalytical or stoichoimetrical way.  
 
 
Scheme 3: Simplified mechanisms of the stoichiometric and catalytic bond activations.  
 
In both pathways, the reactive species R-[Met’] / R-[MetY] are obtained by the interaction of 
the metallic reagent with the reactant R-X/LG / R-Y (Scheme 3). The catalytic activation is 
especially well-suited for domino-reactions.8  The catalytic use of an active metal species 
[Met’] also facilitates enantioselective reactions. These catalytic activations mostly involve 
the use of expensive and/or toxic transition metals and it is therefore important to minimize 
the necessary amount of the catalyst. In the stoichiometric activation pathway, [Met] and [R’-
MetY] have to be used in stoichiometric amounts and are quantitatively consumed during the 
                                                 
8
 a) L. F. Tietze,  Chem. Rev. 1996, 96, 115; b) A. de Meijere, P. v. Zerschwitz, H. Nuske, B. Stulgies, J. Org. 
Chem. 2002, 653, 129; c) S.-I. Ikeda, Acc. Chem. Res. 2000, 33, 511. 
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reaction and therefore entail large amounts of chemical waste. That is why inexpensive and 
readily available metal species have to be used. The following chapters will give an brief 
overview into historic and current developments in organometallic C-H and C-X/L bond 
activations by highlighting recent research results in this field. Different approaches, 
including exchange- as well as catalyzed reactions, for the generation of organomagnesium-, 
organocopper-, and organozinc reagents will be lit up.  
 
1.4. Stoichiometric Bond Activations for the Preparation of 
Organomagnesium and Organocopper Reagents 
 
1.4.1. Halogen Metal Interconversion 
 
In 1900, Grignard reported for the first time the oxidative insertion of magnesium metal into 
a carbon-halogen bond.9 Until now, this reaction is the most commonly used protocol for the 
synthesis of these so called Grignard reagents (Scheme 4, Eq. 1). 
 
 
Scheme 4: Synthesis of Grignard reagents and Schlenk equilibrum. 
 
The mechanism of this reaction is not fully clarified, but it is generally assumed that radicals 
are involved in this transformation.10 In solution, Grignard reagents are in equilibrium with 
R2Mg and MgX2, the so called Schlenk-equilibrium (Scheme 4, Eq. 2). This state is 
influenced by the solvent, the temperature as well as the counterion. Organomagensium 
reagents are also prone to form dimers or oligomers, which is influenced by the 
                                                 
9
 a) V. Grignard, C. R. Acad. Sci. 1900, 130, 1322 ; b) Handbook of Grignard Reagents (Ed.: G. S. Silverman, P. 
E. Rakita), Marcel Dekker, New York, 1966; c) Grignard Reagents, New Developments (Ed.: H. G. Richey, Jr.), 
Wiley, New York, 2000, p. 185. 
10
 a) M. S. Kharasch, O. Reinmuth, Grignard Reactions of Nonmetallic Substances, Prentice Hall, New York, 
1954; b) H. M. Walborsky, Acc. Chem. Res. 1990, 23, 286;  c) J. F. Garst, Acc. Chem. Res. 1991, 24, 95. 
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concentration.11 
Although this method is a convenient way for the preparation of organomagnesium 
compounds, it suffers from drawbacks concerning the functional group tolerance. Exothermic 
conditions during the insertion as well as often necessary activation of the passivated metal 
surface are an explanation for this limitation.12 A Mg insertion at cryogenic temperatures 
using highly active magnesium metal was developed by Rieke. 13  Recently, an improved 
protocol for the Mg-insertion was developed by Knochel. The addition of LiCl to the reaction 
mixture allows the insertion of magnesium into C-X bonds (X: Cl, Br, I) at room temperature 
or below, improving functional group tolerance in insertion reactions significantly (Scheme 
5).14 
 
 
Scheme 5: LiCl faciliated Mg-insertion by Knochel. 
 
The insertion of copper metal into a carbon halogen bond was developed by Rieke in 1984. 15 
The use of lithium naphthalenide to generate highly reactive copper metal allows the 
conversion of organic bromides or iodides into the corresponding copper reagents as shown in 
Scheme 6. 
 
 
 
                                                 
11
 W. Schlenk, W. Schlenk Jr., Chem. Ber. 1929, 62, 620. 
12
 P. Knochel, W. Dohle, N. Gommermann, F. F. Kneisel, F. Kopp, T. Korn, I. Sapountzis, V. A. Vu, Angew. 
Chem. Int. Ed. 2003, 42, 4302. 
13
 R. D. Rieke, Science 1989, 246, 1260; b) R. D. Rieke, M. V. Hanson, Tetrahedron 1997, 53, 1925. 
14
 a) F. M. Piller, P. Appukkuttan, A. Gavryushin, M. Helm, P. Knochel, Angew. Chem. Int. Ed. 2008, 47, 6802; 
b) F. M. Piller, A. Metzger, M. A. Schade, B. A. Haag, A. Gavryushin, P. Knochel, Chem. Eur. J. 2009, 15, 7192; 
c) A. Metzger, F. M. Piller, P. Knochel, Chem. Commun. 2008, 5824. 
15
 a) R. D. Rieke, G. W. Ebert, J. Org. Chem. 1984, 49, 5280; b) R. D. Rieke, R. M. Wehmeyer, T.-C. Wu, G. W. 
Ebert, Tetrahedron 1988, 45, 443; c) G. W. Ebert, J. W. Cheasty, S. S. Tehrani, E. Aouad, Organometallics 1992, 
11, 1560; d) G. W. Ebert, D. R. Pfenning, S. D. Suchan, T. A. Donovan Jr., Tetrahedron Lett. 1993, 34, 2279. 
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Scheme 6: Cu-insertion by Rieke. 
 
Another convenient way for the preparation of organomagnesium or organocopper 
compounds with high functional group tolerance is the halogen/magnesium- or iodine/copper-
exchange reaction. Based on the work of Prévost16 and Villeras17, Knochel demonstrated the 
feasibility of the iodine/magnesium exchange on substrates bearing sensitive functionalities in 
1998 (Scheme 7).18 
 
 
Scheme 7: I/Mg-exchange. 
 
A wide range of polyfunctionalized organomagnesium reagents were prepared using this 
protocol. This method was further improved by the addition of one equivalent of LiCl to the 
exchange reagent iPrMgCl giving the formal composition iPrMgCl·LiCl. Interestingly this 
reagent displays a far higher reactivity, making the Br/Mg-exchange generally possible 
(Scheme 8).19 
 
                                                 
16
 C. Prévost, Bull. Soc. Chem. Fr. 1931, 49, 1372. 
17
 a) J. Villéras, Bull. Chem. Soc. Fr. 1967, 5, 1520; b) J. Villéras, B. Kirschleger, R. Tarhouni, M. Rambaud, 
Bull. Chem. Soc. Fr. 1986, 24, 470. 
18
 a) L. Boymond, M. Rottländer, G. Cahiez, P. Knochel, Angew. Chem. Int. Ed. 1998, 37, 1701; b) I. Sapountzis, 
P. Knochel, Angew. Chem. Int. Ed. 2002, 41, 1610. 
19
 A. Krasovskiy, P. Knochel, Angew. Chem. Int. Ed. 2004, 43, 3333. 
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Scheme 8: Deaggregation of iPrMgCl achieved by LiCl. 
 
The assumed ate like intermediate of this composition is proposed to be responsible for both, 
higher solubility and reactivity of the Grignard reagent. Thus, a broad range of aromatic and 
heteroaromatic bromides were converted into the corresponding Mg-reagents (Scheme 9)20 
 
 
Scheme 9: Br/Mg-exchange using iPrMg·LiCl. 
 
Surprisingly, the increased reactivity does not limit the functional group tolerance. However, 
some electron rich arenes still resisted to undergo the Br/Mg-exchange. This gap was briged 
by the development of exchange reagents of the type RMg2·LiCl.21 
 
 
Scheme 10: Br/Mg-exchange on electron rich substrates using sBuMg2·LiCl. 
 
Quantum chemical model calculations of halogen/magnesium-exchange reactions showed that 
                                                 
20
 For selected examples of Br/Mg-exchange, see: H. Ren, P. Knochel, Chem. Comm. 2006, 726; b) C.-Y. Liu, P. 
Knochel, Org. Lett. 2005, 7, 2543; c) N. Boudet, P. Knochel, Org. Lett. 2006, 8, 3737; d) F. Kopp, A. 
Krasovskiy, P. Knochel, Chem. Commun. 2004, 2288. 
21
 A. Krasovskiy, B. F. Straub, P. Knochel, Angew. Chem. Int. Ed. 2006, 45, 159. 
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the exchange becomes more likely if the the exchange reagent’s ate character is increased. 
Thus, bis-Mg reagents of type RMg2·LiCl could complete the exchange on substrates like 9 
where iPrMgCl·LiCl failed.21 
Corey demonstrated that Li-dialkylcuprates can be used to achieve an iodine copper exchange 
of aryl iodides.22 The limitation of this method was that one alkyl rest was also transferred 
onto the substrate. Knochel improved this method in 2002 by utilizing sterically hindered non 
transferable lithiumdialkyl cuprates. These reagents rapidly react with various functionalized 
aryl halides generating the corresponding copper reagents (Scheme 11).23  
 
 
Scheme 11: I/Cu-exchange using sterically hindered Li-dialkylcuprates. 
 
A drawback in all halogen/metal-exchange reactions, despite excellent functional group 
tolerance, is the necessity of a reactive C-X bond (X: Cl, Br, I) in the molecule. Many organic 
bromides and iodides suffer from dehalogenation reactions due to their thermal- or 
photoinstability. The generation of organometallics by C-H activation will be described in the 
following chapter. 
 
1.4.2. Hydrogen Metal Exchange 
 
Besides metal insertion and halogen/metal-exchange, the directed metalation using metal (R-
Met) and metal amide (R1R2N-Met) bases is the third major pathway for the synthesis of 
organometallics.24, 25 In contrast to the previously presented methods (insertion and exchange 
reaction), there is no need for a halogen-carbon bond. Thus, a more or less activated 
                                                 
22
 a) E. J. Corey, G. H. Posner, J. Am. Chem. Soc. 1967, 89, 3911; b) E. J. Corey, G. H. Posner, J. Am. Chem. 
Soc. 1968, 90, 5615.  
23
 a) C. Piazza, P. Knochel, Angew. Chem. Int. Ed. 2002, 41, 3263; b) X. Yang, T. Rotter, C. Piazza, P. Knochel, 
Org. Lett. 2003, 5, 1229; c) M. I. Calaza, X. Yang, D. Soorukram, P. Knochel, Org. Lett. 2004, 6, 529; d) X. 
Yang, A. Althammer, P. Knochel, Org. Lett. 2004, 6, 1665; e) X. Yang, P. Knochel, Org. Lett. 2006, 8, 1941. 
24
 For an early overview about metalation using organolithium compounds, see: J. M. Mallan, R. L. Bebb, Chem. 
Rev. 1969, 69, 693 and references therein. 
25
 For reviews, see: a) M. Schlosser, Angew. Chem. Int. Ed. 2005, 44, 380; b) R. E. Mulvey, F. Mongin, M. 
Uchiyama, Y. Kondo, Angew. Chem. Int. Ed. 2007, 46, 3802.  
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hydrogen-carbon bond is directly transformed into the corresponding metal species. In 
pioneering studies, Meunier,26 Hauser,27 Eaton28 and Mulzer29 demonstrated the feasibility of 
these metalations mediated by Mg-amide bases (“Hauser-Bases”). However, their reagents 
suffered from low reactivity due to the formation of aggregates. Therefore, a large excess of 
the metalating agent as well as the electrophile had to be used to overcome these problems. 
The observation, that the addition of 1 equiv of LiCl resulted in the formation of highly 
reactive, deaggregated exchange reagents (“Turbo-Grignard” (e.g. iPrMgCl·LiCl, 
(sBu)2Mg·LiCl)) paved the way for the development of highly reactive Mg-amide bases of the 
type R1R2NMgX·LiCl (“Turbo-Hauser-Bases”; Scheme 12). The recent determination of the 
metalated amide’s crystal structure showed that LiCl achieves deaggregation to form a 
monomeric species.30  
 
 
Scheme 12: Preparation of Turbo-Hauser-Bases. 
 
These bases are able to deprotonate many aromatics and heteroaromatics using approx. 1.1 
equiv of the base and the generated organomagnesium reagents react with a wide range of 
electrophiles (Scheme 13).31 
 
 
 
                                                 
26
 L. Meunier, C. R. Hebd. Seances Acad. Sci. 1903, 136, 758. 
27
 a) C. R. Hauser, H. G. Walker, J. Am. Chem. Soc. 1947, 69, 295; b) C. R. Hauser, F. C. Frostick, J. Am. Chem. 
Soc. 1949, 71, 1350. 
28
 a) P. E. Eaton, C. H. Lee, Y. Xiong, J. Am. Chem. Soc. 1989, 111, 8016; b) P. E. Eaton, K. A. Lukin, J. Am. 
Chem. Soc. 1993, 115, 11370. 
29
 A. Schlecker, A. Huth, E. Ottow, J. Mulzer, J. Org. Chem. 1995, 60, 8414. 
30
 a) A. Krasovskiy, V. Krasovskaya, P. Knochel, Angew. Chem. Int. Ed. 2006, 45, 2958;  for a crystal structure 
of 10a, see: P. García-Alvarez, D. V. Graham, E. Hevia, A. R. Kennedy, J. Klett, R. E. Mulvey, C. T. O'Hara, S. 
Weatherstone, S.; Angew. Chem. Int. Ed. 2008, 47, 8079 
31
 Selected examples, see:  a) N. Boudet, J. R. Lachs, P. Knochel, Org. Lett. 2007, 9, 5525; b) N. Boudet, S. R. 
Dubbaka, P. Knochel, Org. Lett. 2008, 10, 1715; c) M. Mosrin, P. Knochel, Org. Lett. 2008, 10, 2497; d) W. Lin, 
O. Baron, P. Knochel, Org. Lett. 2006, 8, 5673; e) A. H. Stoll, P. Knochel, Org. Lett. 2008, 10, 113. 
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Scheme 13: Magnesiation of arenes and heteroarenes using the Base 10a. 
 
However, substrates bearing extremely sensitive groups (e. g. aldehyde, nitro group) as well 
as some heterocycles are precluded from a metalation with 10a. These substrates are best 
metalated with a more sensitive base. Thus, the transmetalation of 10a with ZnCl2 furnishes a 
highly reactive and chemoselective base TMP2Zn·2MgCl2·2LiCl (12a) which is able to 
achieve the zincation of arenes and heteroarenes (Scheme 14).32 
 
 
Scheme 14: Direct zincation using TMP2Zn·2MgCl2·2LiCl (12a). 
 
A direct cupration was developed by Uchiyama in 2007. Thus, the TMP derived base 
MeCu(CN)(TMP)Li2 allowed the metalation of various aromatics and heteroaromatics. The 
generated cuprates may be intercepted with a broad range of electrophiles (Scheme 15).33 
Other metal amide bases have been developed to adress the different demands of metalation 
                                                 
32
 S. H. Wunderlich, P. Knochel, Angew. Chem. Int. Ed. 2007, 46, 7685; b) S. H. Wunderlich, P. Knochel; Org. 
Lett. 2008, 10, 4705; c) S. H. Wunderlich, P. Knochel, Chem. Commun. 2008, 47, 6387. 
33
 S. Usui, Y. Hashimoto, J. V. Morey, A. E. H. Wheatley, M. Uchiyama, J. Am. Chem. Soc. 2007, 129, 15102; b) 
J. Haywood, J. V. Morey, A. E. H. Wheatley, C.-Y. Liu, S. Yasuike, J. Kurita, P. R. Raithby, M. Uchiyama, 
Organometallics 2009, 28, 38.  
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and quenching reactions.34 
 
 
Scheme 15: Direct cupration of arenes. 
 
1.4.3. Directed ortho Metalation 
 
Beak and Snieckus investigated intensively the directed ortho metalation (DoM) using lithium 
bases and the complex-induced proximity effect. 35  The DoM concept describes the 
regioselective functionalization of aromatics if a directing metalation group (DMG) is present 
in the molecule. For example, amides, carbamides, sulfonamides, esters, cyanides or 
phosphorous-containing substituents are considered to be efficient directing groups in contrast 
to ethers or amines. In the presence of such a group, the metalating agent is complexed and 
therefore the corresponding base is conducted to the next activated proton, in general in ortho-
position to the directing group (Scheme 16). In some cases, the directing effect of one group 
can overrule the effect of the other one or the presence of two groups with equal properties 
lead to a decreased regioselectivity of the metalation process. 
 
 
 
 
 
 
                                                 
34
 For the preparation of Al-, Mn-, Fe- and La-amide bases see: a) S. H. Wunderlich, P. Knochel, Angew. Chem. 
Int. Ed. 2009, 48, 1501; b) S. H. Wunderlich, M. Kienle, P. Knochel, Angew. Chem. Int. Ed. 2009, 48, 7256; c) S. 
H. Wunderlich, P. Knochel, Angew. Chem. Int. Ed. 2009, 48, 9717-9720; d) S. H. Wunderlich, P. Knochel, 
Chem. Eur. J. 2010, in press. 
35
 For an overview, see: a) V. Snieckus, Chem. Rev. 1990, 90, 879; b) M. C. Whisler, S. MacNeil, P. Beak, V. 
Snieckus, Angew. Chem. Int. Ed. 2004, 43, 2206; c) P. Beak, A. I. Meyers, Acc. Chem. Res. 1986, 19, 356; d) E. 
Anctil, V. Snieckus, The Directed ortho Metalation-Cross-Coupling Nexus. Synthetic Methodology for Aryl-Aryl 
and Aryl-Heteroatom-Aryl Bonds, in Metal-Catalyzed Cross-Coupling Reactions, 2nd ed. (Eds.: F. Diederich, A. 
de Meijere) Wiley-VCH, Weinheim, 2004, pp 761-813; e) C. G. Hartung, V. Snieckus, The Directed ortho 
Metalation Reacton. A Point of Departure for new Synthetic Aromatic Chemistry, in Modern Arene Chemistry, 
(Ed.: D. Astruc), Wiley-VCH, New York, 2002, pp 330-367. 
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Scheme 16: Directed ortho-metalation using a DMG.  
 
The used DMG must possess special properties. On the one hand, it has to offer a good 
coordinating site for the used base but on the other hand it should not contain a good 
electrophilic site for the attack by the metal base or the formed organometallic intermediates. 
Therefore, heteroatoms are a nearly obligatory component in a DMG. Additionally, existing 
steric hinderance (R-CONEt2 or R1-P(O)NR2R3), charge deactivation (R-CON– or R-CSN–) or 
the combination of both effects may be found in DMGs. Substituent effects on the substrate 
also influence the rate of deprotonation, especially electron withdrawing groups may control 
the compound’s behavior during metalation reactions.35 
 
1.5. Catalytic Bond Activations for the Synthesis of Organometallics 
 
Catalyzed reactions are useful processes in organic chemistry. Numerous helpful and effective 
protocols have been developed until now. Most reactions deal with the formation of  new 
carbon-carbon bonds or tandem reactions using organometallic intermediates and/or 
catalysts.36 The synthesis of organometallics using catalytic conditions is less prominent due 
to limited long term stability of the formed products. An exception are organoboron-37 and 
organotin 38  reagents. Their Pd-catalyzed synthesis from aryl iodides were reported by 
Miyaura, Migita and Beletskaya. Moreover, the synthesis of organozinc reagents via a 
catalytic process was reported by Knochel. A Li(acac)-catalyzed preparation of zincorganyls 
                                                 
36
 a) Metal-catalyzed Cross-coupling Reactions (Eds.: A. de Meijere, F. Diederich), 2nd Ed., Wiley-VCH, 
Weinheim, 2004; b) Transition Metals for Organic Synthesis (Eds.: M. Beller, C. Bolm), 2nd Ed., Wiley-VCH, 
2004; c) Handbook of Functionalized Organometallics (Ed.: P. Knochel), Wiley-VCH, Weinheim, 2005; d) 
Modern Arylation Methods (Ed. L. Ackermann), Wiley-VCH, Weinheim, 2009. 
37
 T. Ishiyama, M. Murata, N. Miyaura, J. Org. Chem. 1995, 60, 7508. 
38
 M, Kosugi, K. Shiminu, A, Ohtani, T. Migita, Chem. Lett. 1981, 829; b) A. N. Kashin, I. G. Bumagina, N. A. 
Bumagin, V. N. Bakunin, I. P. Beletskaya, Zh. Org. Khim. 1981, 17, 905; c) M. Kosugi, T. Ohaya, T. Migita, 
Bull. Chem. Soc. Jpn. 1983, 56, 3855.  
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from aryl halides was developed in 2004 (Scheme 17).39 The reaction mechanism is assumed 
to be the following: in the first step, a mixed arylalkyl zinc reagent is formed which is 
converted into the diaryl zinc species after activation of the complex with the catalyst. The 
formed compounds can be further used in cross-coupling-, acylation- or allylation reactions.  
 
I
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ZnEt
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Et2Zn
Et-I
Zn
Et
acac
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Li acac
I
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Zn
FG 2Et-I
Li
CN
NO2
EtO2C
NCS
SnMe3
N
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O
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OHC
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CO2
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Scheme 17: Li-catalyzed I/Zn-exchange. 
 
Gosmini reported the synthesis of arylzincbromides via cobalt catalysis in the presence of zinc 
dust. After activation of the zinc with traces of acid, the catalyst is reduced and performs 
oxidative addition into the C-Br bond. Subsequent reduction and transmetalation of the 
arylcobalt species leads then to the desired zinc compounds in good yields (Scheme 18).40 
 
 
 
 
                                                 
39
 F. F. Kneisel, M. Dochnahl, P. Knochel, Angew. Chem. Int. Ed. 2004, 43, 1017.  
40
 a) C. Gosmini, Y. Rollin, J.-Y. Nédélec, J. Périchon, J. Org. Chem. 2000, 65, 6024; b) H. Fillion, E. Le Gall, 
C. Gosmini, J. Périchon, Tetrahedron Lett. 2002, 43, 5941; c) H. Fillion, C. Gosmini, J. Périchon, J. Am. Chem. 
Soc. 2003, 125, 3867; d) I. Kazmierski, M. Bastienne, C. Gosmini, J.-M. Paris, J. Périchon, J. Org. Chem. 2004, 
69, 936; e) J.-M. Bégouin, C. Gosmini, J. Org. Chem. 2009, 74, 3221. 
GENERAL INTRODUCTION 
 27 
 
Scheme 18: Mechanism of the Co-catalyzed preparation of arylzinc reagents. 
 
Both reactions have excellent functional group tolerance (aldehydes, esters, nitriles or 
isothiocyanates) but they require the use of expensive aryl bromides or iodides. In a multi-step 
sequence, the conversion of a phenol to a reactive organometallic may be achieved, however 
with moderate atom economy.41  
                                                 
41
 a) OH→OTf→SnR3: R. C. Winstead, T. H . Simpson, G. A. Lock, M. D. Schiavelli, D. W. Thompson, J. Org. 
Chem. 1986, 51, 277; b) ArOH→ArOTf/ArOMs→ArZnX: I. Kazmiersi, C. Gosmini, J.-M. Paris, J. Perichon, 
Synlett 2006, 881; c) for a review see: J. K. Stille, Angew. Chem. Int. Ed. Engl. 1986, 25, 508. 
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1.6. Objectives 
 
The first topic includes the development of a highly active magnesium amide base which is 
able to deprotonate unreactive substrates such as benzoates or benzonitriles. Despite the 
higher reactivity, the new tool should have the same functional group compatibility as 
TMPMgCl·LiCl. The metalation reactions should be easy to handle and the formed Mg-
intermediates should show a certain stability to undergo typical interception reactions 
(Scheme 19). 
 
 
Scheme 19: General pathway for the magnesiation of a poorly activated benzoate. 
 
In addition thereto, a directed metalation group (DMG) should be combined with the new 
base. This group should allow multiple selective metalations without stability problems in 
these reactions. In the end, easy removal and/or further conversion of this group is desirable 
(Scheme 20). 
 
 
Scheme 20: Directed metalation using a new Mg-amide base in combination with a new DMG. 
 
Additionally, different sterically demanding amines should be tested if they are able to replace 
TMP-H as this is the most expensive component in the base. These amines should be easy to 
prepare from inexpensive bulk chemicals (Scheme 21). 
 
 
Scheme 21: General reaction pathway for  the synthesis of alternative sterically hindered amines. 
 
The second part includes the development of a new a catalyzed activation of the carbon-
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oxygen bond in phenol derivatives. This pathway should give an access to organometallic 
reagents without the necessity of halogens in the molecule (Scheme 22).  
 
 
 
Scheme 22: Transition metal-catalyzed bond activation. 
  30 
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3. Magnesiations on Weakly Activated Substrates via 
Stoichiometric C-H Bond Activation 
3.1. Preparation and use of Magnesium bis-amide Bases 
 
 
As mentioned in above, the directed metalation of aromatics and heteroaromatics is a very 
important tool for the functionalization of these scaffolds. Directed lithiations are affected (as 
mentioned above) by serveral problems (high reactivity, low functional group tolerance, 
required cryogenic conditions). Directed magnesiations using mixed Li/Mg-amide bases of 
the type R1R2NMgX·LiCl were used to adress these problems.30 However, some weakly 
activated substrates, such as benzoates, benzonitriles or pyridines only undergo magnesiations 
sluggishly or not at all. By developing TMP2Mg and using it for the deprotonation of methyl 
benzoate, Eaton pointed in the right direction. Though, his reagent suffered from low 
solubility and a large excess of the base was needed to accomplish full magnesiation. 
Additionally, a large excess of electrophile had to be used in the quenching reaction (up to 12 
equiv). 28 Again, deaggregation of the base is achived by the formal addition of two molecules 
of LiCl. Therefore, this new class of mixed Mg/Li bases was able to brigde this gap: 
(R1R2N)2Mg·2LiCl. The reagents 14a-c were readily prepared by reacting R1R2NLi with 
MgCl2 in THF at 0 °C for 0.5 h Alternatively, it was found that these bases can also be 
conveniently prepared by reacting R1R2NMgCl·LiCl with R1R2NLi42 for 30 min at 0 °C. 
Since R1R2NMgCl·LiCl bases can be stored in THF at 25 °C for several months, this method 
appears to be the best for routine experiments. (Scheme 23).  
 
 
 
 
 
                                                 
42
 For a review of the chemistry of LiTMP, see: M. Campbell, V. Snieckus in Encyclopedia of Reagents for 
Organic Synthesis; (ed.: L. A. Paquette), John Wiley & Sons: Chichester, U.K. and New York, 1995; Vol. 5. 
About stability of lithium amide bases in ether solvents see: I. E. Kopka, Z. A. Fataftah, M. W. Rathke, J. Org. 
Chem. 1987, 52, 448. 
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Scheme 23: General reaction pathway for the preparation of bases of type ((R1R2N)2Mg·2LiCl. 
 
Whereas with TMPMgCl·LiCl (10a) no significant deprotonation of 13a-c was observed, the 
use of magnesium bisamides complexed with 2 equivalents of LiCl such as 14a-c led to 
excellent results  (Scheme 24). TMP2Mg·2LiCl (14a) proved to be the most powerful base.43  
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Scheme 24. Comparison between the different Mg-amide bases.44 
 
The best results were obtained when base 14a was freshly prepared as its activity decreased 
significantly after 24 h. Surprisingly, [tBu(iPr)]2Mg·2LiCl (14c) can be stored in THF at 4 °C 
for 3 weeks with no significant reduction of activity (see chapter 3.4. for further results). 
                                                 
43
 For the use of ate Bases see: a) H. Naka, M. U. Uchiyama, Y. Matsumoto, A. E. H, Wheatley, M. McPartlin, J. 
V. Morey, Y. Kondo, J. Am. Chem. Soc. 2007, 129, 1921; b) Y. Kondo, M. Shilai, M. Uchiyama, T. Sakamoto, J. 
Am. Chem. Soc. 1999, 121, 3539; c) M. Uchiyama, T. Miyoshi, T. Sakamoto, Y. Otani, T. Ohwada, Y. Kondo, J. 
Am. Chem. Soc. 2002, 124, 8514; d) M. Uchiyama, H. Naka, Y. Matsumoto, T. Ohwada, J. Am. Chem. Soc. 2004, 
126, 10526. 
44
 Experments were done by G. C. Clososki and are given here for the sake of completeness. 
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Therefore, a number of aromatic and heterocyclic substrates were cleanly metalated with 
TMP2Mg·2LiCl (14a; Table 1). Thus, tert-butyl benzoate (13a) was converted into the ortho-
magnesiated intermediate by the reaction with TMP2Mg·2LiCl (14a) within 1 h at 25 °C. The 
magnesiated intermediate was smoothly transmetalated with ZnCl2 (1.2 equiv) and underwent 
a Negishi cross-coupling1,45 with ethyl 4-iodobenzoate (1.5 equiv), in the presence of P(2-
furyl)3 (4 mol%) and Pd(dba)2 (2 mol%)46 at 25 °C for 12 h, leading to the biphenyl derivative 
15d in 82% yield (Table 1, entry 1). Additionally, reaction of TMP2Mg·2LiCl (1.2 equiv) with 
ethyl 1-naphthoate (13b) led to the corresponding Mg-reagent within 5 h at 0 °C a subsequent 
Negishi-type44, 45 cross-coupling with 4-iodo benzonitrile afforded the corresponding 
functionalized derivative 15e in 81% yield (entry 2). The presence of an electron-withdrawing 
group such as a bromine substituent in the case of tert-butyl 4-bromobenzoate (13d) 
accelerated the metalation, furnishing the magnesiated product within 1 h at –20 °C. A 
copper(I)-mediated benzoylation 47  gave the corresponding tert-butyl 2-benzoyl-4-
bromobenzoate (15f) in 77% yield (entry 3). Whereas benzonitriles are sluggishly metalated 
with TMPMgCl·LiCl (10a), the use of 14a (1.2 equiv) led to a smooth magnesiation of 
benzonitrile (13e) within 3 h at –30 °C. Transmetalation (ZnCl2) followed by a cross-coupling 
with ethyl 4-iodobenzoate afforded the corresponding functionalized biphenyl derivative 15g 
in 70% yield (entry 4). Ester-substituted pyridines are also excellent substrates and the diester 
13f was converted to the corresponding 2-magnesiated pyridine (–40 °C, 5 h), which provided 
after bromolysis with (BrCl2C)2 or Negishi cross-coupling with 4-iodobenzonitrile the 
expected polyfunctional pyridines 15h-i in 70-77% yield (entries 5, 6). Similarly ethyl 
isonicotinate (13g) reacted smoothly with 14a (–40 °C, 12 h) leading after iodolysis to the 3-
iodopyridine 15j in 66% yield (entry 7). 
                                                 
45
 a) E. Negishi, L. F. Valente, M. Kobayashi, J. Am. Chem. Soc. 1980, 102, 3298; b) E. Negishi, J. Org. Chem. 
1980, 45, 5223; c) E. Negishi, Acc. Chem. Res. 1982, 15, 340; for Pd-catalyzed Kumada-Corriu cross-coupling 
reactions see: d) R. Martin, S. L. Buchwald, J. Am. Chem. Soc. 2007, 129, 3844. 
46
 a) V. Farina, B. Krishnan, J. Am. Chem. Soc. 1991, 113, 9585; b) V. Farina, S. Kapadina, B. Krishnan, L. S. 
Liebeskind, J. Org. Chem. 1994, 59, 5905; c) I. Klement, M. Rottländer, C. E. Tucker, T. N. Majid, P. Knochel, 
Tetrahedron 1996, 52, 7201.   
47
 P. Knochel, M. C. P. Yeh, S. C. Berk, J. Talbert, J. Org. Chem. 1988, 53, 2390. 
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Table 1: Products of type 15 obtained after magnesiation with TMP2Mg·2LiCl (14a) and subsequent reaction with an 
electrophile.  
Entry Substrate T [°C], t [h] Electrophile Product/Yield [%]a 
 
CO2tBu
 
 
 
 
1 13a 25, 1  15d: 82c 
 
 
 
 
 
2 13b 0, 5  15e: 81c 
 
 
 PhCOCl 
 
3 13d –20, 1  15f: 77b 
 
CN
 
 
 
 
4 13e –30, 3  15g: 70c 
 
 
 (BrCl2C)2 
 
5 13f –40, 3  15h: 70 
   
 
 
6 13f –40, 3  15i: 73c 
 
N
CO2Et
 
 I2 
 
7 13g –40,12  15j: 66 
aIsolated yield of analytically pure product; b A transmetalation with CuCN·2LiCl (20 mol%) was performed; cObtained by 
palladium-catalyzed cross-coupling after transmetalation with ZnCl2 (1.2 to 1.3 equiv). 
 
The metalating power of 14a was used in the short synthesis of 6-hexylsalicylic acid (16d), a 
natural product, found in the extract of Pelargonium sidoides DC.48 In the first step, the 
acetonide 16a was magnesiated with 14a at –40 °C within 10 min. The arylmagnesium 
compound 16b was then transmetalated with ZnCl2 and subsequently used in a cross-coupling 
reaction45, 46 with the iodo alkene 17 leading to the functionalized arene 16c in 77% yield. The 
final product 16d was obtained after hydrogenation of the double bond in the presence of 
catalytic amounts of Pd/C followed by the cleavage of the acetonide, furnishing 6-
                                                 
48
 a) O. Kayser, K. Lattè, H. Kolodziej, F.-J. Hammerschmidt, Flavour Fragrance J. 1998, 13, 209. 
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hexylsalicylic acid in 89% yield (Scheme 25).49 
 
 
Scheme 25: Synthesis of 6-hexylsalicylic acid (16d). 
 
The base 14a was also used, to bypass problems in the synthesis of fully functionalized 
pyrrazoles. 50  The metalations on position C3 and C5 were readily performed using 
TMPMgCl·LiCl (10a) whereas the remaining C4 position proved to be inert to this base, 
TMP2Mg·2LiCl had to be used to achieve the functionalization of this site. Similarly, the full 
functionalization of 2,4-bis(methyl)thio pyrimidine was only possible when using the highly 
active base TMP2Mg·2LiCl (14a) (Scheme 26).51 
 
 
Scheme 26: Functionalizations of N-heterocycles using TMP2Mg·2LiCl. 
 
 
 
                                                 
49
 Experments were done by G. C. Clososki and are given here for the sake of completeness. 
50
 C. Despotopoulou, L. Klier, P. Knochel, Org. Lett. 2009, 11, 3326. 
51
 M. Mosrin, N. Boudet, P. Knochel, Org. Biomol. Chem. 2008, 6, 3237. 
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3.2. Scale-up Experiments  
 
The above described experiments were mainly conducted on small scale (up to 2 mmol). To 
demonstrate that the reagent 14a is able to provide the magnesiated arenes even on larger 
scale in a satisfying yield some scale-up experiments were conducted. The base 14a was 
prepared as usual and the substrate was added direcly into the solution omitting additional 
solvent for economic and kinetic reasons. Thus, ethyl benzoate 13h was reacted with 14a at 
25 °C giving the magnesiated species after 45 min. After a transmetalation using ZnCl2 in 
THF, a Negishi cross-coupling reaction with 4-bromotoluene in the presence of Pd(OAc)2 (0.5 
mol%) and RuPHOS (1.0 mol%)52 was performed and gave the biphenyl 15k in 71% yield. 
The introduction of an additional ester was achieved by reacting the magnesiated ethyl 
benzoate with Boc2O, yielding the diester 15l in 65% (Scheme 27).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                 
52
 J. E. Milne, S. L.  Buchwald, J. Am. Chem. Soc. 2004, 126, 13028. 
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Scheme 27: Scale-up Experiments using TMP2Mg·2LiCl. 
 
Furthermore, the magnesiation of di-tert-butyl isophthalate (13i) using TMP2Mg·2LiCl (14a; 
1.1 equiv) was complete within 45 min at 25 °C (compared to 1 h for 2 mmol scale). 
Subsequently, after transmetalation with ZnCl2 (90 mL, 1.1 equiv) a Pd-catalyzed cross-
coupling reaction with 4-bromobenzonitrile (1.0 equiv) using Pd(OAc)2 (0.5 mol%) and 
RuPHOS (1.0 mol%)52 as catalytic system provided the functionalized biaryl 15m in 75% 
yield. Additionally, the complete metalation of ethyl 1-naphthoate (13b; 18.0 g) was obtained 
within 45 min at 25 °C using TMP2Mg·2LiCl (14a compared to 1 h for 2 mmol scale 
reactions) by applying this large scale protocol. After quenching with Boc2O (1.4 equiv), the 
desired mixed diester 15h was isolated in 69% yield (Scheme 27). For economic reasons the 
recycling of TMPH was examined as it is used in large quantities in these reactions. A slightly 
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modfied workup allows the recovery of up to 75% of the TMP-H used.   
 
3.3. Formal meta- and para-Functionalizations 
 
As shown above, the directed ortho metalation is an important method for the 
functionalization of various arenes and heterocycles. Various directed-metalation groups 
(DMGs) have been used for achieving efficient lithiations. DMGs mediate fast and ortho 
selective metalation mainly by chelation (entropic effect). Polar DMGs may furthermore 
transfer electron density to the metal base and increase their metalating power.35 During the 
studies on TMP2Mg·2LiCl (14a) (see preceeding chapter) the demand for a new, stable 
protecting group for phenols, which is at the same time a DMG, arose. In the course of these 
studies, it was observed that the DMG N,N,N’,N’-tetramethylphosphorodiamidate 
(OP(O)(NMe2)2)53 is a very strong directing group for magnesiation and that it may overrule 
the effects of other directing substituents present on the aromatic substrate. In contrast to 
directed lithiations which are usually performed at –105 °C to avoid Fries-type 
rearrangements,53 the magnesiation with TMP2Mg·2LiCl (14a) occurs (even at 0 °C) without 
anionic migration of the tetramethylphosphorodiamidate group. This would allow new types 
of functionalization such as formal meta-54 or para-functionalization (Scheme 28).  
 
 
 
 
 
 
 
 
 
 
                                                 
53
 a) M. Watanabe, M. Date, K. Kawanishi, M. Tsukazaki, S. Furukawa, Chem. Pharm. Bull. 1989, 37, 2564; b) 
R. E. Ireland, D. C. Muchmore, U. Hengartner, J. Am. Chem. Soc. 1972, 94, 5098; c) D. Seebach, J.-J. Lohmann, 
M. A. Syfrig, M. Yoshifuji, Tetrahedron 1983, 39, 1963; d) J. H. Näsman, N. Kopola, G. Pensar, Tetrahedron 
Lett. 1986, 27, 1391; e) M. Watanabe, M. Date, K. Kawanishi, M. Tsukazaki, S. Furukawa, Chem. Pharm. Bull. 
1990, 37, 2637; e) M. P. Sibi, V. Snieckus, J. Org. Chem. 1983, 48, 1935; f) O. Middel, Z. Greff, N. J. Taylor, 
W. Verboom, D. N. Reinhoudt, V. Snieckus, J. Org. Chem. 2000, 65, 667. 
54
 a) P. C. Andrikopoulos, D. R. Armstrong, D. V. Graham, E. Hevia, A. R. Kennedy, R. E. Mulvey, C. T. O’ 
Hara, C. Talmard, Angew. Chem. Int. Ed. 2005, 44, 3459; b) D. R. Armstrong, W. Clegg, S. H. Dale, E. Hevia, L. 
M. Hogg, G.W. Honeyman, R. E. Mulvey, Angew. Chem. Int. Ed. 2006, 45, 3775. 
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Scheme 28: Formal meta- and para-functionylization of arenes.  
 
It was found that a range of aromatic phosphorodiamidates bearing a functional group (FG) 
either in the para position (type 18) or in the meta position (type 21) underwent efficient 
magnesiation with TMP2Mg·2LiCl (14a) leading to products of type 19 and 22, respectively, 
after the addition of an electrophile. Substitution of the OP(O)(NMe2)2 group with a 
nucleophile (Nu) should then yield meta, para- and para, meta-difunctionalized molecules of 
the type 20 and 23 as described below (Scheme 28 and Table 2). The magnesiation of 
substrates of type 18 and 21 using TMP2Mg·2LiCl (14a) proceeds smoothly within a few 
hours at 0 °C for cyano- and ester-substituted phosphorodiamidates 18a and 21a (entries 1-3, 
10-13). For halogen-substituted starting materials (18b, 3c and 18d; entries 4-9) as well as for 
the trifluoromethyl-substituted phosphorodiamidate 21b (entry 13), lower temperatures (–40 
to –50 °C) led to optimum results. In general, the regioselectivity of the metalation of 
aromatics is governed by a combination of electronic and/or sterical effects.25, 35 However, the 
tetramethylphosphorodiamidate group is one of the strongest donor in organic synthesis55 and 
kinetically activates the Mg-N bond giving to the base an additional ate character (Scheme 
29).25, 56  
 
 
 
 
 
                                                 
55
 a) C. A. Hunter, Angew. Chem. Int. Ed. 2004, 43, 5310; b) C. Reichardt, Solvents and Solvent Effects in 
Organic Chemistry, Wiley-VCH, Weinheim, 2002. 
56
 a) A. Inoue, K. Kitagawa, H. Shinokubo, K. Oshima, J. Org. Chem. 2001, 66, 4333; b) J. Kondo, A. Inoue, H. 
Shinokubo, K. Oshima, Angew. Chem. Int. Ed. 2001, 40, 2085. 
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Scheme 29: Sugested mechanism of the meta- and para-metalation. 
 
This electronic effect increases the metalation power of the base and no additional chelation 
or inductive effects are necessary for achieving the magnesiation. Normally, this 
phosphorodiamidate-triggered magnesiation preferentially occur at the sterically less hindered 
position of the aromatic ring promoting formal meta-metalation. However, in the case of 
meta-substituted substrates bearing bromo, chloro and fluoro atoms as one of the functional 
groups, it was observed that the regioselectivity of the metalation is affected 57  by the 
competitive directing effects of these halogens. Various electrophiles such as acid chlorides, 
TsCN, allylic halides, aldehydes or aromatic iodides reacted with the magnesium 
organometallic intermediates providing the desired products of type 19 or 22 in 72 to 90% 
yields (Table 2). In the case of allylation and acylation reactions, the best results were 
obtained when the arylmagnesium species were transmetalated with ZnCl2 (1.2 equiv) and 
CuCN·2LiCl47 (0.5 – 1.3 equiv) prior to the addition of the acid chloride, TsCN or the allylic 
halide (entries 2-4, 7, 8 and 12). Similarly, Negishi cross-couplings45 with aryl iodides in the 
presence of Pd(dba)2 (2 mol%) and P(2-furyl)3 (4 mol%)46 were successfully performed after 
transmetalation of the Grignard-reagents with ZnCl2 (entries 1, 5, 6 and 13). The 
phosphorodiamidate 21c derived from 3-iodophenol was smoothly magnesiated within 0.5 h 
at 0 °C without the occurence of halogen dance reactions. Bromolysis of the Mg-reagent gave 
the double halogenated arene 22e in 76% yield (entry 14).  
                                                 
57
 Magnesiation of the phosphorodiamidate prepared from 3-bromophenol gave after iodolysis a mixture of 5-
bromo-2-iodophenyl- (44% yield) and 3-bromo-2-iodophenyl-N,N,N’,N’-tetramethyldiamidophosphate (43% 
yield). For the 3-chlorophenolderivative, a mixture of 5-chloro-2-iodophenyl- (29% yield) and 3-chloro-2-
iodophenyl-N,N,N’,N’-tetramethyldiamidophosphate (57% yield) was obtained. Moreover, metalation of the 3-
fluorophenol derivative gave exclusively after iodolysis the 3-fluoro-2-iodophenyl-N,N,N’,N’-
tetramethyldiamidophosphate in 73% yield. 
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Table 2: Products of Type 19 or 22 obtained after Magnesiation with TMP2Mg·2LiCl (14a) and Subsequent Reaction with an 
Electrophile.  
Entry Substrate T [°C], t [h] Electrophile Product/Yield [%]a 
 
CN
O
(Me2N)2P
O
 
 
 
 
1 18a 0, 1  19a: 83c 
   TsCN 
CN
O
(Me2N)2P
O
CN
 
2 18a 0, 1  19b: 77 
   
 
 
3 18a 0, 1  19c: 84b 
 
Br
O
(Me2N)2P
O
 
 tBuCH2COCl 
 
4 18b –50, 7  19d: 72b 
 
F
O
(Me2N)2P
O
 
 
 
 
5 18c –40, 4  19e: 78c 
   
 
F
O
(Me2N)2P
O Me
 
6 18c –40, 4  19f: 75c 
   
Br
 
F
O
(Me2N)2P
O
 
7 18c –40, 4  19g: 85b 
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Table 2 (continued) 
Entry Substrate T [°C], t [h] Electrophile Product/Yield [%]a 
 
Cl
O
(Me2N)2P
O
 
 PhCOCl 
Cl
O
(Me2N)2P
O
COPh
 
8 18d –40, 1.5  19h: 85b 
   tBuCHO 
Cl
O
(Me2N)2P
O
OH
tBu
 
9 18d –40, 1.5  19i: 79 
 
 
 (BrCl2C)2 
 
10 21a 0, 1  22a: 80 
   PhCOCl 
 
11 21a 0, 1  22b: 73b 
   
 
CO2Et
O
P(NMe2)2
O
CO2Et
 
12 21a 0, 1  22c: 78c 
 
 
 I2 
 
13 21b –40, 2  22d: 88 
 
 
 (BrCl2C)2 
 
14 21c 0, 0.5  22e: 76 
 a
 Isolated yield of analytically pure product; b A transmetalation with ZnCl2 (1.1 equiv) and CuCN·2LiCl (0.5 - 1.3 equiv) was 
performed; c Obtained by a palladium-catalyzed cross-coupling after transmetalation with ZnCl2 (1.1 equiv). 
 
A double functionalization in meta, meta’-positions has also been achieved. Thus, the 
treatment of the nitrile 18a with TMP2Mg·2LiCl (14a; 1.1 equiv, 0 °C, 4 h) followed by a 
copper(I)-catalyzed reaction47 with tBuCOCl provided the ketone 19j in 81% yield. By 
applying the same reaction sequence (metalation at –60 °C for 0.5 h), the ketone 19j was 
converted to the diketone 24a in 77% yield.  
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Br
O
(Me2N)2P
14a (1.1 equiv),
-50 °C, 7 h
ZnCl2, -40 °C, 15 min
Pd(dba)2 (2 mol%)
P(o-furyl)3 (4 mol%)
pIC6H4CN, -40 °C
to 25 °C, 12 h
Me
Br
Br
O
(Me2N)2P CN
Me
24b: 77%
Cl
O
(Me2N)2P
Cl
O
tBuOC
OMe
24c: 82%
18b
18d
(Me2N)2P
Br
O
(Me2N)2P CN
Cl
O
(Me2N)2P OMe
14a (1.1 equiv),
-60 °C, 0.5 h
ZnCl2, -40 °C, 15 min
CuCN·2LiCl (cat.), -40 °C
to 25 °C, 12 h
14a (1.1 equiv),
-40 °C, 1.5 h
ZnCl2, -40 °C, 15 min,
Pd(dba)2 (2 mol%)
P(o-furyl)3 (4 mol%)
pIC6H4OMe, -40 °C
to 25 °C, 12 h
19k: 83%
19l: 90%
14a (1.1 equiv),
-60 °C, 4 h
ZnCl2, -40 °C, 15 min
CuCN·2LiCl (cat.)
tBuCOCl, -40 °C
to 25 °C, 12 h
CN
O
CN
O
24a: 77%18a
COtButBuOC
(Me2N)2P(Me2N)2P
CN
O
COtBu
(Me2N)2P
14a (1.1 equiv),
0 °C, 1 h
ZnCl2, -40 °C, 15 min
CuCN·2LiCl (cat.)
tBuCOCl, -40 °C
to 25 °C, 12 h
14a (1.1 equiv),
-60 °C, 0.5 h
ZnCl2, -40 °C, 15 min
CuCN·2LiCl (cat.)
tBuCOCl, -40 °C
to 25 °C, 12 h
19j: 81%
O O O
O O O
O O O
 
Scheme 30: meta, meta’-functionalization. 
 
Furthermore, the double functionalization of the bromo- and chloro-substituted 
phosphorodiamidates 18b and 18d led to the preparation of the highly functionalized 
phosphorodiamidates 24b and 24c in good overall yields showing the high directing power of 
the OP(O)(NMe2)2 group (Scheme 30).  
The further manipulation of the functionalized aryl phosphorodiamidates of type 19 and 22 
was best achieved by converting these intermediates into nonaflates.58 
 
 
 
 
 
 
                                                 
58
 a) M. Piber, A. E. Jensen, M. Rottländer, P. Knochel, Org. Lett. 1999, 1, 1323; b) M. Rottländer, P. Knochel, J. 
Org. Chem. 1998, 63, 203; c) A. Gavryushin, C. Kofink, G. Manolikakes, P. Knochel, Tetrahedron 2006, 62, 
7521; for a recent application of aryl nonaflates in palladium-catalyzed amination reactions see: d) R. E. Tundel, 
K.W. Anderson, S. L. Buchwald, J. Org. Chem. 2006, 71, 430; e) K.W. Anderson, M. Mendez-Perez, J. Priego, 
S. L. Buchwald, J. Org. Chem. 2003, 68, 9563. 
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Scheme 31: Replacement of the DMG and further functionalization. 
 
Thus, a microwave assisted deprotection of the aryl phosphorodiamidates 19j and 19n with 
formic acid in aqueous ethanol (120 °C, 30 min) provided polyfunctional phenols, which after 
the reaction with C4F9SO2F (NaH, Et2O, 25 °C, 12 h) allowed the isolation of the 
corresponding nonaflates 19m and 19o in 71% yield (Scheme 31). A nickel-catalyzed cross-
coupling of nonaflate 19m with an arylzinc reagent afforded the biphenyl 20a in 90% yield. 
On the other hand, reaction of 19o with dimethylamine-borane complex in the presence of 
catalytic amount of Pd(PPh3)459  gave the reduced derivative 20b in 94% yield. Similarly, the 
aryl phosphorodiamidate 22b was successfully converted to the diester 23a and to the 
ketoester 23b in 74% and 95% yield respectively, showing that this reaction sequence allows 
either efficient functionalization or removal of the directing metalation group (Scheme 31). 49 
 
                                                 
59
 a) B. H. Lipshutz, D. J. Buzard, R.W. Vivian, Tetrahedron Lett. 1999, 40, 6871; for a recent protocol for the 
reduction of aryl sulfonates see: b) B. H. Lipshutz, B. A. Frieman, T. Butler, V. Kogan, Angew. Chem. Int. Ed. 
2006, 45, 800. 
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3.4. Regioselective Metalations on N-Heterocycles 
3.4.1. Metalations on Pyridines, Quinolines and Quinoxalines 
  
Heteroaromatics are important scaffolds in medicinal chemistry.60  Especially skeletons of 
quinolines, pyridines and quinoxalines are often found in modern pharmaceuticals such as the 
quinoline based NK3 receptor antagonist Talnetant61 (25; GSK), the pyridine based COX-2 
inhibitor Etoricoxib62 (26; Arcoxia®, Merck) or the quinoxaline based tachykinin receptor 
antagonist63 (27; Mitsubishi Tanabe Pharma) (Figure 1).  
 
 
Figure 1: Pharmaceuticals containing a quinoline, pyridine or quinoxaline skeleton. 
 
Lithiations and magnesiations of these scaffolds using either halogen/metal exchange64 or 
directed metalation65 have been reported. Lithiations suffer from a lack of regioselectivity 
even when carried out at low temperatures (see chapter 3). The formed organometallic 
reagents are also prone to undergo electrophilic subtitution reactions at the C2 position. 
Recently, it was reported that the use of TMP derived bases allow the efficient magnesiation 
or zincation (see chapter 1.4.2. & 3.1) of functionalized aromatics and heteroaromatics. It has 
                                                 
59
 a) A. F. Pozharskii, A. T. Soldatenkov, A. R. Katritzky, Heterocycles in Life and Society; John Wiley & Sons: 
Weinheim, 1997; b) P. Wipf, Z. Wang, Org. Lett. 2007, 9, 1605. 
61
 a) G. A. M. Giardina, L. F. Raveglia, M. Grugni, H. M. Sarau, C. Farina, A. D. Mendhurst, D. Graziani, D. B. 
Schmidt, R.  Rigolio, M. Luttmann, S. Cavagnera, J. J. Foley, V. Vecchietti, D. W. P. Hay, J. Med. Chem. 1999, 
42, 1053; b) J. M. Elliot, R. W. Carling, M. Chambers, G. C. Chicchi, P. H. Hutson, B. A. Jones, A. MacLeod, R. 
Marwood, G. Meneses-Lorente, E. Mezzogori, F. Murray, M. Rigby, I. Royo, M. G. N. Russel, B. Sohal, K. L. 
Tsao, B. Williams, Bioorg. Med. Chem. Lett. 2006, 16, 5748. 
61
 a) L. A. Sorbera, R. M. Castaner, J. Silvestre, J. Castaner, Drugs Fut. 2001, 26, 346; b) R. W. Firesen, C. 
Brideau, C. C. Chan, S. Charleson, D. Deschêmes D. Dubé, D. Eithier, R. Fortin, J. Y. Gauthier, Y. Girard, R. 
Gordon, G. M. Greig, D. Riendeau, C. Savoie, Z. Wang, E. Wong, D. Visco, L. J. Xu, R. N. Young, Bioorg. Med. 
Chem. Lett. 1998, 8, 2777; c) D. Dubé, C. Brideau, D. Deschêmes, R. Fortin, R. W. Friesen, R. Gordon, Y. 
Girard, D. Riendeau, C. Savoie, C.-C. Chan, Bioorg. Med. Chem. Lett. 1999, 9, 1715. 
63
 M. Takahashi, M. Sugahara, H. Mizuuchi, A. Saito, T. Ishii, PCT Int. Appl. 2002028853 A1, 2002. 
64
 a) D. L. Comins, J. M. I. Nolan, D. Bori, Tetrahedron Lett. 2005, 46, 6697; b) S. Dumouchel, F. Mongin, F. 
Trécourt, G. Quéguiner, Tetrahedron Lett. 2003, 44, 2033; c) H. Ren, P. Knochel, Chem. Comm. 2006, 726 and 
references therein. 
65
 For reviews, see: a) R. Chinchilla, C. Nájera, M. Yus, Chem. Rev. 2004, 104, 2667; b) F. Chevallier, F. 
Mongin, Chem Soc. Rev. 2008, 37, 595.  
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also been investigated that the use of the N,N,N’,N’-tetramethylphosphorodiamidate group is a 
strong DMG and allows fast and selective magnesiations of aromatics with unusual 
regioselectivity (see preceeding chapter). The metalations of pyridines, quinolines and 
quinoxalines using TMPMgCl·LiCl (10a), TMP2Mg·2LiCl (14a) and TMP2Zn·2MgCl2·2LiCl 
(12a) combined with the -P(O)(NMe2)2 DMG has also been studied. Thus, the 
phosphorodiamidate 28a (derived from 2-pyridinol) reacted with TMPMgCl·LiCl (10a) at 0 
°C within 1 h and gave exclusively the 3-magnesiated heterocycle which reacted after 
transmetalation to zinc in a Negishi cross-coupling reaction in the presence of Pd2(dba)3 
(1 mol%) and RuPHOS (2 mol%)52 with 4-bromo thiomethylbenzene giving the biaryl 29a in 
74% yield (Table 3, entry 1). The phosphorodiamidate 28b synthesized from 3-hydroxy 
pyridine was best metalated at 25 °C using 12a. Deprotonations with TMPMgCl·LiCl (10a) or 
TMP2Mg·2LiCl (14a) resulted in lower yields, even when carried out at low temperatures (–
20 to –50 °C). Thus, the pyridine 28b was zincated selectively in position 4 at 25 °C within 1 
h using TMP2Zn·2MgCl2·2LiCl (12a). The formed zinc reagent was quenched in a cross-
coupling reaction using either 4-iodophenyl triflate or 4-chloro iodobenzene with a Pd-
catalyst yielding the 4-arylated pyridines 29b and 29c in 79-88% yield (entries 2, 3; see 
appendix for a x-ray structure of 29b). An allylation of the zinc reagent was achieved with 3-
bromo-2-methylpropene in in the presence of CuCN·2LiCl (10 mol%)47 furnishing the 
allylated pyridine 29d in 74% yield (entry 4). Moreover, a chlorination in position 3 was 
obtained by metalating the pyridine 28c using 10a (0 °C, 1 h). After addtition of 1,1,2-
trichlorotrifluoro ethane, the desired 3-chloro pyridine 29e was isolated in 83% yield (entry 5). 
The magnesium reagent also reacted with S-methyl methanesulfothionate and gave the 
thioether 29f in 88% yield (entry 6).  
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Table 3: Pyridines of type 29 obtained after metalation with TMPMgCl·LiCl (10a) or TMP2Zn·2MgCl2·2LiCl (12a) and subsequent 
reaction with an electrophile. 
Entry Substrate T [°C] , t [h] E+ Product/Yield [%]a 
 
 
 
 
 
1 28a 0, 1  29a: 74b, d 
 
 
 
 
N
OP(O)(NMe2)2
OTf
 
2 28b 25, 1  29b: 88c, e 
 
 
 
 
N
OP(O)(NMe2)2
Cl
 
3 28b 25, 1  29c: 79c, e 
 
 
 
 
 
4 28b 25, 1  29d: 74c, f 
 
N
O
P(NMe2)2
O
 
 
C2Cl3F3 
N
O
P(NMe2)2
O
Cl
 
5 28c 0, 1  29e: 83b 
 
 
 
MeSSO2Me 
N
O
P(NMe2)2
O
MeS
 
6 28c 0, 1  29f: 88b 
aYield of isolated, analytically pure product; bTMPMgCl·LiCl (1.5 equiv) was used; cTMP2Zn·2MgCl·2LiCl (0.75 equiv) was used; 
dObtained by Pd-catalyzed cross-coupling reaction after transmetalation with ZnCl2 (1.6 equiv) using Pd2(dba)3 (1 mol%) and 
RuPHOS (2 mol%) as catalyst; eObtained by Pd-catalyzed cross-coupling reaction using Pd(dba)2 (5 mol%) and P(2-furyl)3 (10 
mol%) as catalyst; fA transmetalation with CuCN·2LiCl (10 mol%) was performed. 
 
Furthermore, the phosphorodiamidate 30a derived from 2-hydroxyquinoline was magnesiated 
regioselectively in position 3 and then thioethylated with EtSSO2Ph66 yielding the thioether 
                                                 
66
 A. H. Stoll, A. Krasovskiy, P. Knochel, Angew. Chem. Int. Ed. 2006, 45, 606. 
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31a in 85% (Table 4, entry 1). Remarkably, magnesiations at the 3 position of the quinoline 
without abstracting the kinetically more active proton at the C2 position were also possible. 
Thus, the quinoline 30b was smoothly deprotonated with TMPMgCl·LiCl (10a) at 0 °C 
within 1 h. The generated magnesium reagent was then transmetalated with ZnCl2 and 
subsequently used in an acylation reaction with pivaloyl chloride in the presence of 
CuCN·2LiCl (10 mol%)47 giving the heteroaromatic ketone 31b in 62 % yield (entry 2). A 
cross-coupling reaction with the Zn-reagent derived from 30b with ethyl 4-iodobenzoate in 
the presence of a Pd-catalyst furnished the 3-arylated quinoline 31c in 83% yield (entry 3). 
Moreover, the regioselective functionalization of the C7 was possible using this protocol. 
Thus, the 2-chloroquinoline derivative 30c was readily magnesiated with TMPMgCl·LiCl 
(10a) at 0 °C in 1 h. A transmetalation with ZnCl2 in THF followed by the addition of 
methallyl bromide in the presence of CuCN·2LiCl (10 mol%)47 led to the allylated product 
31d in 87% yield (entry 4). The addition of 4-chloro benzoyl chloride under the same 
conditions furnished the ketone 31e in 74% yield (entry 5). The 2-bromoquinoline 30d also 
underwent a smooth magnesiation at 0 °C with the base 10a. After transmetalation to zinc, a 
cross-coupling reaction with the (4-iodophenoxy)(triisopropyl)silane in the presence of 
Pd(dba)2 (5 mol%) and P(2-furyl)3 (10 mol%)45, 46 led to the phenylated bromoquinoline 31f 
in 81% yield (entry 6). The introduction of an ethyl ester in position 7 was achieved by 
reacting the magnesiated quinoline derivative 30d with NC-CO2Et leading to the ester 31g in 
77% yield (entry 7). Magnesiations or lithiations on quinoxalines are often difficult to achieve 
due to the electrophilic character of this substrate, leading to competetive dimerizations.65 
However, the quinoxaline 30e bearing a phosphorodiamidate group as DMG, was smoothly 
magnesiated with TMP2Mg·2LiCl (14a) at –30 °C in 1.5 h without any dimerization side 
reaction. After a transmetalation with ZnCl2 it reacted in a Negishi reaction in the presence of 
a Pd-catalyst with either 4-chloro iodobenzene or ethyl 4-iodobenzoate leading to the 2-
arylated quinoxalines 31h and 31i in up to 79% yield (Table 2, entries 8, 9). Treatment of the 
zinc compound with methallyl bromide in the presence of CuCN·2LiCl (10 mol%) furnished 
the allylated quinoxaline 31j in 71% yield (entry 10).  
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Table 4:  Quinolines and quinoxalines of type 31 obtained after magnesiation with TMPMgCl·LiCl (10a) or TMP2Mg·2LiCl (14a) 
and subsequent reaction with an electrophile. 
Entry Substrate T [°C] , t [h] E+ Product/Yield [%][a] 
 
 
 EtSSO2Ph 
 
1 30a 0, 1  31a: 85b 
 
N
O
(Me2N)2P
O
 
 tBuCOCl 
 
2 30b 0, 1  31b: 62b, d 
   
 
 
3 30b 0, 1  31c: 83b, e 
 
N Cl
O
P(NMe2)2
O
 
 
 
 
4 30c 0, 1  31d: 87b, d 
   
 
 
5 30c 0, 1  31e: 74b, d 
 
N Br
O
P(NMe2)2
O
 
 
 
 
6 30d 0, 1  31f: 81b, e 
   NC-CO2Et 
 
7 30d 0, 1  31g: 77b 
 
 
 
 
 
8 30e –30, 1.5  31h: 78d, e 
   
 
 
9 30e –30, 1.5  31i: 79d, e 
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Table 4 (continued) 
   
Entry Substrate T [°C] , t [h] E+ Product/Yield [%][a] 
   
 
 
10 30e –30, 1.5  31j: 71c, d 
aYield of isolated, analytically pure product; bTMPMgCl·LiCl (1.5 equiv) was used; cTMP2Mg·2LiCl (1.5 equiv) was used; d A 
transmetalation with CuCN·2LiCl (10 mol%) was performed after transmetalation with ZnCl2 (1.6 equiv.); eObtained by Pd-
catalyzed cross-coupling reaction after transmetalation with ZnCl2 (1.6 equiv) using Pd(dba)2 (5 mol%) and P(2-furyl)3 (10 mol%) 
as catalyst. 
 
3.4.2. Synthesis of Talnetant, Etoricoxib and a P-Selectin Antagonist 
 
Using this method, the pharmaceutically relevant compounds Etoricoxib, Talnetant and a P-
Selectin67 antagonist were prepared. In this synthesis, the phosphorodiamidate DMG was first 
attached at commercially available 2-pyridinol giving 28a. In a second step, 28a was 
selectively metalated in the 3-position using 10a (1.5 equiv, 0 °C, 1 h). After a 
transmetalation with ZnCl2 a cross-coupling reaction with 4-bromophenyl methylsulfone in 
the presence of Pd2(dba)3 (1 mol%) and RuPHOS (2 mol%)52 gave the arylated pyridine 29g 
in 88% yield. Cleavage of the directing group with a HCl/dioxane mixture68 (25 °C, 24 h) 
gave back the pyridone backbone 32 in 95% yield. Chlorination at C5 position was 
accomplished by reacting 32 with KClO3 in the presence of HCl (conc.)69 furnishing the 5-
chloropyridine 33 quantitatively. The final product was assembled applying a literature 
procedure. Thus, the reaction of the pyridone with POCl3 gave the 2,5-dichloro pyridine 
which was subsequently used in a Stille cross-coupling with the tin reagent 34 derived from 5-
bromo 2-picoline furnishing Etoricoxib 26 (Scheme 32).  
 
 
 
 
 
 
 
                                                 
67
 a) N. Kaila, K. Janz, S. DeBernardo, P. W Bedard, R. Camphausen, S. Tam, D. H. H. Tsao, J. C. Keith, C. 
Nickerson-Nutter, A. Shilling, R. Young-Sicame, Q. Wang,  J. Med. Chem. 2007, 50, 21; b) N. Kaila, K. Janz, A. 
Huang, A. Moretto, S. DeBernardo, P. W. Bedard, S. Tam, V. Clerin, J. C. Keith, D. H. H. Tsao, N. Shushkova, 
G. D. Shaw, R. Camphausen, R. G. Schaub, Q. Wang, J. Med. Chem. 2007, 50, 40. 
68
 H.-G. Chao, B. Leitning, P. D. Reiss, A. L. Burkhardt, C. E. Klimas, J. B. Bolen, G. R. Matsueda, J. Org. 
Chem. 1995, 60, 7710.  
69
 V. Koch, S. Schnatterer, Synthesis, 1990, 499. 
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Scheme 32: Synthesis of Etoricoxib (26). 
The combined use of the phosphorodiamidate and the bases TMPMgCl·LiCl (10a), 
TMP2Mg·2LiCl (14a) was also applied to build up two pharmaceuticals with a quinoline 
salicylic acid spine. Accordingly, the lynchpin for both syntheses is 3-hydroxy quinoline 
which was first converted into the corresponding phosphorodiamidate 30f. The metalation 
with TMP2Mg·2LiCl (14a) occured at the C2 position (–50 °C, 1 h). Transmetalation with 
ZnCl2, followed by a cross-coupling45 with either iodobenzene or 4-chloro iodobenzene in the 
presence of a Pd-catalyst46 furnished the quinolines 31k,l in up to 81% yield. A subsequent 
metalation at the C4 position was obtained using TMPMgCl·LiCl (10a, 25 °C, 1 h). The Mg-
reagent was quenched with NC-CO2Et and gave the desired esters 35a,b in 79 and 81% yield, 
respectively (see appendix for a x-ray structure of 35a). Cleavage of both, the DMG and the 
ester was achieved by refluxing 35a in a HCl/dioxane mixture68 (110 °C, 36 h). The acid was 
then reacted with (S)-phenylpropylamine and CDI providing Talnetant (25) in 86% yield 
(Scheme 33, see appendix for a x-ray structure). For the synthesis of the P-Selectin antagonist 
38 a third metalation for the arylation of the C8 position of 35b is performed using 14a (–
40 °C, 20 h).31 After a transmetalation with ZnCl2 a cross coupling45 reaction with 
iodobenzene in the presence of Pd(dba)2 (5 mol%) and P(2-furyl)3 (10 mol%)46 was 
performed, yielding the highly functionalized quinoline 36 in 76%. Combined 
deprotection/saponification was again achieved by refluxing 36 in a HCl dioxane mixture 
(110 °C, 36 h)68 leading to the P-Selectin Inhibitor 37 quantitatively (Scheme 33). 
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Scheme 33: Synthesis of Talnetant and a P-selectin inhibitor. 
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3.5. Alternative Amines for the Preparation of Mixed Li/Mg and 
Li/Mg/Zn-amide Bases 
 
3.5.1. Preparation and use of the Reagent [tBu(iPr)N]MgCl·LiCl (10b) 
 
During the development of TMP2Mg·2LiCl (14a) the reaction behavior of several sterically 
demanding amines was studied (Scheme 34). It turned out that [tBu(iPr)N]2Mg·2LiCl (14c) 
leads to comparable results concerning activity and isolated yields (see chapter 3.). The used 
sterically hindered acyclic tert-butyl(iso-propyl)amine is therefore a more economical 
alternative to TMP-H, despite its constantly decreasing price. tert-Butyl(iso-propyl)amine can 
be readily prepared starting form cheap bulk chemicals such as iso-propyl bromide, tert-
butylamine and adiponitrile according to a literature procedure of Brown.70 Thus, refluxing 
the 3 components (1:1.5:1 ratio) in the presence of catalytical amounts of Bu4NI (10 mol%) at 
90 °C for 3 d produced after a basic workup the amine 39 in 75% yield (Scheme 34).  This 
synthesis was performed at a 3 mol scale. After treatment of the amine 39 with 
iPrMgCl·LiCl30, the corresponding base 10b was obtained as a 1.45 M solution in THF. This 
concentration is comparable to TMPMgCl·LiCl (10a) letting us suspect a similar aggregation 
of these two bases (monomeric or dimeric in solution). Interestingly, the hindered base 10b is 
twice as soluble in THF as iPr2NMgCl·LiCl (11; max. 0.6 M in THF) which is much more 
aggregated and does not react in a stoichiometric way with aromatic or heteroaromatic 
substrates. 30, 71  
 
 
 
 
 
                                                 
70
 H. C. Brown, J. V. B. Kanth, P. V. Dalvi, M. Zaidlewicz, J. Org. Chem. 1999, 64, 6263.  
71
 R. E. Mulvey (University of Strathclyde, Glasgow), personal communication on 02.12.08 in Munich. 
Crystalline iPr2MgCl·LiCl consists of numerous dimeric species. The LiCl does not achieve full deaggregation in 
this composition. See also upcomming publication by R. E: Mulvey for details. 
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Scheme 34: Preparation of the base 10b. 
Accordingly, the scope of this Li/Mg-amide base was investigated in more detail. The 
magnesiation of the substituted ethyl benzoate derivative 40a with the hindered base 10b gave 
the corresponding magnesium reagent within 1 h which, after a transmetalation with 
CuCN·2LiCl (10 mol%)47, was allylated with 3-bromo-2-methylpropene affording the tetra-
substituted benzoate 41a in 85% yield (Table 5, entry 1). Iodolysis of this magnesium reagent 
led to the iodoester 41b in 81% (entry 2). The magnesiation of the Boc-protected isophtalate 
40b was complete within 1 h at 0 °C. Copper(I)-mediated allylation47 with 3-
bromocyclohexene furnished the allylated product 41c in 93% yield (entry 3). The 
magnesiation of diethyl 2-bromo-terephthalate (40c) and diethyl 4-bromo-isophthalate (40d) 
occured at –30 °C within 30 min. After the addition of anisaldehyde, the newly formed 
lactones 41d and 41e were isolated in 86-96% yield (entries 4 and 5). The metalation of 
heterocycles was performed using similar conditions to those used with the base 10a. Thus, 3-
bromoquinoline (40e) reacted with the magnesium base 10b at –25 °C within 20 min. 
Quenching with N,N-dimethylformamide introduced a formyl function at position 2 and 
produced the aldehyde 41f in 81% yield (entry 6). 2,6-Dichloropyridine (40f) reacted with the 
magnesium amide 10b at 25 °C within 10 min. Transmetalation using ZnCl2 in THF at –40 °C 
gave the corresponding organozinc reagent which underwent a Pd-catalyzed Negishi cross-
coupling45, 46 reaction with 4-iodoanisole affording the 4-substituted pyridine 41g in 85% 
yield (entry 7). A Pd-catalyzed acylation72 of this zinc reagent using Pd(PPh3)4 as catalyst (2 
mol%) and pivaloyl chloride (3.0 equiv, –40 to 25 °C, 2 h) furnished to the ketone 41h in 
86% yield (entry 8). The dibromopyridine 40h required lower temperatures to prevent 
halogen dance reactions.73 The deprotonation at position 4 was complete within 30 min at –50 
°C. After the addition of pivaldehyde, the alcohol 41i was obtained in 86% yield (entry 9). 
The reaction of benzothiazole (40i) with the magnesium base 10b proceeded at 25 °C within 
15 min. After the addition of pivaldehyde, the secondary alcohol 41j was isolated in 86% 
yield (entry 10). A Pd-catalyzed acylation72 with Pd(PPh3)4 (2 mol%) and 2-chloronicotinyl 
chloride led to the ketone 41k in 83% yield (entry 11). Benzothiophene (40h) reacted within 
                                                 
72
 a) E. Negishi, V. Bagheri, S. Chatterjee, F. T. Luo, Tetrahedron Lett. 1983, 24, 5181; b) R. A. Grey, J. Org. 
Chem. 1984, 49, 2288. 
73
 E. Arzel, P. Rocca, F. Marsais, A. Goddard, G. Quéguiner, Tetrahedron Lett. 1998, 39, 6465. 
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12 h at 0 °C with the base 10b. The benzylic alcohol 41l was obtained in 71% yield after 
quenching with PhCHO (entry 12).  
Table 5: Products of Type 41 obtained after magnesiation with [tBu(iPr)N]MgCl·LiCl (10b) and subsequent reaction with an 
electrophile. 
Entry Substrate T [°C] , t [h] Electrophile Product/Yield [%]a 
 
 
 
 
 
1 40a 0, 1  41a: 85b 
   I2 
 
2 40a 0, 1  41b: 81 
 
 
 
 
 
3 40b 0, 1  41c: 93b (92) 
 
CO2Et
CO2Et
Br
 
 
 
 
4 40c –30, 0.5  41d: 96 
 
 
 
 
 
5 40d –30, 0.5  41e: 86 (88) 
 
 
 DMF 
 
6 40e –25, 0.3  41f: 81 (91) 
 
 
 
 
N ClCl
OMe
 
7 40f 25, 0.2  41g: 85c (93) 
   tBuCOCl 
N ClCl
tBuO
 
8 40f 25, 0.2  41h: 86d 
 
 
 tBuCHO 
N BrBr
tBuHO
 
9 40h –50, 0.5  41i: 84 
Table 5 (continued) 
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Entry Substrate T [°C] , t [h] E+ Product/Yield [%][a] 
 
N
S
 
 tBuCHO 
 
10 40i 25, 0.2  41j: 86 (98) 
   
 
 
11 40i 25, 0.2  41k: 83d 
 
S
 
 PhCHO 
 
12 40h 0, 12  41l: 71 (93) 
a
 Isolated yield of analytically pure product, yields in parentheses are obtained by the use of TMPMgCl·LiCl (1); b Obtained after 
transmetalation with CuCN·2LiCl (10 mol%); cObtained after transmetalation with ZnCl2 (1.2 -1.6 equiv) and Pd(dba)2 (5 mol%) 
and P(2-furyl)3 (10 mol%); d Obtained after transmetalation with ZnCl2 (1.2 -1.6 equiv) and Pd(PPh3)4 (2 mol%). 
 
3.5.2. Preparation and use of the Reagent [tBu(iPr)N]2Mg·2LiCl (14c) 
 
As mentioned above, the Mg-bis-amide [tBu(iPr)N]2Mg·2LiCl (14c) displays comparable 
properties to those of TMP2Mg·2LiCl (14a). Its synthesis is similar to that of TMP2Mg·2LiCl 
(14a) as shown in Scheme 23.  Hence, further studies on 14c were conducted to examine its 
scope. Thus, tert-butyl benzoate (13a) was magnesiated with [tBu(iPr)N]Mg·2LiCl (14c; 1.1 
equiv) at 25 °C within 1 h. After transmetalation to the corresponding arylzinc species, a 
copper(I)-mediated allylation47 was performed, to give the allylated benzoate 42a in 91% 
yield (Table 6, entry 1). This arylzinc species was also used for a Pd-catalyzed acylation 
reaction72 (Pd(PPh3)4, 2 mol%) leading to the benzophenone 42b in 77% yield (entry 2). Pd-
catalyzed Negishi cross-coupling45 reactions were also performed using Pd(dba)2 (5 mol%) 
and P(2-furyl)3 (10 mol%)46 and 4-iodotoluene or (4-iodophenoxy)(triisopropyl)silane as 
electrophiles providing the desired products 42c and 42d in 82-89% yield (entries 3 and 4). 
The reaction of tert-butyl 1-naphthoate (43a) with the magnesium bis-amides 14c proceeded 
smoothly at 25 °C within 3 h. The resulting organomagnesium reagent was transmetalated 
with ZnCl2 (1.1 equiv, 1 M in THF) and used in a Negishi cross-coupling reaction with 4-
iodo-1-chlorobenzene affording the naphthyl derivative 42e in 97% yield (entry 5). This 
organozinc species also underwent a copper(I)-mediated47 allylation, yielding 42f in 88% 
yield. After transmetalation with ZnCl2, the addition of Pd(PPh3)4  (2 mol%)72 and pivaloyl 
chloride led to the ketone 42g in 83% yield (entry 6). Palladium-catalyzed acylation was also 
used for the introduction of a new ethyl ester. After the addition of the Pd-catalyst Pd(PPh3)4 
(2 mol%)  and ethyl chloroformate, the diester 42h was isolated in 83% yield (entry 7). The 
formation of tri-tert-butyl benzene-1,2,4-tricarboxylate (42i) was accomplished by the 
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reaction of di-tert-butyl benzene-1,3-dicarboxylate (43b) with [tBu(iPr)N]2Mg·2LiCl (14c) at 
25 °C within 6 h. The resulting magnesium reagent was quenched with Boc2O providing the 
desired tri tert-butyl ester 42i in 90 % (entry 9). This compound is usually prepared by a 
ruthenium catalyzed [2+2+2] alkyne trimerisation reaction and produces mixtures of 
isomers.74 Further treatment of 43b with [tBu(iPr)N]2Mg·2LiCl  at 25 °C (6 h) followed by 
the addition of ZnCl2, methallyl bromide and catalytic amounts of CuCN·2LiCl (1 M in THF, 
10 mol%) gave the allylated benzoate 42j in 77% yield (entry 10).  Moreover, tert-butyl 
isonicotinate (43c) was fully magnesiated within 12 h at –40 °C. After transmetalation with 
ZnCl2, a Pd-catalyzed Negishi reaction45 with iodobenzene was carried out, providing the 
arylated pyridine 42k in 68% yield (entry 11). 2-(Methylthio)pyrimidine (43d) was smoothly 
metalated within 1 h at –30 °C. After transmetalation with ZnCl2, a Negishi cross-coupling 
reaction with 3-iodotoluene was performed yielding the pyrimidine 42l in 76% (entry 12). 
Benzonitrile (13e) was magnesiated within 3 h at –30 °C. After transmetalation with ZnCl2, 
Negishi cross-coupling (Pd(dba)2, 5 mol%; P(2-furyl)3, 10 mol%)46 was conducted leading to 
the biphenyl derivative 42m in 66% yield (entry 13). 
 
These results show that [tBu(iPr)N]2Mg·2LiCl (14c) is a viable alternative to TMP2Mg·2LiCl 
(14a) although some difficulties were observed. For example, ethyl esters are not tolerated 
and the extensive formation of the corresponding amide is observed. Only tert-butyl esters[75] 
can be used as substrates for metalation reactions with the bis-amide base 14c. Surprisingly, 
in the case of di-tert-butyl pyridine-3,5-dicarboxylate the amide formation is still observed 
and TMP2Mg·2LiCl (14a) has to be used for metalating this heterocycle.  
Table 6: Products of Type 42 obtained after Magnesiation with [tBu(iPr)N]2Mg·2LiCl (14c) and Subsequent Reaction with an 
Electrophile. 
Entry Substrate T [°C] , t [h] Electrophile Product/Yield [%]a 
 
CO2tBu
 
 
 
 
1 13a 25, 1  42a: 91b (93) 
   
 
 
2 13a 25, 1  42b: 77d 
                                                 
74
 V. Cadierno, S. E. García-Garrado, J. Gimeno, J. Am. Chem. Soc. 2006, 128, 15094.  
75
 For preparation of tBu-esters see: D. Lagnoux, E. Delort, C. Douat-Cassassus, A. Esposito, J.-L. Reymond 
Chem. Eur. J. 2004, 10, 1215. 
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Table 6 (continued) 
Entry Substrate T [°C] , t [h] Electrophile Product/Yield [%]a 
   
 
 
3 13a 25, 1  42c: 82c 
   
 
 
4 13a 25, 1  42d: 89c 
 
 
 
 
 
5 43a 25, 3  42e: 97c (83) 
   
 
 
6 43a 25, 3  42f: 88b 
   tBuCOCl 
 
7 43a 25, 3  42g: 83d 
   EtOCOCl 
 
8 43a 25, 3  42h: 83d 
 
 
 Boc2O 
 
9 43b 25, 6  42i: 90 (94) 
   
 
 
10 43b 25, 6  42j: 77b 
 
N
CO2tBu
 
 Ph-I 
 
11 43c –40, 12  42k: 68c 
 
 
 
 
 
12 43d –30, 1  42l: 76c (93) 
 
 
 
 
CN
OMe
 
13 13e –30, 3  42m: 66c (70) 
a
 Isolated yield of analyticaly pure product, yields in parentheses obtained by the use of TMP2MgCl·2LiCl; b Obtained after 
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transmetalation with CuCN·2LiCl (10 mol%); c Obtained after transmetalation with ZnCl2 (1.2 -1.6 equiv.) and Pd(dba)2 (5 mol%) 
and P(2-furyl)3 (10 mol%); d Obtained after transmetalation with ZnCl2 (1.2 -1.6 equiv.) and Pd(PPh3)4 (2 mol%). 
 
3.5.3. Preparation and use of the Reagent 
[tBu(iPr)N]2Zn·2MgCl2·2LiCl (12b) 
 
To complete the studies on the non-cyclic sterically demanding amides the investigations 
were extended to mixed Li/Mg/Zn-amides. Thus, the transmetalation of 
[tBu(iPr)N]MgCl·LiCl (10b) with ZnCl2 (0.5 equiv) furnished the corresponding zinc-base 
[tBu(iPr)N]2Zn·2MgCl2·2LiCl 12b. A concentration of 0.5 M in THF was obtained (Scheme 35). 
The related base TMP2Zn·2MgCl2·2LiCl (12a) has been found to be a mild zincation reagent 
for highly functionalized substrates (aldehydes, nitro groups).  
 
 
Scheme 35: Synthesis of the zinc bis-amide 12b. 
 
Thus, 2-phenyl-1,3,4-oxadiazole (44a) was metalated within 45 min at 25 °C using zinc base 
12b (0.55 equiv). The resulting diorganozinc reagent underwent a copper-catalyzed allylation 
reaction furnishing the allylated product 45a in 88% yield (Table 7, entry 1). The 
magnesiation or lithiation of this substrate is complicated by a competitive ring opening 
reaction leading to benzonitrile (13e). This can be completely avoided by using the zinc bis-
amides 12a,b as base.32 Quinoxaline (44b) was readily zincated within 9 h at 25 °C. After a 
Pd-catalyzed45, 46 cross-coupling reaction, the quinoxaline derivative 45b was isolated in 81% 
yield (entry 2). During this reaction, no dimerization of quinoxaline (44b) was noted. Such 
dimerization reactions are typically observed during magnesiation or lithiation reactions of 
this substrate (see chapter 3.3.). Nitro groups were also tolerated as shown for the zincation of 
5-nitro-1,3-benzothiazole (44c). This metalation occured at –50 °C within 1 h selectively at 
position 2. After a copper(I)-mediated47 allylation reaction with 3-bromocyclohexene, the 2-
allylated benzothiazole 45c was obtained in 79% yield (entry 3). For poorly activated 
substrates, the zincation can be accelerated by microwave irradiation.32 Thus, 4-fluoro 
benzonitrile (44d) was mixed with 0.55 equiv of the zinc bis-amide 12b. This mixture was 
subjected to microwave irradiation on a Initiator Sixty EXP Microwave System from Biotage. 
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After 2 h at 100 °C, a full conversion to the corresponding Zn-reagent was observed which 
underwent a copper(I)-catalyzed allylation reaction yielding the allylated benzonitrile 45d in 
81% yield (entry 4). The 2-fluoro isomer 44e required higher temperatures (140 °C) and 2 h 
of reaction time for a complete formation of the zinc reagent. A Pd-catalyzed cross-coupling 
reaction with (4-iodophenoxy)(triisopropyl)silane provided the biphenyl 45e in 83% yield 
(entry 5). Benzothiophene (40h) was zincated at 140 °C within 1 h and underwent a Pd-
catalyzed acylation with pivaloyl chloride affording the polyfunctionalized ketone 45f in 83% 
yield (entry 6). The new zinc bis-amide base 12b displays a similar reactivity than 
TMP2Zn·2MgCl2·2LiCl (12a). However, this last base seems to have a broader scope than 
12b as ethyl esters are converted to the corresponding amides under these harsh metalation 
conditions.  
Table 7: Products of Type 45 obtained after zincation with [tBu(iPr)N]2Zn·2MgCl2·2LiCl (12b) and Subsequent Reaction with an 
Electrophile. 
Entry Substrate T [°C] , t [h] E+ Product/Yield [%]a 
 
 
 
 
 
1 44a 25, 0.75  45a: 88b, 76 
 
 
 
 
 
2 44b 25, 9  45b: 81c, 76 
 
 
 
 
 
3 44c –50, 1  45c: 79b, 76 
 
 
 
 
 
4 44d 100, 2  45d: 81b 
 
CN
F
 
 
 
 
5 44e 140, 2  45e: 83c 
 
S
 
 
 
tBuCOCl 
 
6 40h 140, 1  45f: 83b 
a
 Isolated yield of analytically pure product, yields in parentheses obtained by the use of TMP2Zn·2MgCl2·2LiCl; b Obtained after 
transmetalation with CuCN·2LiCl (10 mol%); c Obtained via Pd-catalyzed cross-coupling with Pd(dba)2 (5 mol%) and P(2-furyl)3 
(10 mol%). 
 
                                                 
76
 These experiments were done by S. H. Wunderlich and are shown here for the sake of completeness. 
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3.5.4. Preparation and use of the Reagent PMPMgCl·LiCl (10c) 
 
Another approch towards alternative amines was to start from the TMP-H precursor 2,2,6,6-
tetramethyl-4-piperidone (46) which is comparatively cheap.77 Thus, the conversion of the 
amino ketone 46 into the corresponding exo-methylene derivative 47 by a Wittig reaction was 
envisioned. The treatment of MePPh3I or MePPh3Br with nBuLi at –78 °C and subsequent 
addition of 46 led to the unsaturated amine 47 in 76% yield.78 Catalytic reduction with H2 in 
the presence of Pd/C79 provided 2,2,4,6,6-pentamethylpiperidine (PMPH; 48) in 90% yield 
(Scheme 36). 
 
 
Scheme 36: Preparation of the mixed Li/Mg-amide 10c. 
 
Thus, the treatment of the new piperidine 48 with iPrMgCl·LiCl (0.95 equiv, 25 °C, 24 h)30 
led to the corresponding PMPMgCl·LiCl (10c) as a 1.45 M solution in THF. The additional 
methyl group in 48 compared to TMP-H does not increase the base solubility in THF. Its 
concentration is comparable to those of TMPMgCl·LiCl (10a) and [(tBu)(iPr)]NMgCl·LiCl 
(10b). Magnesiations of various aromatics with the magnesium base 10c are summarized in 
Table 8. As expected, sensitive functional groups such as esters or a Boc-group are well 
tolerated and the metalation of heterocycles was also possible. The quenching of these 
magnesium reagents with various electrophiles led to products of type 41-47 in 87-95% yield. 
Thus, the metalation of the dichlorobenzoate 40a proceeded smoothly at 0 °C within 1 h. A 
copper(I)-mediated47 allylation reaction gave the allylated product 41a in 93% yield (Table 8, 
entry 1). Also the trapping of the intermediate organomagnesium reagent derived from the 
diester 40d generated within 30 min at –30 °C with an aldehyde was readily achieved. After 
                                                 
77
 D. Kampmann, G. Stuhlmüller, R. Simon, F. Cotett, F. Leroux, M. Schlosser, Synthesis 2005, 1028. Estimated 
retail prices: TMPH: ca. 350 €/mol; 2,2,6,6-tetramethyl-4-piperidone (46): ca. 20 €/mol; VWR International, 
retail prices 2009: TMPH ca. 270 €/mol; 46: ca. 50 €/mol. 
78
 a) P. L. Hall, J. H. Gilchrist, A. T. Harrison, D. J. Fuller, D. B. Collum, J. Am. Chem. Soc. 1991, 113, 9575; b) 
compound 5 was synthesized according to: P. Karrer, J.-M. Mas, G. Mignani, Rhone-Poulenc Chimie, Int. Pat. 
Appl. WO 96/16124, 1996. 
79
 P. N. Rylander, Hydrogenation Methods, Academic Press, London, 1985. 
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the addition of anisaldehyde, the newly formed lactone 41d was obtained in 90% yield (entry 
2). 2,6-Dichloropyridine (40g) reacted  with 10c (1.5 equiv) within 10 min at 25 °C while the 
dibromo derivative 40h again required lower temperatures (–30 °C, 0.5 h) to suppress 
possible halogen dance reactions.73 After iodolysis, the iodopyridines 46 and 47 were isolated 
in 91 and 87% yield (entries 3 and 4). Benzothiazole (40i) reacted at 25 °C with the base 10c 
providing the corresponding Grignard reagent within 10 min. The addition of pivaldehyde led 
to the secondary alcohol 41l in 91% yield (entry 5).  
Table 8: Products of type 41-47 obtained after magnesiation with PMPMgCl·LiCl (10c) and subsequent reaction with an 
electrophile. 
Entry Substrate T [°C] , t [h] Electrophile Product/Yield [%]a 
 
 
 
 
 
1 40a 0, 1  41a: 93b 
 
CO2Et
CO2Et
Br
 
 
 
 
2 40d –30, 0.5  41d: 90 (88) 
 
 
 I2 
N ClCl
I
 
3 40g 25, 0.2  46: 91 (93) 
 
 
 I2 
 
4 40h –30, 0.5  47: 87 
 
N
S
 
 tBuCHO 
 
5 40i 25, 0.2  41l: 91 (98) 
a
 Isolated yield of analytically pure product, yields in parentheses obtained by the use of TMPMgCl·LiCl; b Obtained after 
transmetalation with CuCN·2LiCl (10 mol%). 
 
These results show that the magnesium bases 10a-c display a similar behaviour concerning 
solubility, metalation rates and yields of the resulting products. However, PMPH is gained 
from a two step synthesis, which includes a Wittig-reaction. Although this reaction is used in 
industry for the synthesis of Vitamine A,80 the use of the amine 39 for the preparation of the 
corresponding base 10b is favored because of its easy one step synthesis. 
 
                                                 
80
 a) H. Pommer, Angew. Chem. Int. Ed. Engl. 1977, 16, 423; b) W. Reif, H. Grassner, Chem. Ing.-Techn., 1973, 
43, 646; c) R. W. Hoffmann, Angew. Chem. Int. Ed. 2001, 40, 1411. 
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3.6. Preparation of Aryl Copper Reagents via a Cobalt-
Catalyzed C-O Bond Activation 
 
 
As described in chapter 1.2., organocopper reagents display a special role within 
organometallic reagents. The high reactivity combined with high functional group tolerance 
as well as their high thermal stability makes them to preferred reagents in chemical 
transformations. Alternatively, phenol derivatives such as sulfonates have been seldomly used 
for the preparation of aryl organometallics due to the strength of the carbon oxygen bond.81, 82 
Transformations starting from aryl triflates are also known. These intermediates are converted 
into the corresponding tin species which can subsequently be transmetalated to organocopper 
reagents. However, this method suffers from low atom economy and the toxicity of the used 
tin reagents (see chapter 1.5.). Therefore, a transition metal-catalyzed activation of the aryl-
oxygen bond has been envisioned to achieve this goal. Due to its high reactivity and moderate 
price, cobalt has been the metal of choice for elaborating new organometallic reactions.83, 84 A 
preparation of polyfunctional arylcopper reagents of type 49 bearing a range of sensitive 
functional groups (ester, nitrile or aldehyde) starting from aryl sulfonates of type 50 using a 
cobalt-catalyzed sulfonate/copper-exchange reaction mediated by phenylcopper (PhCu) was 
found to be possible (Scheme 37). During studies on Co-catalyzed cross-couplings85 it has 
been observed that the reaction of electron-deficient aryl p-tolylsulfonates (ArOTs) with PhCu 
produced together with the cross-coupling product (Ar-Ph) of type 51, an arylcopper ArCu 
(49) which is the result of a OTs/Cu-exchange. Although this was a minor product under 
                                                 
81
 a) R. J. K. Taylor, Organocopper Reagents, Oxford University Press, Oxford, 1994; b) Modern Organocopper 
Chemistry (Ed. N. Krause), Wiley-VCH, Weinheim, 2002; c) A. Hoffmann-Röder, N. Krause, Synthesis 2001, 
171. 
82
 a) M. Yus, Recent Res. Devel. Org. Chem. 1997, 1, 397; b) Guijarro, M. Yus, Recent Res. Devel .Org. Chem. 
1998, 2, 713; c) D. J. Ramón, M. Yus, Eur. J. Org. Chem. 2000, 225; d) C. G. Screttas, M. Micha-Screttas, J. 
Org. Chem. 1978, 43, 1064. 
83
 a) H. Avedissian, L. Bérillon, G. Cahiez, P. Knochel, Tetrahedron Lett. 1998, 39, 6163; b) C. Gosmini, Y. 
Rollin, J.-Y. Nédélec, J. Périchon, J. Org. Chem. 2000, 65, 6024; c) H. Fillion, E. Le Gall, C. Gosmini, J. 
Périchon, Tetrahedron Lett. 2002, 43, 5941, d) T. Tsuji, H. Yorimitsu, K. Oshima, Angew. Chem. Int. Ed. 2002, 
41, 4137; e) H. Fillion, C. Gosmini, J. Périchon, J. Am. Chem. Soc. 2003, 125, 3867; f) H. Ohmiya, H. Yorimitsu, 
K. Oshima, Chem. Lett. 2004, 33, 1240; g) I. Kazmierski, M. Bastienne, C. Gosmini, J.-M. Paris, J. Périchon, J. 
Org. Chem. 2004, 69, 936; h) T. J. Korn, P. Knochel, Angew. Chem. Int. Ed. 2005, 44, 2947; i) J.-M. Bégouin, C. 
Gosmini, J. Org. Chem. 2009, 74, 3221. 
84
 H. Shinokubo, K. Oshima, Eur. J. Org. Chem. 2004, 2081. 
85
 a) T. J. Korn, M. A. Schade, S. Wirth, P. Knochel, Org. Lett. 2006, 8, 725.; b) T. J. Korn, M. A. Schade, M. N. 
Cheemala, S. Wirth, S. A. Guevara, G. Cahiez, P. Knochel, Synthesis 2006, 3547. 
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standard cross-coupling conditions, it was possible to optimize its formation. By replacing the 
Ts-group by an aryl sulfonate bearing a donor substituent in para-position (e.g.: –OMe; –
NMe2), by using a higher catalyst loading (from 7.5 mol% to 20 mol%) and by performing the 
reaction in a 5:2 THF:DMPU mixture, the sulfonate/copper-exchange became the major 
reaction pathway (ratio of ArCu (1):Ar-Ph (3) up to 10:1) (Scheme 37).  
 
 
Scheme 37: CoII-catalyzed aryl sulfonate/copper-exchange reaction. 
 
Thus, the reaction of 1,3-dicarbethoxy benzenesulfonate (50a; 1 equiv) with PhCu (3 equiv) 
in the presence of Co(acac)2 (20 mol%), 4-fluorostyrene (50 mol%)86, Bu4NI (1.0 equiv)87 in a 
5:2 THF:DMPU mixture furnished the arylcopper reagent 49a within 2 h at 25 °C and 
provided after iodolysis the aryl iodide (52a) in 72% yield. Similarly, trapping the arylcopper 
species 49b obtained by the reaction with PhCu (3.0 equiv after 3 h at 25 °C) with iodine 
furnished ethyl 3-cyano-5-iodobenzoate (52b) in 65% yield. The copper reagent 49a could 
also be trapped by various other electrophiles. Thus, its allylation with 3-bromopropene 
afforded the allylated product 52c in 78% yield. An acylation using pivaloyl chloride gave the 
ketone 52d in 61% yield. The organocopper reagent derived from 50a underwent a smooth 
substitution reaction with 3-iodocyclohexen-1-one yielding the cyclohexenone 52e in 64% 
yield. A carbocupration88 of ethyl propiolate with the copper reagent 49a furnished the alkene 
52f in 61% yield. The related copper reagent 49b underwent a 1,4-addition with 
cyclohexenone in the presence of TMSCl affording the corresponding Michael-adduct 52g in 
                                                 
864-Fluorostyrene facilitates the reductive elimination step during the catalytic cycle. Its presence is essential for 
performing the sulfonate/copper-exchange reaction. Apparently, 4-fluorostyrene is not consumed during the 
reaction as shown by GC-analysis using an internal standard; see: a) M. Piber, A. E. Jensen, M. Rottländer, P. 
Knochel, Org. Lett. 1999, 1, 1323; b) A. E. Jensen, P. Knochel, J. Org. Chem. 2002, 67, 79.  
87
 The role of the Bu4NI may be to deaggregate organometallic reagents. See: a) S. W. Wright, D. L. Hageman, L. 
D. McClure, J. Org. Chem. 1994, 59, 6095; b) M. T. Reetz, R. Breinbauer, K. Wanninger, Tetrahedron Lett. 
1996, 37, 4499; c) N. A. Powell, S. D. Rychnowski, Tetrahedron Lett. 1996, 37, 7901; d) K. Nakamura, H. 
Okubo, M. Yamaguchi, Synlett, 1999, 549; e) T. Jeffrey, J.-C. Galland, Tetrahedron Lett. 1994, 35, 4103; f) V. 
Penalva, L. Lavenot, C. Gozzi, M. Lemaire, App. Cat. A 1999, 182, 399; g) W. J. Scott, J. K. Stille, J. Am. Chem. 
Soc. 1986, 108, 3033; h) C. Amatore, A. Jutland, A. Suarez, J. Am. Chem. Soc. 1993, 115, 9531; i) A. Jutland, A. 
Mosleh, Organometallics 1995, 14, 1810; i) C. Amatore, M. Azzabi, A. Jutland, J. Am. Chem. Soc. 1991, 113, 
1670; j) A. H. Roy, J. F. Hartwig, J. Am. Chem. Soc. 2003, 125, 8704. 
88
 J.-F. Normant, A. Alexakis, Synthesis 1981, 841. 
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66% yield. The reaction of the arylcopper 49b with S-methyl thiomethylsulfonate furnished 
the thioether 52h in 73% yield (Scheme 38). Further trapping reactions of arylcopper reagents 
prepared from the aryl sulfonates 50c-h are summarized in Table 9. Aromatic compounds 
with a 1,3,5-trisubstitution pattern which are usually difficult to prepare, can also be easily 
accessed via this methodology.89 Thus, 3,5-dicyanophenyl 4-methoxybenzenesulfonate 50c 
reacted under standard conditions within 6 h at 45 °C leading to the corresponding copper 
reagent which was quenched with iodine yielding 5-iodo isophthalonitrile 52i in 63 % yield 
(Table 9, entry 1).  
 
 
Scheme 38: Aryl sulfonate/copper-exchange of the sulfonates 50a,b and trapping with various electrophiles. 
Reagents and conditions: a) PhCu (3.0 equiv) Co(acac)2 (20 mol%), 4-fluorostyrene (50 mol%), Bu4NI (1.0 
equiv), THF:DMPU = 5:2, 25 °C, 2-3 h; b) I2 (2.0 equiv), –20 °C, 30 min, 25 °C, 2 h; c) 3-bromopropene (2.0 
equiv), –20 °C, 30 min, 25 °C, 2 h; d) tBuCOCl (2.0 equiv), –20 °C, 30 min, 25 °C, 2 h, e) 3-iodocyclohexene-1-
one (2.0 equiv), –20 °C, 30 min, 25 °C, 2 h; f) ethyl propiolate (2.0 equiv), –40 °C, 30 min, 25 °C, 2 h; g) 
cyclohexenone (2.0 equiv), TMSCl (2.0 equiv), –20 °C, 30 min, 25 °C, 2 h; h) MeSSO2Me (2.0 equiv), –20 °C, 
30 min, 25 °C, 2 h. 
 
Other aryl sulfonates bearing electron-withdrawing groups were readily converted to the 
corresponding copper species. Thus, 3,5-bis(trifluoromethyl)phenyl 4-
(dimethylamino)benzenesulfonate 50d gave the arylcopper 49d within 4 h at 25 °C. Its 
benzoylation yielded the benzophenone 52j in 61% yield (entry 2). Alternatively, its allylation 
                                                 
89
 J. M. Murphy, X. Liao, J. F. Hartwig, J. Am. Chem. Soc 2007, 129, 15434. 
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with ethyl 2-(bromomethyl)acrylate90 gave the 1,3,5-trisubstituted arene 52k in 71% yield 
(entry 3).  
Table 9: Products obtained via Co-catalyzed arylsulfonate/copper-exchange and reaction with an electrophile. 
Entry Substrate T [°C] , t [h] E+ Yield/Product [%]b 
 
 
 I2 
 
1 50c 45, 6  52i: 63 
 
 
 PhCOCl 
F3C CF3
O Ph
 
2 50d 25, 4  52j: 61 
   
 
F3C CF3
CO2Et
 
3 50d 25, 4  52k: 71 
 
 
 PhCOCl 
CO2Et
NC
PhO
 
4 50e 25, 5  52l: 7091 
 
OSO2Dma
CO2Et
 
 
 
CO2Et
CO2Et
 
5 50f 50, 5  52m:6291 
 
 
 
 
 
6 50g 25, 1  52n: 7091 
 
 
 
 
 
7 50h 25, 3  52o:5391 
a
 An= 4-MeOC6H4, Dma= 4-Me2NC6H4; b Isolated yield of analytically pure product. 
 
Remarkably, an aldehyde function was also tolerated during the exchange reaction. Thus, 3-
cyano-5-formylphenyl 4-methoxybenzenesulfonate (50i) afforded under standard conditions 
the arylcopper reagent 49i which was then trapped with S-methyl thiomethylsulfonate 
                                                 
90
 J. Villiéras, M. Rambaud, Org. Synth. 1988, 66, 220. 
 
91
 Experiments were done by C. R. Diène and are shown here for the sake of completeness. 
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yielding the thioether 52p in 68% yield. Acylation of 49i furnished the ketone 52q in 60% 
yield (Scheme 39). 
 
CHONC
OSO2An
NC CHO
Cu
NC CHO
SMe
NC CHO
tBuO
52p: 68%
52q: 60%
50i 49i
a)
b)
c)
 
Scheme 39: Aryl sulfonate/copper-exchange on substituted benzaldehydes. Reagents and conditions: a) PhCu 
(3.0 equiv) Co(acac)2 (20 mol%), 4-fluorostyrene (50 mol%), Bu4NI (1.0 equiv), THF:DMPU = 5:2, 25 °C, 1 h; 
b) MeSSO2Me (2.0 equiv), –20 °C, 30 min, 25 °C, 2 h, c) tBuCOCl (2.0 equiv), –20 °C, 30 min, 25 °C, 2 h. 
 
This new sulfonate/copper-exchange reaction allows the elaboration of various substitution 
patterns of aromatics, otherwise difficult to access. Under the current reaction conditions, the 
presence of electron-withdrawing groups is necessary for obtaining the exchange reaction in 
satisfactory yields. 
 
 
Scheme 40. Tentative reaction mechanism. 
 
As a tentative reaction mechanism, the following catalytic cycle is proposed. In a first step, 
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PhCu undergoes a transmetalation to the corresponding cobalt derivative Ph2Co (53). Its 
addition to an electron-deficient  aryl sulfonate of type 50 would lead via nucleophilic attack 
to a CoIV-intermediate of type 54 stabilized by a η5-complexation which may explain why 
electron-poor aromatic systems react faster. After rearomatization, this cobalt complex 
produces a cobalt(IV)-intermediate92 of type 55. Reductive elimination of the cobalt reagent 
55 will afford biphenyl93 and the arylcobalt(II) reagent 56. The reaction of this intermediate 
with PhCu results in the formation of compound 57 which only slowly undergoes a reductive 
elimination to Ar-Ph (51). A subsequent transmetalation with PhCu leads to the arylcopper 
reagent 49 and regenerates Ph2Co (53) (Scheme 40). This pathway is preferred over the 
formation of 51 as ratios of 10:1 are obtained (Scheme 37).
                                                 
92
 We have tested that Co(0)-species (generated by a prereduction of Co(acac)2 with PhCu) is not a catalytically 
active species. The use of Co(acac)3 as a catalyst did not lead to any conversion. For a report of a CoIV species 
see: Z. Nagy-Magos, L. Markó, G. Bor, J. Organomet. Chem. 1968, 14, 205. 
93
 Co(acac)2 promotes the decomposition of PhCu to biphenyl. The additional presence of 4-fluorostyrene and 
Bu4NI even accelerates this homo-coupling process explaining the need of an excess of PhCu. 
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3.7. Summary and Outlook 
 
 
In this work, two different pathways for the synthesis of organometallic reagents were 
presented, the stoichiometric activation of carbon-hydrogen bonds as well as the catalytic 
activation of a carbon-oxygen bond in phenol derivatives (aryl sulfonates). 
 
3.8. Stoichiometric Bond Activation Using Mixed Li/Mg- and Li/Mg/Zn-
Amide Bases 
 
3.8.1. Preparation and use of the Highly Active Base TMP2Mg·2LiCl 
 
The new reagent TMP2Mg·2LiCl allowed a smooth C-H activation on poorly activated arenes 
and heteroarenes. These substrates were only sluggishly metalated with the mixed Li/Mg-base 
TMPMg·LiCl (Scheme 41).  
 
 
Scheme 41: Efficient magnesiation using TMP2Mg·2LiCl (14a). 
 
Remarkably, the functional group compatibility was not affected by the high reactivity of the 
new base. Functionalities like esters, nitriles or ketones were well tolerated during the 
magnesiation. A scale-up of these metalations was also possible (Scheme 42). 
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Scheme 42:  Various polyfunctionalized arenes and heterocycles obtained using TMP2Mg·2LiCl. 
 
3.8.2. Formal meta- and para-Functionalization of Arenes using 
TMP2Mg·2LiCl 
 
Furthermore, the use of the N,N,N’,N’-tetramethylphosphorodiamidate as DMG permitted 
formal meta- and para-functionalizations by overruling the directing effects of other groups 
present in the molecule. This high directing power was used to generate unusual substitution 
patterns, which are normally diffucult to achieve (Scheme 43).  
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Br
O
(Me2N)2P
Me
Br
Br
O
(Me2N)2P CN
Me
77%
Br
O
(Me2N)2P CN
83%
CN
COtBu
CN
COtBu
CO2Et
CO2Et
OR
COPh
IZn
CO2Et
NiCl2(PPh3)2 (5 mol%)
THF-NEP, 25 °C, 3 h
IZn CO2Et
CO2Et
COPh
CO2Et
90%
R=P(O)(NMe2)2
95%
R=SO2(CF2)3CF3 71%
OR
NiCl2(PPh3)2 (5 mol%)
THF-NEP, 25 °C, 3 h
CN
O
(Me2N)2P
1) TMP2Mg·2LiCl
THF, 0 °C, 1 h
2) ZnCl2, -40 °C, 15 min
3) tBuCOCl, CuCN·2LiCl
R=P(O)(NMe2)2
R=SO2(CF2)3CF3 75%
CO2Et
O
O
P(NMe2)2O
1) TMP2Mg·2LiCl
THF, 0 °C, 1 h
2) ZnCl2, -40 °C, 15 min
3) PhCOCl, CuCN·2LiCl
meta-, para-functionalization
para-, meta-functionalization
1) TMP2Mg·2LiCl,
THF, -50 °C, 7 h
2) ZnCl2, -40 °C, 15 min
3) Pd(dba)2 (2 mol%)
P(o-furyl)3 (4 mol%)
4-IC6H4CN
1) TMP2Mg·2LiCl
-60 °C, 0.5 h
2) ZnCl2, -60 °C, 15 min
3) PhCOCl, CuCN·2LiCl
meta-, meta'-functionalization
O O O
 
Scheme 43: Formal meta-, para-, para-, meta- or meta-, meta’-functionalizations on arenes. 
 
Using this method, a meta-, para-functionalization, a para-, meta-functionalization or a meta-, 
meta’-functionalization pattern was readily installed on aromatics. Further studies on the 
selectivities of phosphorodiamdates derived from anilines and aromatic thiols might be of 
interest. Investigations concering the use of the DMG as aleaving group in cross-coupling 
reactions would also be challenging. 
 
3.8.3. Improved Selectivity for the Metalation of N-Heterocycles 
 
The N,N,N’,N’-tetramethylphosphorodiamidate attached to N-heterocycles and the TMP-
derived bases developed by Knochel led to smooth and regioselective functionalizations of 
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these scaffolds (Scheme 44). Other DMGs (e. g. Boc) failed to succeed in these reactions due 
to stability and selectivity problems.  
 
 
Scheme 44:  Efficient and regioselctive functionalizations on N-heteroarenes. 
 
This new protocol was used for the preparation of the pyridine based COX-2 inhibitor 
Etoricoxib (Arcoxia, Merck). The straightforward synthesis only required five steps starting 
from comercially available 2-hydroxy pyridine (Scheme 45).  
 
N O
P(NMe2)2O
SO2Me
N
SO2Me
Cl
N Me
Etoricoxib
1) TMPMgCl·LiCl,
THF, 0 °C, 1 h
2) ZnCl2,
3) Pd2(dba)3
RuPHOS
88%
N
H
O
SO2Me
HCl 2 M/
dioxane 1/1
25 °C, 24 h
HCl conc.
KClO3, 50 °C,
0.5 h
N
H
O
SO2Me
Cl
95%
95%
N Me
Me3Sn
1) POCl3,
150 °C, 15 h
2) Pd(PPh3)4,
100 °C, 15 h
N O
P(NMe2)2O
Br
SO2Me
 
Scheme 45: Synthesis of Etoricoxib. 
 
The synthesis of two active compounds with a quinoline salicylic acid backbone was also 
accomplished applying this new method (Scheme 46). 
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1) TMP2Mg·2LiCl
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1) TMPMgCl·LiCl
THF, 25 °C, 1 h
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1) TMP2Mg·2LiCl
THF, -50 °C, 1 h
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Et
Ph-I pClC6H4-I
 
Scheme 46: Synthesis of Talnetant and a P-Selectin Inhibitor. 
 
Both compounds were obtained starting from commercially available 3-hydroxy quinoline 
after only five steps. This developed method is also an alternative for the Pfitzinger reaction 
which is commonly used to build up quinoline salicyclic acids starting from substituted 
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isatines (Scheme 47).  
 
 
Scheme 47: Pfitzinger synthesis leading to quinoline salicylic acids. 
Further work could be the functionalization of indoles using this method. 
 
3.8.4. Alternative Sterically Demanding Amines to TMP-H 
 
As TMP-H is the most expensive compound for metalation reactions two readily prepared, 
less expensive amines were tested for their performance in magnesiations and zincations. It 
turned out, that their efficiency is comparable to TMP-H in terms of concentration and 
reaction behavior (Scheme 48). 
 
N
MgCl·LiCl
THF, -50 to 140 °C,
up to 12 h
E+
Me
H
FG
MgX
FG
E
FG
up to 93 %
N MgCl·LiCl
iPr
tBu
N
tBu
iPr
Zn·2MgCl2·2LiClN
tBu
iPr
Mg·2 LiCl
CO2Et
ClCl
Me
CN
F
TIPSO
tBuO2C CO2tBu
CO2tBu
2 2
91% 90% 83%
Mg- or Zn base
 
Scheme 48: Economically interesting amines as an alternative to TMP-H. 
 
The use of these amines in the preparation of manganese-, iron- and lanthanum bases would 
be of great interest. 
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3.9. Cobalt-Catalyzed Aryl Sulfonate/Copper Exchange 
 
A new cobalt-catalyzed aryl sulfonate/copper exchange reaction was developed. This method 
allowed the synthesis of highly functionalized aryl copper reagents from sulfonates bearing 
electron-deficient substituents under mild conditions (25-45 °C, 1-6 h). Sensitive functional 
groups, such as aldehydes, esters, and nitriles, were well-tolerated (Scheme 49). 
 
 
Scheme 49: Co-catalyzed arylsulfonate/copper exchange. 
 
Further studies involving other leaving groups as well as different transitionmetal-catalysts for 
the preparation of various organometallic species would be challenging. 
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4.1. General Considerations 
 
All reactions were carried out with magnetic stirring and, if air or moisture sensitive, in flame 
dried glassware under argon. For this case, all glassware was oven dried (80 °C) overnight 
(min. 12 h), evacuated in high vacuum (1·10-3mbar) and backfilled with argon (this procedure 
was repeated three times). Syringes were used to transfer solvents and reagents, and were 
purged with argon prior to use. 
 
Solvents 
 
Solvents were dried according to standard methods by distillation over drying agents as stated 
below and were stored under argon. 
DMF was heated to reflux for 14 h over CaH2 and distilled from CaH2. 
DMPU was stirred over CaH2 for 12 h, distilled and stored under argon and over molecular 
sieves. 
THF was continuously refluxed and freshly distilled from sodium benzophenone ketyl under 
nitrogen. 
Triethylamine was dried over KOH and distilled. 
 
Chromatography 
 
Thin layer chromatography (TLC) was performed using aluminium plates coated with SiO2 
(Merck 60, F-254). The spots were visualized by UV light or by staining of the TLC plate 
with the solution below followed by heating if necessary: 
- Phosphomolybdic acid (5.0 g), Ce(SO4)2 (2.0 g) and conc. H2SO4 (12.0 mL) in water       
(230 mL) 
- Iodine absorbed on silica gel 
- KMnO4 (0.3 g), K2CO3 (20 g) and KOH (0.3 g), in water (300 mL). 
Flash column chromatography was performed using SiO2 60 (0.04-0.063 mm, 230-400 mesh) 
from Merck. 
Analytical data 
 
NMR spectra were recorded on Bruker ARX 200, AC 300, WH 400 or AMX 600 
instruments. Chemical shifts are reported as δ-values in ppm relative to the solvent peak. 
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NMR spectra were recorded on solutions in CDCl3 (residual chloroform: δ 7.25 ppm for 1H 
NMR and δ 77.0 ppm for 13C NMR), d6-DMSO (residual DMSO: δ 2.49 ppm for 1H NMR 
and δ 39.5 ppm for 13C NMR. For the characterization of the observed signal multiplicities the 
following abbreviations were used: s (singlet), d (doublet), t (triplet), dd (doublet of doublet), 
ddd (doublet of doublet of doublet), dt (doublet of triplet), q (quartet), qn (quintet), m 
(multiplet), as well as br (broad). 
 
Melting points are uncorrected and were measured on a Büchi B.540 apparatus. 
 
Infrared spectra were recorded from 4000-400 cm-1 on a Perkin 281 IR spectrometer. 
Samples were measured neat (ATR, Smiths Detection DuraSampl IR II Diamond ATR). The 
absorption bands were reported in wave numbers (cm-1).  
 
Gas chromatography was performed with machines of type Hewlett-Packard 6890 or 5890 
series II, using a column of type HP 5 (Hewlett-Packard, 5% phenylmethylpolysiloxane; 
length: 15 m, diameter: 0.25 mm; film thickness 0.25 µm). The detection was accomplished 
by using a flame ionization detector. The carrier gas was air; alkanes like decane or 
tetradecane were used as internal standards. 
 
Mass Spectra were recorded on Finnigan MAT 95Q or Finnigan MAT 90 instrument for 
electron impact ionization (EI). High resolution mass spectra (HRMS) were recorded on the 
same instrument. 
 
Reagents 
 
As not otherwise stated, all reagents were obtained from commercial sources. Reagents of 
>97% purity were used without purification, except technical grade tosyl cyanide (purity 
95%). Liquid acid chlorides and aldehydes were distilled prior to use. TMPH was distilled 
from CaH2 and stored under argon.  
 
The following substances were prepared according to literature procedures: 
2,2,4,6,6-pentamethylpiperidine (48), 94  tert-butyl(isopropyl)amine (39), tert-butyl benzoate 
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 P. L. Hall, J. H. Gilchrist, A. T. Harrison, D. J. Fuller, D. B. Collum, J. Am Chem. Soc. 1991, 113, 9575. 
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(13a), 95  tert-butyl naphthoate95 (43b), tert-butyl isonicotinate95 (43c), di-tert-butyl 
isophtalate95 (43b), diethyl 5-[(tert-butoxycarbonyl)oxy]isophthalate95 (40b), ethyl 3,5-
dichlorobenzoate95 (40a), diethyl 4-bromoisophthalate95 (40d), diethyl 2-bromoterephthalate95 
(40c). 
 
Co(acac)2 was dried in high vacuum (1·10-3mbar) with stirring for 5 h at 140 °C and stored 
under argon. 
 
nBuLi was obtained from Chemetall GmbH (Frankfurt, Germany) and titratred96 prior to use 
(approx. 2.5 M in hexane). 
 
PhMgCl was obtained from Chemetall GmbH (Frankfurt, Germany) and titratred97 prior to 
use (1.72 M in THF). 
 
iPrMgCl·LiCl was obtained from Chemetall GmbH (Frankfurt, Germany) and titratred97 
prior to use (1.33 M in THF). 
 
ZnCl2 (1.0 M in THF) was prepared by drying ZnCl2 (68.2 g, 500 mmol) under high vacuum 
(1·10-3mbar) for 6 h at 150 °C. After cooling to 25 °C, dry THF (500 mL) was added and 
stirring was continued until the salt was completely dissolved. 
 
CuCN·2LiCl (1.0 M in THF) was prepared by drying LiCl (6.8 g, 160 mmol) and CuCN 
(7.2 g, 80 mmol, 99% pure) at 150 °C for 5 h under high vacuum (1·10-3mbar), cooled to 25 
°C and charged with freshly distilled THF (80 mL) under argon with vigorous stirring. The 
mixture was stirred for at least 24 h at 25 °C. CuCN·2LiCl (1.0 M in THF) appears as a pale 
yellow solution. 
 
Preparation of the reagent TMPMgCl·LiCl (10a):  
 
A dried and argon-flushed 1-L Schlenk-flask, equipped with a magnetic stirring bar and 
rubber septum, is charged with iPrMgCl·LiCl (792 mL, 1.2 m in THF, 950 mmol) then 
                                                 
95
 For preparation of tert-butyl esters see: D. Lagnoux, E. Delort, C. Douat-Cassassus, A. Esposito, J.-L. 
Reymond Chem. Eur. J. 2004, 10, 1215. 
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 H.-S. Lin, L. A. Paquette, Synth. Commun. 1994, 24, 2503.  
97
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2,2,6,6-tetramethylpiperidine (141.3 g, 1.00 mol) is added dropwise within 5 min via syringe. 
The mixture is stirred until gas evolution ceases (24–48 h). Complete formation of the base 
was checked by GC/MS analysis of aliquots quenched with benzaldehyde. The absence of 2-
methyl-1-phenylpropan-1-ol (M+=150) indicates a full conversion. Titration30 prior to use at 
0 °C against benzoic acid using 4-(phenylazo)-diphenylamine as indicator shows a 
concentration of 1.45 M. 
 
Preparation of the reagent [(tBu)(iPr)]NMgCl·LiCl (10b):  
 
A dry and argon flushed Schlenk-flask was charged with iPrMgCl·LiCl (1.2 M in THF, 208 
mL, 250 mmol). tert-Butyl(iso-propyl)amine (39; 30.3 g, 263 mmol) was added dropwise 
within 5 min. The mixture was stirred at 25 °C, until gas evolution ceased (48 h). Complete 
formation of the base was checked by GC/MS analysis of aliquots quenched with 
benzaldehyde. The absence of 2-methyl-1-phenylpropan-1-ol (M+=150) indicates a full 
conversion. The freshly prepared [(tBu(iPr))NMgCl·LiCl solution was titrated30, 98 prior to use 
at 0 °C against benzoic acid using 4-(phenylazo)-diphenylamine as indicator. A concentration 
of 1.45 M in THF was obtained. 
 
Preparation of the reagent PMPMgCl·LiCl (10c):  
 
A dry and argon flushed Schlenk-flask was charged with iPrMgCl·LiCl (1.2 M in THF, 208 
mL, 250 mmol). 2,2,4,6,6-Pentamethylpiperidine (48, 40.8 g, 263 mmol) was added dropwise 
within 5 min. The mixture was stirred at 25 °C, until gas evolution ceased (24-48 h). 
Complete formation of the base was checked by GC/MS analysis of aliquots quenched with 
benzaldehyde. The absence of 2-methyl-1-phenylpropan-1-ol (M+=150) indicates a full 
conversion. The freshly prepared PMPMgCl·LiCl solution was titrated30, 98 prior to use at 0 °C 
against benzoic acid using 4-(phenylazo)-diphenylamine as indicator. A concentration of 1.45 
M in THF was obtained. 
 
Preparation of the reagent TMP2Mg·2LiCl (14a) from TMPMgCl·LiCl (10a) and 
TMPLi: 
 
In an argon flushed Schlenk-flask, 2,2,6,6-tetramethylpiperidine (TMPH, 5.07 mL, 30.0 mmol) 
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was dissolved in THF (30 mL). This solution was cooled to –40 °C and n-BuLi (2.4 M in 
hexane, 12.5 mL, 30.0 mmol) was added dropwise. After the addition was complete, the 
reaction mixture was warmed to 0 °C and stirred at this temperature for 30 min. Freshly 
titrated TMPMgCl·LiCl (10a) (1.45 M in THF, 20.7 mL, 30.0 mmol) was then added 
dropwise to the LiTMP solution, the reaction mixture was stirred at 0 °C for 30 min, warmed 
to 25 °C and stirred for 1 h. The solvents were then removed in vacuo without heating, 
affording a yellowish solid. Freshly distilled THF was then slowly added under vigorous 
stirring, until a complete dissolution of the salts was observed. The fresh TMP2Mg·2LiCl (14a) 
solution was titrated30 prior to use at 0 °C against benzoic acid using 4-(phenylazo)-
diphenylamine as indicator. A concentration of 0.7 M in THF was obtained. 
 
Preparation of the reagent [(tBu)(iPr)]N2Mg·2LiCl (14c) from [(tBu)(iPr)]NMgCl·LiCl 
(10b) and [(tBu)(iPr)]N-Li: 
 
In an argon flushed Schlenk-flask, tert-Butyl(iso-propyl)amine (39, 2.30, 30.0 mmol) was 
dissolved in THF (30 mL). This solution was cooled to –40 °C and n-BuLi (2.4 M in hexane, 
12.5 mL, 30.0 mmol) was added dropwise. After the addition was complete, the reaction 
mixture was warmed to 0 °C and stirred at this temperature for 30 min. Freshly titrated 
[(tBu)(iPr)]NMgCl·LiCl (10b) (1.45 M in THF, 20.7 mL, 30.0 mmol) was then added 
dropwise to the LiTMP solution, the reaction mixture was stirred at 0 °C for 30 min, warmed 
to 25 °C and stirred for 1 h. The solvents were then removed in vacuo without heating, 
affording a yellowish solid. Freshly distilled THF was then slowly added under vigorous 
stirring, until a complete dissolution of the salts was observed. The fresh 
[(tBu)(iPr)]N2Mg·2LiCl (14c) solution was titrated30 prior to use at 0 °C against benzoic acid 
using 4-(phenylazo)-diphenylamine as indicator. A concentration of 0.85 M in THF was 
obtained. 
 
Preparation of the reagent TMP2Zn·2MgCl2·2LiCl (12a):  
 
A dried, argon flushed 250 mL Schlenk-flask equipped with magnetic stirring bar and rubber 
septum was charged with ZnCl2 (4.09 g, 30 mmol). The flask was heated to 150 °C under 
high vacuum (1·10-3 mbar) for at least 6 h under vigorous stirring. After cooling to 25 °C, dry 
THF (10 mL) was added and the resulting slurry was cooled to 0 °C with an ice bath. Then 
TMPMgCl·LiCl (10; 42.9 mL, 1.4 M in THF, 60 mmol) was added via syringe. The mixture 
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was stirred for 12 h until complete dissolution of the salts. Precipitates of the base can easily 
be redissolved by adding a few mL of dry THF. The freshly prepared TMP2Zn·2MgCl2·2LiCl 
(12a) solution was titrated30 prior to use at 0 °C against benzoic acid using 4-(phenylazo)-
diphenylamine as indicator. A concentration of 0.6 M in THF was obtained. 
 
Preparation of [(tBu)N(iPr)]2Zn·2MgCl2·2LiCl (12b):  
 
A dried, argon flushed 250 mL Schlenk-flask equipped with magnetic stirring bar and rubber 
septum was charged with ZnCl2 (4.09 g, 30 mmol). The flask was heated to 150 °C under 
high vacuum for at least 6 h under vigorous stirring. After cooling to 25 °C, dry THF (10 mL) 
was added and the resulting slurry was cooled to 0 °C with an ice bath. Then 
[(tBu)(iPr)]NMgCl·LiCl (10b; 41.4 mL, 1.45 M in THF, 60 mmol) was added via syringe. The 
mixture was stirred for 12 h until complete dissolution of the salts. Precipitates of the base can 
easily be redissolved by adding a few mL of dry THF. The freshly prepared 
[(tBu)(iPr)N]2Zn·2MgCl2·2LiCl) (12b) solution was titrated30 prior to use at 0 °C against 
benzoic acid using 4-(phenylazo)diphenylamine as indicator. A concentration of 0.5 M in THF 
was obtained. 
 
4.2. Typical Procedures 
 
Typical Procedure 1 (TP1): Synthesis of the phosphorodiamidates from phenols: 
 
In a 100 mL round-bottom flask the phenol (20.0 mmol) and 4-DMAP (244 mg, 2.0 mmol) 
were dissolved in THF (20 mL), then Cl-P(O)(NMe2)2 (4.50 g, 3.9 mL, 24.0 mmol) was 
carefully added, followed by the addition of triethylamine (2.43 g, 3.33 mL, 24.0 mmol). The 
resulting suspension was stirred at 25 °C for 12 h. The reaction mixture was quenched by the 
addition of a half concentrated aq. NH4Cl solution (20 mL) and extracted with EtOAc (3 x 20 
mL). The combined organic layers were washed with brine, dried over MgSO4, filtered and 
concentrated in vacuo. 
 
Typical Procedure 2 (TP2): Synthesis of the phosphorodiamidates from the corresponding 
hydroxy pyridines, hydroxy quinolines and hydroxy quinoxalines: 
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In a 100 mL round-bottom flask the hydroxy compound (20.0 mmol) and 4-DMAP (244 mg, 
2.0 mmol) were dissolved or slurried up in THF (20 mL), then Cl-P(O)(NMe2)2 (4.50 g, 3.9 
mL, 24.0 mmol) was added, followed by the addition of triethylamine (2.43 g, 3.33 mL, 24.0 
mmol). The resulting suspension was stirred at 25 °C for 12 h. The reaction mixture was 
quenched by the addition of brine (20 mL) and extracted with EtOAc (3 x 20 mL). The 
combined organic layers were dried over MgSO4, filtered and concentrated in vacuo. 
 
Typical Procedure 3 (TP3): Preparation of aryl sulfonates from phenols: 
 
In a 100 mL round bottom flask equipped with a magnetic stirring bar the phenol (20 mmol) 
was dissolved in 40 mL of dry THF. Then, NEt3 (2.43 g, 24 mmol) was added and the mixture 
was cooled with an ice bath (approx. 0 °C). The sulfonyl chloride (24 mmol) was added 
portionwise and the resulting mixture was stirred and allowed to reach 25 °C within 12 h. 
Then 50 mL of a saturated aqueous NH4Cl solution were added and the resulting mixture was 
extracted into EtOAc (50 mL). The organic layer was washed twice with 50 mL of a saturated 
aqueous NH4Cl solution. The combined organic layers were washed with brine, dried over 
MgSO4 and concentrated in vacuo. The resulting solids were recrystallized from n-
heptane/EtOAc. 
 
Typical procedure 4 (TP4): Br/Mg-Exchange or I/Mg-Exchange on aryl sulfonates: 
 
In a dry and argon flushed Schlenk-tube, the arylsulfonate (20 mmol) was dissolved in dry 
THF and cooled to –40°C. Then, iPrMgCl·LiCl (16.5 mL, 1.33 M in THF, 22 mmol) was 
dropwise added. The resulting mixture was stirred until GC showed full conversion to the 
organomagnesium reagent (aliquots were quenched with I2 in THF and extracted with Et2O). 
Then, the electrophile (20 mmol) was added. The reaction mixture was stirred for 30 min at –
40°C and 1 h at 25 °C. The reaction was quenched with 50 mL of a saturated aqueous NH4Cl 
solution and extracted into 50 ml EtOAc. The organic layer was washed twice with 50 mL of 
a saturated aqueous NH4Cl solution. The combined organic layers were washed with brine, 
dried over MgSO4 and concentrated in vacuo. The resulting solids recrystallized from n-
heptane/EtOAc. 
 
 
Typical Procedure 5 (TP5): Metalation using metal amide bases:   
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In a flame dried and argon flushed Schlenk-tube equipped with a rubber septum and a 
magnetic stirring bar the substrate (1 equiv) was dissolved in dry THF (1 M solution). The 
mixture was cooled to the indicated temperature. Then the Mg- or Zn-base (0.6-2.0 equiv) 
was added dropwise via syringe. The mixture was stirred at the given temperature. Complete 
metalation was detected by GC-analysis of reaction aliquots, quenched with allyl bromide 
(approx. 5 drops) in the presence of CuCN·2LiCl (approx. 0.5 mL). The reaction mixture was 
then quenched with an electrophile according to TP7-9. The reaction mixture was quenched 
by the addition of 15-30 mL of brine (N-heterocycles) or a sat. aq. NH4Cl solution. Formed 
precipitate was filtered off with a fritted funnel (P3, 300 mbar). The filter cake was washed 
with EtOAc (3 x 25 ml) and the filtrate was brought into a separatory funnel with Et2O (10-20 
mL) and EtOAc (10-20 mL). The organic layer was extracted with brine (3 x 15 mL). The 
combined aqueous layers were extracted with EtOAc (2 x 20 mL). The organic layers were 
washed with brine (20 mL) dried over anhydrous MgSO4 filtered and concentrated in vacuo. 
The residue was subjected to flash column chromatographical purification on silica. 
 
Typical Procedure 6 (TP6): Microwave  assisted zincation reaction: 
 
In a flame dried and argon flushed 10 mL µW sealed tube equipped a magnetic stirring bar 
the corresponding substrate (1 equiv.) was dissolved in the indicated amount of 54 (0.6 
equiv.). The mixture was heated to the indicated temperature with an Initiator Sixty EXP 
Microwave System (Biotage) and stirred at this temperature for the given period. Complete 
metalation was detected by GC-Analysis of reaction aliquots, quenched with I2 in dry THF. 
Then the reaction mixture was then quenched with an electrophile and worked up as described 
below (according to TP7-9). 
 
Typical Procedure 7 (TP7): Quenching by performing a Negishi Cross-Coupling Reaction: 
 
After complete metalation was achieved according to TP5 ZnCl2 (1 M in THF, 1.6 – 2.2 equiv) 
was added at –40 °C (if required, see specific procedures). The resulting mixture was stirred 
for 15 min. Then Pd(dba)2 (5 mol%) and P(2-furyl)3 (10 mol%) (for aryl iodides) or Pd2(dba)3 
(1 mol%) and RuPHOS (2 mol%) (for aryl bromides) was added together with the 
corresponding aryl iodide or bromide and the mixture was allowed to warm to 25 °C. 
Complete consumption of the organozinc reagent was monitored via GC-analysis (approx. 1 - 
EXPERIMENTAL SECTION 
 85 
3 h). The reaction mixture was quenched by the addition of 15-30 mL of brine (N-
heterocycles) or a sat. aq. NH4Cl solution. Formed precipitate was filtered off with a fritted 
funnel (P3, 300 mbar). The filter cake was washed with EtOAc (3 x 25 ml) and the filtrate 
was brought into a separatory funnel with Et2O (10-20 mL) and EtOAc (10-20 mL). The 
organic layer was extracted with brine (3 x 15 mL). The combined aqueous layers were 
extracted with EtOAc (2 x 20 mL). The organic layers were washed with brine (20 mL) dried 
over anhydrous MgSO4 filtered and concentrated in vacuo. The residue was subjected to flash 
column chromatographical purification on silica. 
 
Typical Procedure 8 (TP8): Quenching by performing an Acylation Reaction: 
 
After complete metalation was achieved according to TP5 ZnCl2 (1 M in THF, 1.6 equiv) was 
added at –40 °C (if required, see specific procedures). The mixture was the stirred for 15 min. 
Then CuCN·2LiCl (1 M in THF, 0.1 equiv) or Pd(PPh3)4 (2 mol%) was added (see specific 
procedures). After the addition of the corresponding acid chloride, the mixture was briefly 
warmed with to 25 °C. Complete consumption of the organozinc reagent was monitored via 
GC-analysis (approx. 1 - 3 h). The reaction mixture was quenched by the addition of 15-30 
mL of brine (N-heterocycles) or a sat. aq. NH4Cl solution. Formed precipitate was filtered off 
with a fritted funnel (P3, 300 mbar). The filter cake was washed with EtOAc (3 x 25 ml) and 
the filtrate was brought into a separatory funnel with Et2O (10-20 mL) and EtOAc (10-20 mL). 
The organic layer was extracted with brine (3 x 15 mL). The combined aqueous layers were 
extracted with EtOAc (2 x 20 mL). The organic layers were washed with brine (20 mL) dried 
over anhydrous MgSO4 filtered and concentrated in vacuo. The residue was subjected to flash 
column chromatographical purification on silica. 
 
Typical Procedure 9 (TP9): Quenching by performing an Allylation Reaction : 
 
After complete metalation was achieved according to TP5 ZnCl2 (1 M in THF, 1.6 equiv) (if 
required, see specific procedures) was added at –40 °C. The resulting mixture was stirred for 
15 min. CuCN·2LiCl (1 M in THF, 0.1 equiv) was added together with the corresponding 
allylbromide and the mixture was allowed to warm to room temperature. Complete 
consumption of the organozinc reagent was monitored via GC-analysis (approx. 1 - 3 h). The 
reaction mixture was quenched by the addition of 15-30 mL of brine (N-heterocycles) or a sat. 
aq. NH4Cl solution. Formed precipitate was filtered off with a fritted funnel (P3, 300 mbar).  
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The filter cake was washed with EtOAc (3 x 25 ml) and the filtrate was brought into a 
separatory funnel with Et2O (10-20 mL) and EtOAc (10-20 mL). The organic layer was 
extracted with brine (3 x 15 mL). The combined aqueous layers were extracted with EtOAc (2 
x 20 mL). The organic layers were washed with brine (20 mL) dried over anhydrous MgSO4 
filtered and concentrated in vacuo. The residue was subjected to flash column 
chromatographical purification on silica.  
 
Typical Procedure 10 (TP10): Co-catalyzed aryl sulfonate/copper-exchange: 
 
A dry and argon flushed 25 mL Schlenk-tube was charged with PhMgCl (1.74 mL, 1.72 M in 
THF, 3.00 mmol) and cooled to –20 °C. Then, CuCN·2LiCl (3.6 mL, 1.0 M in THF, 3.6 mmol) 
was dropwise added. The resulting yellow solution was stirred for 20 min at –20 °C. Then, 
Bu4NI (369 mg, 1.00 mmol), the arylsulfonate (1.00 mmol), Co(acac)2 (51 mg, 20 mol%), 4-
fluorostyrene (65 mg, 50 mol%) and dry DMPU (2.2 mL) were added. The resulting 
suspension was warmed to 25 °C (or 45 °C see specific procedure) and stirred until GC-
analysis showed full consumption of the starting material. The formation of the copper 
reagent was monitored by performed iodolysis of reaction aliquots (GC-analysis). The 
reaction mixture was cooled to –20 °C and the electrophile (2.00 mmol) was added. The 
reaction mixture was stirred 30 min at –20 °C and for 2 h at 25 °C. The mixture was quenched 
by the addition of NH4Cl/NH3 (9:1) (15 mL) and extracted with Et2O (3 x 25 mL). The 
aqueous phase was extracted with EtOAc (25 mL) twice. The combined organic layers were 
washed with brine and dried over MgSO4 and concentrated in vacuo. Column 
chromatography on silica furnished the desired product. 
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4.3. Magnesiation on Weakly Activated Substrates Using a 
Highly Reactive Mg-Base. 
 
4.3.1. Directed Metalation and Reaction with Electrophiles 
 
Synthesis of 2-t-butyl 4'-ethyl biphenyl-2,4'-dicarboxylate (15d): 
 
 
 
The title compound was prepared from tert-butyl benzoate (13a; 178 mg, 1.00 mmol), 
TMP2Mg·2LiCl (1.57 mL, 0.7 M in THF, 1.1 mmol), 4-iodobenzoate (414 mg, 1.5 mmol), 
ZnCl2 (1.6 ml, 1 M in THF, 1.6 mmol), Pd(dba)2 (11 mg, 2 mol%) and P(2-furyl)3 (9 mg, 4 
mol%) applying TP5 and TP7. Metalation conditions: 25 °C, 60 min. Flash chromatography 
on silica (n-pentane/Et2O, 9:1) gave a colorless oil (267 mg, 82%). 
1H-NMR (300 MHz, CDCl3) δ: 8.11 (d, J = 8.2 Hz, 2 H), 7.86 (dd, J = 7.7 Hz, J = 1.5 Hz, 1 
H), 7.54 (dd, J = 7.4 Hz, J = 1.4 Hz, 1 H), 7.46 (dd, J = 7.5 Hz, J = 1.4 Hz, 1 H), 7.42 (d, J = 
8.2 Hz, 2 H), 7.33 (dd, J = 7.5 Hz, J = 1.3 Hz, 1 H), 4.43 (q, J = 7.1 Hz, 2 H), 1.45 (t, J = 7.1 
Hz, 3 H), 1.29 (s, 9 H). 
13C-NMR (75 MHz, CDCl3) δ: 167.8, 166.8, 146.9, 141.4, 138.8, 132.9, 131.1, 130.6, 130.2, 
129.4, 128.9, 127.9, 81.8, 61.2, 27.9, 14.6.  
MS (70 eV, EI) m/z (%): 326 (5) [M+], 281 (5), 270 (100), 253 (7), 242 (32), 225 (71), 181 
(10), 152 (15), 151 (6), 57 (8). 
IR (ATR) ν~  (cm-1): 2978, 2933, 1707, 1610, 1367, 1268, 1125, 1098, 847, 752, 703. 
HRMS (EI): 326.1500 (calcd.: 326.1518). 
 
Synthesis of ethyl 2-(4-cyanophenyl)-1-naphthoate (15e): 
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The title compound was prepared from ethyl 1-naphtoate (13b; 200 mg, 1.00 mmol), 
TMP2Mg·2LiCl (1.57 mL, 0.7 M in THF, 1.1 mmol), 4-iodobenzonitrile (342 mg, 1.5 mmol), 
ZnCl2 (1.6 ml, 1 M in THF, 1.6 mmol), Pd(dba)2 (11 mg, 2 mol%) and P(2-furyl)3 (9 mg, 4 
mol%) applying TP5 and TP7. Metalation conditions: 0 °C, 3 h. Flash chromatography on 
silica (n-pentane/Et2O 4:1) furnished a pale yellow solid (244 mg, 81%).  
m.p.: 105.6 - 107.9 °C 
1H-NMR (400 MHz, CDCl3) δ : 8.00 (m, 2 H), 7.90 (m, 1 H), 7.72 (ddd, J = 8.4 Hz, J = 1.9 
Hz, J = 1.7 Hz, 2 H), 7.58 (m, 4 H), 7.44 (d, J = 8.4 Hz, 1 H), 4.18 (q, J = 7.0 Hz, 2 H), 1.03 (t, 
J = 7.1 Hz, 3 H).  
13C-NMR (100 MHz, CDCl3) δ: 169.0, 146.1, 136.3, 133.0, 132.3, 132.0, 130.7, 130.5, 130.1, 
129.7, 128.4, 127.2, 126.7, 125.4, 118.9, 111.7, 61.7, 14.0. 
MS (70 eV, EI) m/z (%): 302 (17), 301 (77) [M+], 273 (9),257 (27), 256 (100), 228 (36), 227 
(71), 226 (13), 201 (18), 200 (15).  
IR (ATR) ν~  (cm-1): 2977, 2899, 2223, 1711, 1604, 1593, 1502, 1470, 1429, 1377, 1281, 
1233, 1149, 1137, 1033, 1022, 1002, 959, 862, 822, 801, 757, 663. 
HRMS (EI): 301.1084 (calcd.: 301.1103). 
 
Synthesis of t-butyl 2-benzoyl-4-bromobenzoate (15f): 
 
 
 
The title compound was prepared from tert-butyl 4-bromobenzoate (13d; 257 mg, 1.00 mmol), 
TMP2Mg·2LiCl (1.57 mL, 0.7 M in THF, 1.1 mmol), benzoyl chloride (265 ml, 2.2 mmol), 
CuCN·2LiCl (0.1 mL, 1 M in THF, 10 mol%) applying TP5 and TP8. Metalation conditions: 
–20 °C, 1 h. Flash chromatography on silica (n-pentane/Et2O 5:1) furnished a pale yellow 
solid (278 mg, 77%).  
m.p.: 71.1 - 73.3 °C.  
1H-NMR (300 MHz, CDCl3) δ : 7.90 (d, J = 8.4 Hz, 1H), 7.80 – 7.78 (m, 2 H), 7.70 (dd, J = 
8.4 Hz, J = 2.1 Hz, 1 H), 7.62 – 7.57 (m, 1 H), 7.53 – 7.44 (m, 3 H), 1.24 (s, 9 H). 
13C-NMR (75 MHz, CDCl3) δ: 195.2, 164.7, 142.8, 136.9, 133.7, 132.9, 131.8, 130.8, 130.2, 
129.9, 128.8, 127.1, 83.4, 27.7. 
MS (70 eV, EI) m/z (%): 360 (7) [M+-H], 307 (89), 305 (39), 287 (65), 227 (11), 181 (100), 
152 (39), 105 (80), 77 (35), 57 (43). 
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IR (ATR) ν~  (cm-1): 2979, 2933, 1713, 1674, 1538, 1449, 1392, 1368, 1299, 1289, 1128, 
1093, 946, 848, 696. 
HRMS (EI): 360.0343 (calcd.: 360.0361). 
 
Synthesis of ethyl 2'-cyanobiphenyl-4-carboxylate (15g): 
 
 
 
The title compound was prepared from benzonitrile (13e; 103 mg, 1.00 mmol), 
TMP2Mg·2LiCl (1.57 mL, 0.7 M in THF, 1.1 mmol), ethyl 4-iodobenzoate (414 mg, 1.5 
mmol), ZnCl2 (1.6 ml, 1 M in THF, 1.6 mmol), Pd(dba)2 (11 mg, 2 mol%) and P(2-furyl)3 (9 
mg, 4 mol%) applying TP5 and TP7. Metalation conditions: –30 °C, 3 h. Flash 
chromatography on silica (n-pentane/Et2O 4:1) furnished a colorless solid (176 mg, 70%). 
m.p.: 115.0 - 117.3 °C.  
1H-NMR (300 MHz, CDCl3) δ : 8.1 (d, J = 8.2 Hz, 2 H), 7.8 (d, J = 8.2 Hz, 1 H), 7.6 (m, 3 
H), 7.5 (m, 2 H), 4.4 (q, J = 7.3 Hz, 2 H), 1.4 (t, J = 7.1 Hz, 3 H). 
13C-NMR (75 MHz, CDCl3) δ: 166.4, 144.7, 142.6, 134.1, 133.2, 131.1, 130.3, 130.2, 129.1, 
128.4, 118.6, 11.6, 61.4, 14.6. 
MS (70 eV, EI) m/z (%): 251 (30) [M+], 223 (33), 207 (17), 206 (100), 179 (26), 178 (32), 
177 (30), 152 (11), 151 (39), 150 (15), 75 (9). 
IR (ATR) ν~  (cm-1): 2908, 2224, 1708, 1607, 1594, 1559, 1478, 1406, 1366, 1315, 1272, 
1184, 1110, 1097, 1030, 860, 763, 740, 721, 704. 
HRMS (EI): 251.0960 (calcd.: 251.0946). 
 
Synthesis of diethyl 2-bromopyridine-3,5-dicarboxylate (15h): 
 
 
 
The title compound was prepared from diethyl pyridine-3,5-dicarboxylate (13f; 223 mg, 1.00 
mmol), TMP2Mg·2LiCl (1.57 mL, 0.7 M in THF, 1.1 mmol), BrCl2CCCl2Br (779 mg, 2.4 
mmol) applying TP5. Metalation conditions: –40 °C, 3 h. Flash chromatography on silica (n-
pentane/Et2O 9:1) furnished a pale yellow solid (211 mg, 70%). 
EXPERIMENTAL SECTION 
 90 
m.p.: 40.2 - 41.8 °C. 
1H-NMR (300 MHz, CDCl3) δ: 8.9 (d, J = 2.3 Hz, 1 H), 8.5 (d, J = 2.3 Hz, 1 H), 4.3 (q, J = 
7.1 Hz, 2 H), 4.3 (q, J = 7.1 Hz, 2 H), 1.3 (t, J = 7.1 Hz, 3 H), 1.3 (t, J = 7.1 Hz, 3 H).  
13C-NMR (75 MHz, CDCl3) δ: 164.6, 164.0, 152.7, 140.3, 139.0, 130.2, 125.6, 63.3, 62.8, 
14.4, 14.3. 
MS (70 eV, EI) m/z (%): 301 (40) [M+], 275 (28), 273 (30), 258 (100), 255 (94), 230 (37), 
228 (39), 202 (11), 194 (27), 166 (15), 76 (15), 45 (10).  
IR (ATR) ν~  (cm-1): 2996, 1733, 1717, 1588, 1551, 1380, 1243, 1229, 1109, 1049, 1017, 762. 
HRMS (EI): 300.9952 (calcd.: 300.9949). 
 
Synthesis of diethyl 2-(4-cyanophenyl)pyridine-3,5-dicarboxylate (15i): 
 
 
 
The title compound was prepared from diethyl pyridine-3,5-dicarboxylate (13f; 223 mg, 1.00 
mmol), TMP2Mg·2LiCl (1.57 mL, 0.7 M in THF, 1.1 mmol), ethyl 4-iodobenzonitrile (342 mg, 
1.5 mmol), ZnCl2 (1.6 ml, 1 M in THF, 1.6 mmol), Pd(dba)2 (11 mg, 2 mol%) and P(2-furyl)3 
(9 mg, 4 mol%) applying TP5 and TP7. Metalation conditions: –40 °C, 3 h. Flash 
chromatography on silica (n-pentane/Et2O 3:1) furnished a colorless solid (237 mg, 73%).  
m.p.: 119.0 - 113.9 °C. 
1H-NMR (600 MHz, CDCl3) δ: 9.3 (d, J = 2.0 Hz, 1 H), 8.7 (d, J = 2.2 Hz, 1 H), 7.7 (d, J = 
8.6 Hz, 2 H), 7.6 (d, J = 8.6 Hz, 2 H), 4.5 (d, J = 7.1 Hz, 2 H), 4.2 (d, J = 7.1 Hz, 2 H), 1.4 (t, 
J = 7.1 Hz, 3 H), 1.1 (t, J = 7.1 Hz, 3 H). 
13C-NMR (150 MHz, CDCl3) δ: 166.5, 164.4, 160.5, 152.4, 144.0, 139.6, 132.1, 129.7, 127.2, 
125.5, 118.8, 113.2, 62.3, 62.2, 14.5, 14.0. 
MS (70 eV, EI) m/z (%): 324 (9) [M+], 296 (17), 295 (100), 179 (24), 267 (59), 251 (11), 223 
(10), 152 (10),140 (7), 102 (4). 
IR (ATR) ν~  (cm-1): 2979, 2911, 2224, 1721, 1596, 1448, 1398, 1319, 1244, 1227, 1148, 
1091, 1018, 149, 852, 798, 775, 743, 646. 
HRMS (EI): 324.1111 (calcd.: 324.1110). 
 
Synthesis of ethyl 3-iodopyridine-4-carboxylate (15j): 
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The title compound was prepared from ethyl isonicotinate (13g; 151 mg, 1.00 mmol), 
TMP2Mg·2LiCl (1.57 mL, 0.7 M in THF, 1.1 mmol), I2 (609 mg, 2.4 mmol) applying TP5. 
Metalation conditions: –40 °C, 12 h. Flash chromatography on silica (n-pentane/Et2O 7:3) 
furnished  a pale brown oil (152 mg, 66 %). 
1H-NMR (300 MHz, CDCl3) δ: 9.1 (s, 1 H), 8.6 (d, J = 4.9 Hz, 1 H), 7.6 (d, J = 4.9 Hz, 1 H), 
4.4 (q, J = 7.1 Hz, 2 H), 1.4 (t, J = 7.1 Hz, 3 H).  
13C-NMR (75 MHz, CDCl3) δ: 165.2, 159.8, 149.3, 142.7, 124.6, 92.6, 62.7, 14.4.  
MS (70 eV, EI) m/z (%): 277 (100) [M+], 248 (47), 232 (57), 204 (24), 177 (23), 127 (5), 122 
(10), 94 (7), 78 (4), 50 (1).  
IR (ATR) ν~  (cm-1): 2980, 1727, 1464, 1260, 1078, 1010, 776, 700, 662.  
HRMS (EI): 276.9590 (calcd.: 276.9599). 
 
4.3.2. Scale up Experiments 
 
Synthesis of ethyl 4'-methylbiphenyl-2-carboxylate (15k): 
 
EtO2C
Me
 
 
In a flame-dried and nitrogen-flushed 500 mL Schlenk-flask, equipped with a magnetic 
stirring bar and rubber septum, the freshly prepared solution of TMP2Mg·2LiCl (110 mL, 100 
mmol) was provided, ethyl benzoate (13h; 13.5 g, 90 mmol) was added and the reaction 
mixture was stirred for 45 min at 25 °C. The resulting solution was cooled to –40 °C and 
ZnCl2 (100 mL, 100 mmol, 1.1 equiv) was added and the resulting mixture is stirred for 15 
min. Then, Pd(OAc)2 (0.5 mol%), RuPHOS (1 mol%) and 4-bromotoluene (16.2 g, 95 mmol, 
1.05 equiv) were added. After warming to 25 °C and stirring for 12 h at 25 °C, the reaction 
was quenched with a sat. aqueous NH4Cl solution (250 mL) and extracted with Et2O (3 x 250 
mL). The combined organic layers were washed with brine (250 mL) and dried over 
anhydrous MgSO4. After filtration, the solvent was removed in vacuo. The crude product was 
purified by column chromatography (n-pentane/Et2O 9:1) and gave a pale yellow oil (15.4 g, 
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71%). 
1H-NMR (300 MHz, CDCl3) δ: 7.8 (m, 1 H), 7.5 (m, 1 H), 7.4 (m, 2 H), 7.2 (m, 4 H), 4.2 (q, 
J = 7.0 Hz, 2 H), 2.4 (s, 3 H), 1.1 (t, J = 7.2 Hz, 3 H).  
13C-NMR (75 MHz, CDCl3) δ: 168.9, 142.5, 138.6, 136.8, 131. 5, 131.1, 130.7, 129.7, 128.8, 
128.37, 127.0, 60.9, 21.2, 13.8. 
MS (70 eV, EI) m/z: 240 (51) [M+], 213 (10), 212 (10), 196 (18), 195 (100),167 (23), 166 
(18), 165 (51), 153 (10), 152 (48), 82 (8). 
IR (ATR) ν~  (cm-1): 3060, 3024, 2981, 2924, 2870, 1713, 1600, 1518, 1445, 1365, 1286, 
1276, 1241, 1172, 1125, 1112, 1085, 1047, 1016, 1006, 854, 819, 758, 730, 709, 656.  
HRMS (EI): 240.1142 (calcd.: 240.1150). 
 
Synthesis of 2-tert-butyl ethyl phthalate (15l) 
 
 
 
In a flame-dried and nitrogen-flushed 500-mL Schlenk flask, equipped with a magnetic 
stirring bar and rubber septum, the freshly prepared solution of TMP2Mg·2LiCl (110 mL, 100 
mmol) was added followed by ethyl benzoate (13h; 13.5 g, 90 mmol) and the reaction mixture 
was stirred for 45 min at 25 °C. Boc2O (28.0 g, 130 mmol, 1.44 equiv) was added in one 
portion at 25 °C and the reaction mixture was stirred for 2 h. A sat. aqueous NH4Cl solution 
(250 mL) was added and the mixture was extracted with Et2O (3 x 250 mL). The combined 
organic layers were washed with brine (250 mL) and dried over anhydrous MgSO4. After 
filtration, the solvent was removed in vacuo. The crude product was purified by column 
chromatography (n-pentane/Et2O  4:1) and gave a yellow oil (15.1 g, 67%). 
1H-NMR (400 MHz, CDCl3) δ: 7.6 (m, 2 H), 7.4 (m, 2 H), 4.3 (q, J = 7.2 Hz, 2 H), 1.5 (s, 9 
H), 1.3 (t, J = 7.0 Hz, 3 H). 
13C-NMR (75 MHz, CDCl3) δ: 167.8, 166.3, 133.2, 132.3, 130.5, 130.45, 128.8, 128.4, 81.8, 
61.3, 27.8, 13.9.  
MS (70 eV, EI) m/z: 251 (29), 246 (21), 195 (100), 177 (23) [M+-CO2Et], 150 (4), 149 (35). 
IR (ATR) ν~  (cm-1): 2979, 1715, 1599, 1579, 1477, 1447, 1392, 1367, 1286, 1255, 1172, 
1123, 1072, 1038, 1017, 845, 784, 737, 705. 
HRMS (EI): 251.1280 (calcd.: 251.1278). 
  
EXPERIMENTAL SECTION 
 93 
Preparation of di-tert-butyl 4'-cyanobiphenyl-2,4-dicarboxylate (15m) 
 
 
 
In a flame-dried and nitrogen-flushed 500 mL Schlenk-flask, equipped with a magnetic 
stirring bar and rubber septum, the freshly prepared solution of TMP2Mg·2LiCl (100 mL, 90 
mmol) was provided, di-tert-butylisophthalate (13i; 22.2 g, 80 mmol) was added and the 
reaction mixture was stirred for 45 min at 25 °C. The resulting solution was cooled to –40 °C 
and ZnCl2 (90 mL, 90 mmol, 1.1 equiv) was added and the resulting mixture was stirred for 
15 min. Then, Pd(OAc)2 (0.5 mol%), RuPHOS (1 mol%) and 4-bromobenzonitrile (15.3 g, 84 
mmol, 1.05 equiv) were added. After warming to 25 °C and stirring for 12 h at 25°C, the 
reaction mixture was quenched with a sat. aqueous NH4Cl solution (250 mL) and extracted 
with Et2O (3 x 250 mL). The combined organic layers were washed with brine (250 mL) and 
dried over anhydrous MgSO4. After filtration, the solvent was removed in vacuo. The crude 
product was purified by recrystallization (n-heptane/EtOAc) and gave a yellow solid (22.8 g, 
75%). 
m.p.: 158.5 - 158.8 °C. 
1H-NMR (300 MHz, CDCl3) δ: 8.4 (d, J=1.5 Hz, 1 H), 8.1 (dd, J = 8.0, 1.9 Hz, 1 H), 7.7 (d, 
J = 8.5 Hz, 2 H), 7.4 (d, J = 8.5 Hz, 2 H), 7.3 (d, J = 8.0 Hz, 1 H), 1.6 (s, 9 H), 1.3 (s, 9 H). 
13C-NMR (75 MHz, CDCl3) δ: 166.3, 164.5, 146.0, 143.9, 132.6, 132.0, 131.8, 131.7, 131.13, 
130.3, 129.2, 118.6, 111.4, 82.2, 81.8, 28.2, 27.6. 
MS (70 eV, EI) m/z: 323 (19) [M+ - tBu], 306 (17), 268 (53), 267 (100), 266 (11), 250 (50), 
177 (22), 166 (10), 57 (76), 56 (17). 
IR (ATR) ν~  (cm-1): 2972, 2933, 2228, 1722, 1711, 1604, 1477, 1368, 1324, 1302, 1276, 
1254, 1250, 1158, 1146, 1121, 1089, 838, 775, 754, 740. 
HRMS (EI): 379.1785 (calcd.: 379.1784). 
  
Preparation of 2-tert-butyl 1-ethyl naphthalene-1,2-dicarboxylate (15n) 
 
EtO2C
CO2tBu
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In a flame-dried and nitrogen-flushed 500-mL Schlenk flask, equipped with a magnetic 
stirring bar and rubber septum, the freshly prepared solution of TMP2Mg·2LiCl (110 mL, 100 
mmol) was added followed by ethyl 1-naphthoate (13b; 18.0 g, 90 mmol) and the reaction 
mixture was stirred for 45 min at 25 °C. Boc2O (28.0 g, 130 mmol, 1.44 equiv) was added in 
one portion at 25 °C and the reaction mixture was stirred for 2 h. A sat. aqueous NH4Cl 
solution (250 mL) was added and the mixture was extracted with Et2O (3 x 250 mL). The 
combined organic layers were washed with brine (250 mL) and dried over anhydrous MgSO4. 
After filtration, the solvent was removed in vacuo. The crude product was purified by 
recrystallization (n-heptane/EtOAc) and gave a colorless solid (12.4 g, 69%). 
m.p.: 70.5 - 70.9 °C. 
1H-NMR (300 MHz, CDCl3) δ: 7.9 (m, 4 H), 7.5 (m, 2 H), 4.5 (q, J = 7.3 Hz, 2 H), 1.64 (s, 9 
H), 1.4 (t, J = 7.2 Hz, 3 H). 
13C-NMR (75 MHz, CDCl3) δ: 169.0, 165.0, 134.8, 134.3, 129.3, 129.2, 128.0, 127.5, 127.0, 
125.9, 125.2, 82.2, 61.7, 28.1, 14.1.  
MS (70 eV, EI) m/z: 300 (16) [M+], 244 (41), 227 (10), 216 (11), 200 (20), 199 (100), 198 
(10), 172 (21), 155 (29), 154 (14), 127 (25), 126 (30), 57 (15). 
IR (ATR) ν~  (cm-1): 3058, 2982, 2939, 1720, 1708, 1365, 1294, 1269, 1238, 1168, 1139, 
1116, 1036, 1014, 860, 848, 833, 798, 790, 764, 733. 
HRMS (EI): 300.1358 (calcd.: 300.1362). 
 
 
4.4. Formal meta- and para-functionalizations 
 
4.4.1. Starting Material Synthesis 
 
Synthesis of 4-cyanophenyl-N,N,N’,N’-tetramethyldiamido-phosphate (18a): 
 
CN
O
(Me2N)2P
O
 
 
Prepared according to TP1 from 4-cyanophenol (2.38 g, 20.0 mmol). The colorless oil was 
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used without further purification (4.72 g, 93%). 
1H-NMR (300 MHz, CDCl3) δ: 7.6 (d, J = 9.0 Hz, 2 H), 7.3 (dd, J = 8.9 Hz, J = 1.0 Hz, 2 H), 
2.7 (m, 12 H).  
13C-NMR (75 MHz, CDCl3) δ: 155.4, 134.2, 121.2, 118.8, 108.7, 36.8. 
MS (70 eV, EI) m/z (%): 253 (27) [M+], 209 (12), 155 (11), 145 (22), 136 (11), 135 (100), 
102 (15), 92 (27), 90 (16), 76 (10). 
IR (ATR) ν~  (cm-1): 3456, 2932, 2900, 2856, 2816, 2228, 1604, 1500, 1456, 1416, 1308, 
1216, 1164, 1108, 1068, 988, 896, 848, 792, 760, 684, 664.  
HRMS (ESI): 253.1050 (calcd.: 253.0980). 
 
Synthesis of 4-bromophenyl-N,N,N’,N’-tetramethyldiamido-phosphate (18b): 
 
Br
O
(Me2N)2P
O
 
 
Prepared according to TP1 from 4-bromophenol (3.46 g, 20.0 mmol). The colorless oil was 
used without further purification (5.28 g, 86%). 
1H-NMR (300 MHz, CDCl3) δ: 7.4 (d, J = 9.0 Hz, 2 H), 7.1 (m, 2 H), 2.7 (m, 12 H).  
13C-NMR (75 MHz, CDCl3) δ: 150.8, 132.9, 132.7, 122.2, 122.1, 117.1 , 36.9. 
MS (70 eV, EI) m/z (%): 309 (20), 308 (100), 307 (27), 306 (100) [M+], 293 (12), 291 (12), 
264 (32), 262 (33), 220 (15), 218 (16), 201 (53), 200 (82), 199 (55), 198 (80), 174 (40), 173 
(31), 172 (41), 171 (29), 157 (17), 155 (18), 145 (30), 143 (31), 136 (40), 135 (100), 92 (66), 
91 (16), 64 (10), 63 (19). 
IR (ATR) ν~  (cm-1): 3452, 2928, 2896, 2852, 2812, 1580, 1484, 1456, 1400, 1304, 1272, 
1208, 1164, 1096, 1068, 984, 900, 832, 768, 748, 700, 668.    
HRMS (EI): 306.0124 (calcd.: 306.0133). 
  
Synthesis of 4-fluorophenyl-N,N,N’,N’-tetramethyldiamido-phosphate (18c): 
 
F
O
(Me2N)2P
O
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Prepared according to TP1 from 4-fluorophenol (2.24 g, 20.0 mmol). The colorless oil was 
used without further purification (2.23 g, 92%). 
1H-NMR (600 MHz, CDCl3) δ: 7.1 (ddd, J = 9.0 Hz, J = 4.5 Hz, J = 1.2 Hz, 2 H), 7.0 (m, 2 
H), 2.7 (m, 12 H). 
 
13C-NMR (150 MHz, CDCl3) δ: 160.3, 158.7, 147.5, 121.7, 116.4, 115.8, 36.9. Observed 
complexity due to C-F splitting, definitive assignments have not been made. 
MS (70 eV, EI) m/z (%): 246 (43) [M+], 202 (19), 158 (10), 139 (19), 138 (44), 136 (20), 135 
(100), 112 (21), 111 (31), 95 (20), 92 (66), 90 (12), 83 (33), 76 (12), 75 (16), 57 (12).  
IR (ATR) ν~  (cm-1): 3456, 3000, 2932, 2896, 2856, 2812, 1644, 1500, 1456, 1364, 1304, 
1224, 1180, 1092, 1068, 984, 904, 840, 820, 760, 704, 664.    
HRMS (EI): 246.0925 (calcd.: 246.0933). 
 
Synthesis of 4-chlorophenyl-N,N,N’,N’-tetramethyldiamido-phosphate (18d): 
 
Cl
O
(Me2N)2P
O
 
 
Prepared according to TP1 from 4-chlorophenol (2.57 g, 20.0 mmol). The colorless oil was 
used without further purification (4.73 g, 90%). 
1H-NMR (600 MHz, CDCl3) δ: 7.3 (m, 2 H), 7.1 (d, J = 8.6 Hz, 2 H), 2.7 (m, 12 H). 
13C-NMR (150 MHz, CDCl3) δ: 150.3, 129.7, 129.5, 121.7, 36.9. 
MS (70 eV, EI) m/z (%): 262 (18) [M+], 218 (6), 155 (11), 154 (18), 136 (10), 135 (100), 127 
(11), 99 (12), 92 (25), 75 (11). 
IR (ATR) ν~  (cm-1): 2928, 2892, 2852, 2812, 1592, 1484, 1456, 1404, 1304, 1232, 1212, 
1184, 1164, 1088, 1068, 984, 900, 832, 772, 752, 704, 672.   
HRMS (EI): 262.0637 (calcd.: 262.0638). 
 
Synthesis of ethyl 3-{[bis(dimethylamino)phosphoryl]oxy} benzoate (21a): 
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Prepared according to TP1 from ethyl 3-hydroxybenzoate (3.32 g, 20.0 mmol). The colorless 
oil was used without further purification (5.57 g, 93%). 
 1H-NMR (300 MHz, CDCl3) δ: 7.8 – 7.7 (m, 2 H), 7.5 – 7.4 (m, 2 H), 4.4 (q, J = 7.1 Hz, 2 
H), 2.8 (m, 12 H) 1.4 (t, J = 7.1 Hz, 3 H).  
13C-NMR (75 MHz, CDCl3) δ: 166.1, 151.7, 132.4, 129.8, 125.5, 124.9, 121.5, 61.4, 36.9, 
14.5. 
MS (70 eV, EI) m/z (%): 301 (11), 300 (65) [M+], 255 (20), 226 (13), 192 (36), 135 (100), 92 
(16), 44 (32). 
IR (ATR) ν~  (cm-1): 3435, 2997, 1715, 1584, 1483, 1440, 1366, 1268, 1229, 1203, 1097, 
1072, 986, 947, 849, 752, 673.  
HRMS (EI): 300.1247 (calcd.: 300.1239).  
 
Synthesis of 3-(trifluoromethyl)phenyl N,N,N',N'-tetramethyldiamidophosphate (21b): 
 
 
 
Prepared according to TP1 from 3-(trifluoromethyl)phenol (3.24 g, 20.0 mmol). The colorless 
oil was used without further purification (5.33 g, 90%). 
1H-NMR (300 MHz, CDCl3) δ: 7.4 (m, 4 H), 2.7 (m, 12 H). 
13C-NMR (75 MHz, CDCl3) δ: 151.9, 132.3 (q, J(C-F) = 32.6 Hz), 130.4, 123.9, 123.8 (q, 
J(C-F) = 272.2 Hz), 121.1, 117.6, 36.9.    
MS (70 eV, EI) m/z (%): 296 (15) [M+], 188 (13), 135 (100), 92 (18), 44 (49). 
IR (ATR) ν~  (cm-1): 2932, 2900, 1596, 1492, 1448, 1324, 1308, 1280, 1228, 1208, 1164, 
1120, 1092, 1064, 988, 928, 884, 796, 760, 732, 696, 676.   
HRMS (ESI): 296.0896 (calcd.: 296.0901). 
 
Synthesis of 3-iodophenyl N,N,N',N'-tetramethyldiamido-phosphate (21c): 
 
 
 
Prepared according to TP1 from 3-iodophenol (4.4 g, 20.0 mmol). Flash chromatography on 
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silica (Et2O) furnished 4c as a colorless solid (6.5 g, 92%). 
m.p.: 75.0 - 77.2 °C. 
1H-NMR (300 MHz, CDCl3) δ: 7.5 (m, 1 H), 7.4 (m, 2 H), 7.0 (t, J = 7.9 Hz, 1 H), 2.7 (m, 12 
H). 
13C-NMR (75 MHz, CDCl3) δ: 151.7, 133.3, 130.8, 129.3, 119.6, 93.8, 36.6.  
MS (70 eV, EI) m/z (%): 355 (2) [M++H], 354 (12) [M+], 246 (12), 135 (100), 92 (8), 44 (20). 
IR (ATR) ν~  (cm-1): 3056, 2922, 2176, 1572, 1463, 1299, 1228, 1199, 1067, 991, 915, 794, 
758, 687, 670, 584.   
HRMS (ESI): 355.007 (calcd.: 355.007). 
 
4.4.2. Directed Magnesiation Using TMP2Mg·2LiCl and Reaction 
with Electrophiles
 
 
Synthesis of 5-cyano-4'-[(triisopropylsilyl)oxy]biphenyl-2-yl N,N,N',N'-
tetramethyldiamidophosphate (19a): 
 
 
 
The title compound was prepared from 18a (506 mg, 2.00 mmol), TMP2Mg·2LiCl (3.14 mL, 
0.7 M in THF, 2.2 mmol), (4-iodophenoxy)-(triisopropyl)silane (828 mg, 2.2 mmol), ZnCl2 
(2.2 ml, 1 M in THF, 2.2 mmol), Pd(dba)2 (22 mg, 2 mol%), P(2-furyl)3 (18 mg, 4 mol%) 
applying TP5 and TP7. Metalation conditions: 0 °C, 1 h. Flash chromatography on silica 
(EtOAc) furnished a yellow oil (833 mg, 83%). 
1H-NMR (400 MHz, CDCl3) δ: 7.6 (m, 3 H), 7.3 (d, J = 8.1 Hz, 2 H), 6.9 (d, J = 8.4 Hz, 2 
H), 2.5 (m, 12 H), 1.3 (m, 3 H), 1.1 (m, 18 H). 
13C-NMR (100 MHz, CDCl3) δ: 156.4, 152.3, 135.0, 134.6, 132.4, 130.8, 128.7, 121.5, 120.0, 
118.8, 108.1, 36.7, 18.1, 12.9. 
MS (70 eV, EI) m/z (%): 501 (16) [M+], 459 (30), 458 (100), 415 (10), 135 (40). 
IR (ATR) ν~  (cm-1): 2944, 2892, 2868, 2228, 1604, 1512, 1484, 1464, 1420, 1392, 1260, 
1216, 1172, 1132, 1104, 1068, 1040, 988, 900, 856, 836, 764, 740, 684, 660.    
HRMS (ESI): 502.2653 (calcd.: 502.2655). 
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Synthesis of 2,4-dicyanophenyl N,N,N',N'-tetramethyldi-amidophosphate (19b): 
 
CN
O
(Me2N)2P
O
CN
 
The title compound was prepared from 18a (254 mg, 1.00 mmol), TMP2Mg·2LiCl (1.57 mL, 
0.7 M in THF, 1.1 mmol), TsCN (199 mg, 1.10 mmol), ZnCl2 (1.2 ml, 1 M in THF, 1.2 mmol), 
CuCN·2LiCl (1 m in THF, 1.3 mL, 1.30 mmol) applying TP5 and TP8. Metalation conditions: 
0 °C, 1 h. Flash chromatography on silica (EtOAc) furnished a colorless solid (209 mg, 77%). 
m.p.: 143.0 - 144.2 °C. 
1H-NMR (300 MHz, CDCl3) δ: 7.9 (d, J = 1.1 Hz, 1 H), 7.8 (m, 2 H), 2.8 (m, 12 H).  
13C-NMR (75 MHz, CDCl3) δ: 156.9, 138.0, 137.4, 122.0, 116.7, 114.0, 108.7, 106.9, 36.8. 
MS (70 eV, EI) m/z (%): 278 (66) [M+], 207 (100), 206 (23), 135 (50), 97 (16), 95 (14), 83 
(32), 73 (54), 57 (18), 55 (27), 43 (13), 41 (23). 
IR (ATR) ν~  (cm-1): 3056, 2936, 2892, 2236, 1604, 1488, 1456, 1312, 1296, 1252, 1224, 
1192, 1164, 1108, 1068, 1000, 984, 924, 912, 864, 844, 764, 744, 716, 684, 660.  
HRMS (EI): 278.0920 (calcd.: 278.0933). 
 
Synthesis of 4-cyano-2-(2-methylprop-2-en-1-yl)phenyl N,N,N',N'-
tetramethyldiamidophosphate (19c): 
 
 
The title compound was prepared from 18a (254 mg, 1.00 mmol), TMP2Mg·2LiCl (1.57 mL, 
0.7 M in THF, 1.1 mmol), ZnCl2 (1 M in THF, 1.2 mL, 1.2 mmol), 3-bromo-2-methylpropene 
(156 mg, 1.2 mmol), CuCN·2LiCl (0.5 mL, 1 M in THF, 50 mol%) applying TP5 and TP9. 
Metalation conditions: 0 °C, 1 h. Flash chromatography on silica (EtOAc) furnished a 
colorless oil (258 mg, 84%).  
1H-NMR (300 MHz, CDCl3) δ: 7.5 (m, 2 H), 7.5 (s, 1 H), 4.9 (d, J = 1.8 Hz, 1 H), 4.6 (d, J = 
0.9 Hz, 1 H), 3.4 (s, 2 H), 2.7 (m, 12 H) 1.7 (s, 3 H).   
13C-NMR (75 MHz, CDCl3) δ: 153.7, 142.8, 135.0, 132.2, 131.8, 120.1, 119.0, 113.3, 107.6, 
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38.0, 36.9, 22.7.   
MS (70 eV, EI) m/z (%): 307 (29) [M+], 306 (23), 263 (22), 200 (15), 199 (13), 173 (15), 156 
(11), 154 (14), 136 (15), 135 (100), 92 (32).  
IR (ATR) ν~  (cm-1): 3460, 2932, 2904, 2856, 2812, 2228, 1652, 1600, 1580, 1492, 1456, 
1412, 1376, 1304, 1248, 1212, 1180, 1112, 1068, 988, 940, 924, 876, 832, 756, 724, 704, 684, 
664.  
HRMS (EI): 307.1410 (calcd.: 307.1450). 
 
Synthesis of 4-bromo-2-(3,3-dimethyl-2-oxobutyl)phenyl N,N,N',N'-
tetramethyldiamidophosphate (19d) 
 
 
 
The title compound was prepared from 18b (614 mg, 2.00 mmol), TMP2Mg·2LiCl (3.14 mL, 
0.7 M in THF, 2.2 mmol), ZnCl2 (1 M in THF, 1.2 mL, 1.2 mmol), 3,3-dimethylbutanoyl 
chloride (323 mg, 2.4 mmol), CuCN·2LiCl (0.5 mL, 1 M in THF, 50 mol%) applying TP5 and 
TP8. Metalation conditions: –50 °C, 7 h. Flash chromatography on silica (EtOAc) furnished  
a colorless oil (293 mg, 72%).  
1H-NMR (300 MHz, CDCl3) δ: 7.5 (m, 1 H), 7.5 (m, 2 H), 2.9 (s, 2 H), 2.7 (m, 12 H),  1.1 (s, 
9 H).  
13C-NMR (75 MHz, CDCl3) δ: 201.3, 153.4, 148.2, 135.0, 131.8, 122.4, 116.8, 55.4, 36.9, 
31.8, 30.0.    
MS (70 eV, EI) m/z (%): 404 (5) [M+], 363 (10), 362 (62), 361 (17), 360 (62), 346 (20), 344 
(20), 335 (34), 333 (35), 307 (45), 306 (100), 305 (52), 304 (100), 303 (19), 299 (11), 297 
(11), 262 (12), 260 (11), 225 (21), 224 (11), 201 (10), 199 (11), 198 (12), 135 (100), 92 (19), 
57 (17). 
IR (ATR) ν~  (cm-1): 3460, 2952, 2904, 2868, 2812, 1688, 1588, 1568, 1472, 1388, 1364, 
1304, 1264, 1212, 1176, 1116, 1068, 988, 896, 820, 760, 744, 724, 676.   
HRMS (EI): 404.0811 (calcd.: 404.0863). 
 
Synthesis of ethyl 2'-{[bis(dimethylamino)phosphoryl]oxy}-5'-fluorobiphenyl-4-
carboxylate (19e): 
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The title compound was prepared from 18c (246 mg, 1.00 mmol), TMP2Mg·2LiCl (1.57 mL, 
0.7 M in THF, 1.1 mmol), ethyl-4-iodobenzoate (414 mg, 1.5 mmol), ZnCl2 (1.2 ml, 1 M in 
THF, 1.2 mmol), Pd(dba)2 (11 mg, 2 mol%), P(2-furyl)3 (9 mg, 4 mol%) applying TP5 and 
TP7. Metalation conditions: –40 °C, 4 h. Flash chromatography on silica (EtOAc) furnished a 
pale yellow solid (307 mg, 78%). 
m.p.: 77.0 - 78.6 °C. 
1H-NMR (600 MHz, CDCl3) δ: 8.1 (d, J = 8.4 Hz, 2 H), 7.6 (d, J = 8.6 Hz, 2 H), 7.5 (dd, J = 
9.8 Hz, J = 5.4 Hz, 1 H), 7.0 (m, 2 H), 4.4 (q, J = 7.1 Hz, 2 H), 2.7 (m, 2 H), 2.5 (m, 10 H), 
1.4 (t, J = 7.2 Hz, 3 H).    
13C-NMR (150 MHz, CDCl3) δ: 166.6, 159.9, 158.3, 144.6, 141.9, 133.9, 129.9, 129.7, 129.6, 
122.3, 117.5, 116.0, 115.8, 61.3, 36.9, 36.7, 14.5. Observed complexity due to C-F splitting, 
definitive assignments have not been made. 
MS (70 eV, EI) m/z (%): 394 (3) [M+], 286 (13), 260 (10), 186 (10), 157 (10), 135 (100). 
IR (ATR) ν~  (cm-1): 3040, 3004, 2928, 2908, 2856, 2816, 1708, 1668, 1608, 1592, 1568, 
1512, 1488, 1452, 1424, 1400, 1372, 1304, 1280, 1252, 1224, 1172, 1128, 1100, 1068, 1016, 
992, 940, 912, 884, 860, 828, 772, 756, 732, 712, 700, 672.    
HRMS (ESI): 395.1529 (calcd.: 395.1536). 
 
Synthesis of 5-fluoro-3'-methylbiphenyl-2-yl N,N,N',N'-tetra-methyldiamidophosphate 
(19f):  
 
F
O
(Me2N)2P
O Me
 
 
The title compound was prepared from 18c (1.23 g, 5.0 mmol), TMP2Mg·2LiCl (7.85 mL, 0.7 
M in THF, 5.5 mmol), 3-iodotoluene (1.2 g, 5.5 mmol)., ZnCl2 (6.0 ml, 1 M in THF, 6.0 
mmol), Pd(dba)2 (55 mg, 2 mol%), P(2-furyl)3 (45 mg, 4 mol%) applying TP5 and TP7. 
Metalation conditions: –40 °C, 4 h. Flash chromatography on silica (EtOAc) furnished a pale 
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yellow oil (1.26 g, 75%). 
1H-NMR (600 MHz, CDCl3) δ: 7.4 (ddd, J = 9.0 Hz, J = 4.9 Hz, J = 1.2 Hz, 1 H), 7.3 (ddd, 
J = 15.2 Hz, J = 7.8 Hz, J = 7.7 Hz, 3 H), 7.1 (d, J = 7.6 Hz, 1 H), 7.0 (ddd, J = 9.0 Hz, J = 
3.2 Hz, J = 1.0 Hz, 1 H), 7.0 (ddd, J = 9.0 Hz, J = 7.7 Hz, J = 3.2 Hz, 1 H), 2.7 (m, 1 H), 2.5 
(m, 11 H), 2.4 (s, 3 H).  
13C-NMR (150 MHz, CDCl3) δ: 159.9, 158.4, 144.6, 137.8, 137.2, 130.4, 128.6, 128.3, 126.7, 
122.1, 117.5, 115.1, 36.9, 21.6. Observed complexity due to C-F splitting, definitive 
assignments have not been made.  
MS (70 eV, EI) m/z (%): 337 (15), 336 (100) [M+], 248 (12), 247 (14), 228 (83), 185 (13), 
183 (12), 169 (10), 136 (12), 135 (42), 92 (11), 44 (71). 
IR (ATR) ν~  (cm-1): 3464, 2992, 2924, 2896, 2852, 2812, 1608, 1584, 1496, 1476, 1412, 
1396, 1304, 1220, 1164, 1116, 1096, 1068, 1044, 984, 936, 892, 816, 788, 760, 720, 700, 664. 
HRMS (EI): 336.1377 (336.1403). 
 
Synthesis of  2-cyclohex-2-en-1-yl-4-fluorophenyl N,N,N',N'-
tetramethyldiamidophosphate (19g): 
 
F
O
(Me2N)2P
O
 
 
The title compound was prepared from 18c (246 mg, 1.00 mmol), TMP2Mg·2LiCl (1.57 mL, 
0.7 M in THF, 1.1 mmol), ZnCl2 (1 M in THF, 1.2 mL, 1.2 mmol), 3-bromocyclohexene (354 
mg, 1.2 mmol), CuCN·2LiCl (0.5 mL, 1 M in THF, 50 mol%) applying TP5 and TP9. 
Metalation conditions: –40 °C, 4 h. Flash chromatography on silica (EtOAc) furnished a 
colorless oil (277 mg, 85%). 
1H-NMR (600 MHz, CDCl3) δ:  7.2 (ddd, J = 8.9 Hz, J = 4.9 Hz, J =  1.2 Hz, 1 H), 6.9 (ddd, 
J = 9.6 Hz, J = 3.2 Hz, J = 1.0 Hz, 1 H), 6.8 (ddd, J = 8.9 Hz, J = 7.7 Hz, J = 3.2 Hz, 1 H), 
6.0 (m, 1 H), 5.6 (m, 1 H), 3.8 (s, 1 H), 2.7 (m, 12 H), 2.1 (m, 2 H), 2.0 (m, 1 H), 1.7 (m, 1 H), 
1.6 (m, 2 H).    
13C-NMR (150 MHz, CDCl3) δ: 160.1, 145.2, 138.8, 129.8, 129.0, 120.3, 115.9, 113.6, 36.9, 
35.1, 30.4, 25.1, 20.8. Observed complexity due to C-F splitting, definitive assignments have 
not been made. 
MS (70 eV, EI) m/z (%): 327 (20), 326 (100) [M+], 192 (12), 190 (12), 153 (23), 135 (95), 92 
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(15), 44 (39). 
IR (ATR) ν~  (cm-1): 3456, 3220, 3020, 2928, 2856, 2812, 1652, 1616, 1592, 1484, 1456, 
1420, 1392, 1308, 1240, 1220, 1168, 1096, 1068, 984, 956, 900, 864, 816, 756, 736, 708, 664.   
HRMS (EI): 326.1574 (326.1559). 
 
Synthesis of 2-benzoyl-4-chlorophenyl N,N,N',N'-tetramethyl-diamidophosphate (19h):  
 
Cl
O
(Me2N)2P
O
COPh
 
The title compound was prepared from 18d (1.31 g, 5.0 mmol), TMP2Mg·2LiCl (7.85 mL, 0.7 
M in THF, 5.5 mmol), ZnCl2 (1 M in THF, 6.0 mL, 6.0 mmol), benzoyl chloride (773 mg, 5.5 
mmol), CuCN·2LiCl (2.5 mL, 1 M in THF, 50 mol%) applying TP5 and TP8. Metalation 
conditions: –40 °C, 4 h. Flash chromatography on silica (EtOAc) furnished a pale red oil 
(1.57 g, 85%). 
1H-NMR (600 MHz, CDCl3) δ: 7.8 (m, 2 H), 7.6 (m, 1 H), 7.5 (dd, J = 8.8 Hz, J = 0.9 Hz, 1 
H), 7.5 (t, J = 7.8 Hz, 2 H), 7.4 (m, 1 H), 7.4 (dd, J = 2.7 Hz, J = 1.0 Hz, 1 H), 2.4 (m, 12 H).   
13C-NMR (150 MHz, CDCl3) δ: 194.2, 147.8, 137.2, 133.8, 132.6, 131.8, 130.1, 129.4, 128.8, 
121.8, 36.5. 
MS (70 eV, EI) m/z (%): 366 (3) [M+], 324 (35), 323 (24), 322 (100), 321 (11), 280 (12), 278 
(34), 258 (13), 228 (12), 135 (100), 105 (10), 77 (16), 44 (36). 
IR (ATR) ν~  (cm-1): 3460, 3064, 2928, 2896, 2852, 2812, 1668, 1596, 1472, 1448, 1400, 
1312, 1288, 1264, 1216, 1180, 1156, 1116, 1068, 988, 956, 900, 832, 808, 788, 760, 740, 712, 
700, 668.   
HRMS (EI): 366.0900 (calcd.: 366.0900). 
 
Synthesis of  4-chloro-2-(1-hydroxy-2,2-dimethylpropyl)phenyl N,N,N',N'-
tetramethyldiamidophosphate (19i): 
 
Cl
O
(Me2N)2P
O
OH
tBu
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4-Chlorophenyl N,N,N',N'-tetramethyldiamidophosphate (18d) (525 mg, 2.0 mmol) was 
reacted with TMP2Mg·2LiCl (3.14 mL, 0.7 M in THF, 2.2 mmol) in THF (2 mL) at –40 oC for 
1.5 h. Complete metalation was detected by GC-analysis of reaction aliquots, quenched with 
I2 in THF. Then the mixture was cooled to –80 °C and pivaline aldehyde (215 mg, 2.5 mmol) 
was slowly added. The reaction mixture was slowly warmed to 25 oC and stirred for 1 h. The 
reaction mixture was quenched with sat. aq. NH4Cl solution (5 mL), extracted with Et2O (3 × 
15 mL) and dried over anhydrous MgSO4. After filtration, the solvent was evaporated in 
vacuo. Purification by flash chromatography (EtOAc) furnished a colorless solid (550 mg, 
79%). 
m.p.: 158.3 - 160.5 °C. 
1H-NMR (300 MHz, CDCl3) δ: 7.5 (d, J = 2.0 Hz, 1 H), 7.2 (m, 2 H), 4.8 (s, 1 H), 3.1 (br, 1 
OH), 2.7 (m, 12 H), 1.0 (s, 9 H).  
13C-NMR (75 MHz, CDCl3) δ: 147.5, 136.3, 129.5, 129.4, 128.2, 120.6, 74.3, 36.9, 36.5, 
26.1.        
MS (70 eV, EI) m/z (%): 348 (2) [M+], 290 (16), 189 (12), 288 (44), 247 (31), 246 (10), 245 
(100), 153 (21), 135 (67), 91 (10), 44 (31). 
IR (ATR) ν~  (cm-1): 3336, 2944, 2928, 2904, 2876, 1472, 1384, 1348, 1312, 1292, 1256, 
1232, 1208, 1168, 1116, 1092, 1060, 1000, 984, 928, 908, 896, 868, 808, 752, 724, 672. 
HRMS (EI): 348.1354 (calcd.: 348.1370). 
 
Synthesis of ethyl 3-{[bis(dimethylamino)phosphoryl]oxy} 4-bromobenzoate (22a): 
 
 
 
Ethyl 3-{[bis(dimethylamino)phosphoryl]oxy}benzoate (21a) (300 mg, 1.0 mmol) was 
dissolved in THF (1 mL) and cooled to 0 °C. Then TMP2Mg·2LiCl (0.6 M in THF, 1.83 mL, 
1.1 mmol) was added dropwise. The mixture was stirred for 1 h, and after that BrCl2CCCl2Br 
(779 mg, 2.4 mmol), dissolved in dry THF (2 mL), was added dropwise at –40 °C and the 
resulting mixture was warmed to 25 °C and stirred for 1 h. The reaction mixture was 
quenched with sat. aq. NH4Cl solution (5 mL), extracted with Et2O (3 × 15 mL) and dried 
over anhydrous Na2SO4. After filtration, the solvent was evaporated in vacuo. Purification by 
flash chromatography (EtOAc) furnished  a pale yellow oil (302 mg, 80%). 
1H-NMR (600 MHz, CDCl3) δ: 8.0 (m, 1 H), 7.7 (m, 1 H), 7.6 (d, J = 7.9 Hz, 1 H), 4.4 (q, J 
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= 7.1 Hz, 2 H), 2.8 (m, 12 H), 1.4 (m, 3 H). 
13C-NMR (150 MHz, CDCl3) δ: 165.6, 150.0, 133.6, 131.4, 126.1, 121.8, 120.1, 61.6, 37.0, 
14.5.   
MS (70 eV, EI) m/z (%): 378 (1) [M+-H], 299 (39), 135 (100), 92 (17), 63 (8).  
IR (ATR) ν~  (cm-1): 2929, 2811, 1717, 1589, 1573, 1475, 1405, 1366, 1279, 1212, 1101, 
1068, 988, 954, 850, 754, 680, 663. 
HRMS (EI): 378.0377 (calcd.: 378.0344). 
 
Synthesis of ethyl 4-benzoyl-3-{[bis(dimethylamino)-phosphoryl]oxy}benzoate (22b): 
 
 
 
The title compound was prepared from 21a (300 mg, 1.0 mmol), TMP2Mg·2LiCl (1.57 mL, 
0.7 M in THF, 1.1 mmol), ZnCl2 (1 M in THF, 1.2 mL, 1.2 mmol), benzoyl chloride (155 mg, 
1.1 mmol), CuCN·2LiCl (0.5 mL, 1 M in THF, 50 mol%) applying TP5 and TP8. Metalation 
conditions: 0 °C, 1 h. Flash chromatography on silica (EtOAc) furnished a greenish yellow oil 
(296 mg, 73%). 
1H-NMR (600 MHz, CDCl3) δ: 8.1 (m, 1 H), 7.9 (dd, J = 7.9 Hz, 1.3 Hz, 1 H), 7.8 (m, 2 H), 
7.6 (m, 1 H), 7.4 (m, 3 H), 4.4 (q, J = 7.1 Hz, 2 H), 2.5 (m, 12 H), 1.4 (t, J = 7.2 Hz, 3 H).  
13C-NMR (150 MHz, CDCl3) δ: 195.0, 165.5, 149.1, 137.1, 135.5, 134.0, 133.8, 130.2, 129.5, 
128.9, 127.6, 125.1, 121.5, 61.7, 36.5, 14.5. 
MS (70 eV, EI) m/z (%): 404 (1) [M+], 361 (23), 360 (100), 359 (15), 317 (35), 289 (15), 269 
(10), 266 (14), 168 (13), 152 (11), 135 (45), 105 (26), 92 (16), 77 (39). 
IR (ATR) ν~  (cm-1): 2929, 1718, 1668, 1596, 1405, 1281, 1205, 1089, 990, 964, 920, 851, 
756, 703, 652. 
HRMS (EI): 404.1493 (calcd.: 404.1501). 
 
Synthesis of diethyl 2-{[bis(dimethylamino)phosphoryl]oxy}-biphenyl-4,4'-dicarboxylate 
(22c): 
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CO2Et
O
P(NMe2)2
O
CO2Et
 
The title compound was prepared from 21a (300 mg, 1.00 mmol), TMP2Mg·2LiCl (1.57 mL, 
0.7 M in THF, 1.1 mmol), ethyl-4-iodobenzoate (414 mg, 1.5 mmol), ZnCl2 (1.2 ml, 1 M in 
THF, 1.2 mmol), Pd(dba)2 (11 mg, 2 mol%), P(2-furyl)3 (9 mg, 4 mol%) applying TP5 and 
TP7. Metalation conditions: –40 °C, 4 h. Flash chromatography on silica (EtOAc) a yellowish 
solid (351 mg, 78%). 
m.p.: 53.0 - 55.9 °C. 
1H-NMR (600 MHz, CDCl3) δ: 8.1 (m, 2 H), 8.0 (m, 1 H), 7.9 (m, 1 H), 7.6 (m, 2 H), 7.4 (dd, 
J = 8.1 Hz, J = 1.0 Hz, 1 H), 4.4 (m, 4 H), 2.5 (m, 12 H), 1.4 (m, 6 H).  
13C-NMR (150 MHz, CDCl3) δ: 166.6, 165.9, 148.6, 148.5, 142.1, 137.2, 131.8, 131.1, 130.0, 
129.8, 129.6, 125.6, 121.9, 61.5, 61.3, 36.7, 14.5. 
MS (70 eV, EI) m/z (%): 448 (4) [M+], 403 (3), 374 (10), 340 (24), 314 (31), 195 (11), 169 
(7), 139 (15), 135 (100), 92 (8). 
IR (ATR) ν~  (cm-1): 2987, 2901, 1707, 1605, 1556, 1518, 1474, 1392, 1366, 1272, 1235, 
1181, 1197, 1124, 1099, 1070, 1026, 999, 958, 958, 906, 854, 845, 781, 757, 728, 675. 
HRMS (EI): 448.1777 (calcd.: 448.1763). 
 
Synthesis of 2-iodo-5-(trifluoromethyl)phenyl N,N,N',N'-tetramethyldiamidophosphate 
(22d): 
 
 
 
A solution of 21b (592 mg, 2.0 mmol) in THF (2 mL) was cooled to -40 °C. Then 
TMP2Mg·2LiCl (0.6 M in THF, 3.67 mL, 2.2 mmol) was added dropwise and the resulting 
mixture was stirred for 2 h at –40 °C. Complete metalation was detected by GC-analysis of 
reaction aliquots, quenched with I2 in THF. I2 (558 mg, 2.2 mmol) in THF (2 mL) was added 
and the mixture was warmed to 25 °C within 12 h. The reaction mixture was quenched by the 
addition of sat. aq. Na2S2O3 (10 mL) and sat. aq. NH4Cl solution (10 mL). The mixture was 
extracted with Et2O (3 x 20 mL) and with EtOAc (3 x 20 mL). The combined organic layers 
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were washed with brine, dried over Na2SO4 and the solvent was evaporated in vacuo. The 
residue was purified by flash chromatography on silica (Et2O/n-pentane 3:1) furnishing a 
colorless solid (749 mg, 88%). 
m.p.: 85.3 - 86.1 °C. 
1H-NMR (300 MHz, CDCl3) δ: 7.9 (d, J = 8.4 Hz, 1 H), 7.7 (s, 1 H), 7.1 (dd, J = 8.3 Hz, J = 
2.1 Hz, 1 H), 2.8 (m, 12 H).  
13C-NMR (75 MHz, CDCl3) δ: 152.1, 140.3, 132.4 (q, J(C-F) = 33.3 Hz), 123.8, 123.7 (q, 
J(C-F) = 272.2 Hz), 122.0, 116.6, 37.1. 
MS (70 eV, EI) m/z (%): 423 (16), 422 (93), 378 (39), 314 (41), 296 (57), 295 (100), 287 (10), 
276 (47), 252 (15), 250 (14), 232 (10), 207 (23), 188 (19), 160 (37), 145 (11), 144 (34), 141 
(11), 136 (25), 135 (100), 132 (29), 92 (46), 91 (12), 90 (20), 76 (14), 63 (11).  
IR (ATR) ν~  (cm-1): 2932, 2908, 2856, 1596, 1576, 1480, 1460, 1404, 1324, 1292, 1260, 
1232, 1204, 1168, 1120, 1080, 1028, 1000, 980, 940, 892, 824, 764, 732, 716, 676.   
HRMS (EI): 421.9870 (calcd.: 421.9868). 
 
Synthesis of 2-bromo-5-iodophenyl N,N,N',N'-tetramethyldiamidophosphate (22e):  
 
 
 
3-Iodophenyl N,N,N',N'-tetramethyldiamidophosphate (21c) (400 mg, 1.0 mmol) was 
dissolved in THF (1 mL) and cooled to 0 °C. Then TMP2Mg·2LiCl (0.6 M in THF, 1.83 mL, 
1.1 mmol) was added dropwise. The mixture was stirred for 1 h, and after that BrCl2CCCl2Br 
(488 mg, 1.5 mmol), dissolved in dry THF (1 mL), was added dropwise at 0 °C and the 
resulting mixture was warmed to 25 °C and stirred for 1 h. The reaction mixture was 
quenched with sat. aq. NH4Cl solution (5 mL), extracted with Et2O (3 × 15 mL) and dried 
over anhydrous Na2SO4. After filtration, the solvent was evaporated in vacuo. Purification by 
flash chromatography (EtOAc) furnished a yellowish solid (329 mg, 76%). 
m.p.: 64.9 - 66.9 °C. 
1H-NMR (600 MHz, CDCl3) δ: 7.7 (m, 1 H), 7.3 (dd, J = 1.2 Hz, J = 8.4 Hz, 1 H), 7.2 (dd, J 
= 0.9 Hz, J = 8.2 Hz, 1 H), 2.7 (, 12 H). 
13C-NMR (150 MHz, CDCl3) δ: 149.6, 134.9, 134.6, 130.2, 114.7, 92.5, 37.2.   
MS (70 eV, EI) m/z (%): 432 (1) [M++H], 353 (100), 135 (90), 92 (5), 63 (2), 44(11).  
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IR (ATR) ν~  (cm-1): 2931, 2884, 2845, 2811, 1566, 1467, 1383, 1310, 1290, 1215, 1172, 
1068, 999, 983, 920, 799, 755, 675. 
HRMS (EI): 432.9178 (calcd.: 432.9178). 
 
Synthesis of 4-cyano-2-(2,2-dimethylpropanoyl)phenyl N,N,N',N'-
tetramethyldiamidophosphate (19j): 
 
 
The title compound was prepared from 5a (1.27 g, 5.0 mmol), TMP2Mg·2LiCl (7.85 mL, 0.7 
M in THF, 5.5 mmol), ZnCl2 (1 M in THF, 6.0 mL, 6.0 mmol), pivaloyl chloride (664 mg, 5.5 
mmol), CuCN·2LiCl (2.5 mL, 1 M in THF, 50 mol%) applying TP5 and TP8. Metalation 
conditions: 0 °C, 1 h. Flash chromatography on silica (EtOAc) furnished a colorless solid 
(1.32 g, 78%). 
m.p.: 65.4 - 67.9 °C. 
1H-NMR (300 MHz, CDCl3) δ: 7.8 (m, 1 H), 7.6 (dd, J = 8.7 Hz, J = 2.1 Hz, 1 H), 7.4 (m, 1 
H), 2.7 (m, 12 H), 1.2 (s, 9 H). 
13C-NMR (75 MHz, CDCl3) δ: 209.4, 151.5, 134.3, 133.7, 130.3, 120.8, 118.2, 107.2, 45.5, 
36.9, 26.8.  
MS (70 eV, EI) m/z (%): 338 (1) [M+], 337 (1), 295 (47), 294 (100), 293 (10), 281 (85), 280 
(100), 278 (13), 237 (18), 230 (19), 186 (59), 184 (10), 173 (12), 146 (10), 145 (23), 136 (12), 
135 (100), 92 (34), 90 (10), 57 (19). 
IR (ATR) ν~  (cm-1): 3392, 3196, 3076, 2228, 1696, 1600, 1484, 1408, 1364, 1300, 1224, 
1132, 988, 892, 852, 764, 748, 692, 660.   
HRMS (EI):  337.1566 (calcd.: 337.1555). 
 
Synthesis of 4-cyano-2,6-bis(2,2-dimethylpropanoyl)phenyl N,N,N',N'-
tetramethyldiamidophosphate (24a): 
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The title compound was prepared from 19j (1.67 g, 5.0 mmol), TMP2Mg·2LiCl (7.85 mL, 0.7 
M in THF, 5.5 mmol), ZnCl2 (1 M in THF, 6.0 mL, 6.0 mmol), pivaloyl chloride (660 mg, 5.5 
mmol), CuCN·2LiCl (2.5 mL, 1 M in THF, 50 mol%) applying TP5 and TP8. Metalation 
conditions: –60 °C, 0.5 h. Flash chromatography on silica (n-pentane/Et2O 1:1) furnished a 
colorless solid (648 mg, 77%). 
m.p.: 167.3 - 168.7 °C. 
1H-NMR (300 MHz, CDCl3) δ: 7.6 (s, 2 H), 2.6 (m, 12 H), 1.3 (s, 18 H).   
13C-NMR (75 MHz, CDCl3) δ: 208.1, 148.2, 136.9, 131.2, 117.7, 107.0, 45.1, 36.8, 27.8.    
MS (70 eV, EI) m/z (%): 421 (1) [M+], 378 (15), 377 (78), 365 (58), 364 (31), 319 (68), 135 
(54), 46 (100). 
IR (ATR) ν~  (cm-1): 2972, 2932, 2912, 2872, 2808, 2236, 1752, 1692, 1676, 1592, 1576, 
1476, 1436, 1408, 1392, 1364, 1304, 1284, 1240, 1220, 1192, 1148, 1080, 1044, 1020, 996, 
944, 904, 888, 872, 836, 800, 780, 752, 712, 696, 668.  
HRMS (EI): 421.2127 (calcd.: 421.2130). 
 
Synthesis of 5-bromo-4'-cyanobiphenyl-2-yl N,N,N',N'-tetramethyldiamidophosphate 
(19k): 
 
Br
O
(Me2N)2P CN
O
 
 
The title compound was prepared from 18b (1.54 g, 5.00 mmol), TMP2Mg·2LiCl (7.85 mL, 
0.7 M in THF, 5.5 mmol), 4-iodobenzonitrile (1.26 g, 5.50 mmol), ZnCl2 (6.0 ml, 1 M in THF, 
6.0 mmol), Pd(dba)2 (55 mg, 2 mol%), P(2-furyl)3 (45 mg, 4 mol%) applying TP5 and TP7. 
Metalation conditions: –50 °C, 7 h. Flash chromatography on silica (EtOAc) furnished a pale 
yellow solid (1.63 g, 80%). 
m.p.: 128.8 - 129.8 °C. 
1H-NMR (300 MHz, CDCl3) δ: 7.7 (d, J = 8.6 Hz, 2 H), 7.6 (d, J = 8.6 Hz, 2 H), 7.5 (m, 1 
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H), 7.4 (m, 2 H), 2.5 (m, 12 H).  
13C-NMR (75 MHz, CDCl3) δ: 147.7, 141.7, 135.4, 133.5, 132.9, 132.2, 130.5, 122.6, 118.8, 
117.3, 111.8, 36.7.   
MS (70 eV, EI) m/z (%): 407 (4) [M+], 193 (13), 164 (6), 135 (100). 
IR (ATR) ν~  (cm-1): 3076, 2928, 2904, 2856, 2808, 2224, 1608, 1508, 1468, 1452, 1408, 
1384, 1300, 1260, 1228, 1212, 1184, 1124, 1108, 1068, 1028, 1016, 984, 904, 852, 816, 804, 
768, 756, 728, 684.   
HRMS (EI):  407.0386 (calcd.: 407.0398). 
 
Synthesis of  5-bromo-4'-cyano-3-(2-methylprop-2-en-1-yl)bi-phenyl-2-yl N,N,N',N'-
tetramethyldiamidophosphate (24b): 
 
Br
O
(Me2N)2P CN
Me
O
 
 
The title compound was prepared from 19k (408 mg, 1.0 mmol), TMP2Mg·2LiCl (1.57 mL, 
0.7 M in THF, 1.1 mmol), ZnCl2 (1 M in THF, 1.2 mL, 1.2 mmol), 3-bromo-2-methylpropene 
(150 mg, 1.1 mmol), CuCN·2LiCl (0.5 mL, 1 M in THF, 50 mol%) applying TP5 and TP9. 
Metalation conditions: –60 °C, 0.5 h. Flash chromatography on silica (EtOAc) furnished a 
colorless solid (356 mg, 77%). 
m.p.: 124.0 - 125.2 °C. 
1H-NMR (600 MHz, CDCl3) δ: 7.7 (d, J = 7.9 Hz, 2 H), 7.6 (d, J = 8.2 Hz, 2 H), 7.4 (d, J = 
2.4 Hz, 1 H), 7.3 (d, J = 2.4 Hz, 1 H), 4.9 (s, 1 H), 4.6 (s, 1 H), 3.6 (s, 2 H), 2.3 (m, 12 H), 1.8 
(s, 3 H).    
13C-NMR (150 MHz, CDCl3) δ: 145.7, 143.7, 136.5, 135.3, 134.3, 132.3, 132.1, 130.6, 118.8, 
118.3, 113.3, 111.5, 39.1, 36.4, 22.8. 
MS (70 eV, EI) m/z (%): 452 (1) [M+], 410 (15), 409 (10), 408 (41), 397 (30), 396 (19), 395 
(100), 135 (100), 44 (10). 
IR (ATR) ν~  (cm-1): 3068, 2932, 2904, 2848, 2804, 2228, 1648, 1608, 1572, 1552, 1504, 
1484, 1448, 1412, 1396, 1376, 1300, 1256, 1224, 1196, 1176, 1112, 1096, 1072, 1004, 988, 
940, 912, 880, 844, 808, 776, 748, 688, 664.   
HRMS (EI): 461.0865 (calcd.: 461.0868). 
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Synthesis of 5-chloro-4'-methoxybiphenyl-2-yl N,N,N',N'-tetra-methyldiamidophosphate 
(19l): 
 
 
 
The title compound was prepared from 18d (2.62 g, 8.0 mmol), TMP2Mg·2LiCl (12.6 mL, 0.7 
M in THF, 8.8 mmol), ZnCl2 (1 M in THF, 9.6 mL, 9.6 mmol), 3-bromo-2-methylpropene 
(150 mg, 1.1 mmol), Pd(dba)2 (88 mg, 2 mol%), P(2-furyl)3 (72 mg, 4 mol%) applying TP5 
and TP7. Metalation conditions: –40 °C, 1.5 h. Flash chromatography on silica (EtOAc) 
furnished an orange oil (2.78 g, 90%). 
1H-NMR (600 MHz, CDCl3) δ: 7.5 (dd, J = 8.7 Hz, J = 1.2 Hz, 1 H), 7.4 (d, J = 8.8 Hz, 2 
H), 7.3 (dd, J = 2.6 Hz, J = 1.1 Hz, 1 H), 7.2 (dd, J = 8.6 Hz, J = 2.6 Hz, 1 H), 6.9 (d, J = 8.8 
Hz, 2 H), 3.8 (s, 3 H), 2.5 (m, 12 H).  
13C-NMR (150 MHz, CDCl3) δ: 159.4, 147.3, 134.8, 134.7, 130.8, 129.5, 129.4, 128.2, 122.1, 
113.7, 55.5, 36.7. 
MS (70 eV, EI) m/z (%): 370 (29), 369 (17), 368 (100) [M+], 279 (27), 260 (21), 236 (18), 
234 (61), 198 (14), 139 (17), 136 (13), 135 (64), 91 (10), 44 (47). 
IR (ATR) ν~  (cm-1): 3464, 3000, 2932, 2900, 2852, 2812, 1608, 1580, 1564, 1516, 1480, 
1464, 1420, 1388, 1296, 1244, 1204, 1176, 1128, 1112, 1096, 1068, 1040, 1024, 984, 904, 
816, 780, 756, 724, 696, 668.   
HRMS (EI):  326.1574 (calcd.: 326.1559). 
 
Synthesis of 5-chloro-3-(2,2-dimethylpropanoyl)-4'-methoxybi-phenyl-2-yl N,N,N',N'-
tetramethyldiamidophosphate (24c): 
 
 
 
The title compound was prepared from 19l (738 g, 2.0 mmol), TMP2Mg·2LiCl (3.14 mL, 0.7 
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M in THF, 2.2 mmol), ZnCl2 (1 M in THF, 2.2 mL, 2.2 mmol), pivaloyl chloride (265 mg, 2.2 
mmol), CuCN·2LiCl (1.0 mL, 1 M in THF, 50 mol%) applying TP5 and TP8. Metalation 
conditions: –60 °C, 0.5 h. Flash chromatography on silica (n-pentane/Et2O 1:2) furnished  a 
colorless solid (744 mg, 82%). 
m.p.: 155.2 - 156.3 °C. 
1H-NMR (300 MHz, CDCl3) δ: 7.4 (d, J = 8.8 Hz, 2 H), 7.3 (m, 1H), 7.2 (d, J = 2.6 Hz, 1 H), 
7.0 (d, J = 8.8 Hz, 2 H), 3.9 (s, 3 H), 2.3 (m, 12 H), 1.4 (s, 9 H).  
13C-NMR (75 MHz, CDCl3) δ: 209.1, 159.6, 143.7, 137.9, 137.0, 132.2, 131.0, 130.2, 128.9, 
125.9, 114.0, 55.6, 44.8, 36.4, 28.6.    
MS (70 eV, EI) m/z (%): 463 (10), 461 (10) [M+], 135 (100), 44 (16). 
IR (ATR) ν~  (cm-1): 2972, 2956, 2928, 2904, 2852, 2816, 1752, 1728, 1692, 1608, 1576, 
1508, 1480, 1456, 1428, 1412, 1388, 1364, 1296, 1268, 1248, 1236, 1204, 1188, 1172, 1120, 
1108, 1072, 1028, 988, 932, 900, 872, 832, 816, 796, 784, 756, 724, 692, 664.  
HRMS (EI): 452.1650 (calcd.: 452.1632). 
 
4.5. Regioselective Metalation on N-Heterocycles 
 
4.5.1. Starting Material Synthesis:  
 
Synthesis of pyridin-2-yl N,N,N',N'-tetramethyldiamidophosphate (28a): 
 
 
 
The title compound was prepared from 2-hydroxypyridine (1.90 g, 20 mmol) applying TP2. 
The dark red oil (4.12 g, 90%) was used without further purification.  
 
1H-NMR (600 MHz, CDCl3) δ (ppm): 8.2 (m, 1 H), 7.7 (t, J = 7.9 Hz, 1 H), 7.1 (d, J = 8.1 
Hz, 1 H), 7.0 (t, J = 6.0 Hz, 1 H),  2.7 (m, 12 H).  
13C-NMR (100 MHz, CDCl3) δ (ppm): 158.3, 148.1, 139.6, 120.1, 113.9, 106.5, 36.7. 
Observed complexity due to C-P splitting, definitive assignments have not been made. 
IR (ATR) ν~  (cm-1): 3466, 2930, 2894, 1590, 1468, 1430, 1302, 1246, 1214, 1180, 986, 908, 
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794, 770, 750, 670. 
MS (70 eV, EI) m/z (%): 186 (42), 185 (63), 141 (100), 139 (35), 122 (13), 96 (42), 78 (69), 
51 (11), 44 (70). 
HRMS (EI): 229.0966 (calcd.: 229.0980). 
 
Synthesis of pyridin-3-yl N,N,N',N'-tetramethyldiamidophosphate (28b): 
 
 
 
The title compound was prepared from 3-hydroxypyridine (1.90 g, 20 mmol) applying TP2. 
The dark red oil (4.03 g, 88%) was used without further purification.  
 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.5 (m, 1 H), 8.4 (d, J = 4.2 Hz, 1 H), 7.7 (m, 1 H), 7.3 
(dd, J = 8.4, 4.7 Hz, 1 H), 2.7 (m, 12 H). 
13C-NMR (75 MHz, CDCl3) δ (ppm): 148.48, 145.05, 142.07, 127.84, 124.18, 36.66. 
IR (ATR) ν~  (cm-1): 3446, 2930, 2896, 2814, 1476, 1424, 1306, 1230, 1210, 1188, 986, 896, 
814, 770, 752, 706, 670.  
MS (70 eV, EI) m/z (%): 229 (54) [M+], 186 (52), 135 (90), 121 (23), 92 (32), 78 (20), 44 
(23). 
HRMS (EI): 229.0955 (calcd.: 229.0980). 
 
Synthesis of pyridin-4-yl N,N,N',N'-tetramethyldiamidophosphate (28c): 
 
 
 
The title compound was prepared from 4-hydroxypyridine (1.90 g, 20 mmol) applying TP2. 
The yellow oil (3.71 g, 81%) was used without further purification.  
 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.4 (m, 2 H), 7.1 (m, 2 H), 2.6 (m, 12 H).  
13C-NMR (75 MHz, CDCl3) δ (ppm): 158.4 (dd, J(C-P) = 5.7, 1.7 Hz, 1 C), 151.3, 110.3, (d, 
J(C-P) = 5.7, 2 C), 36.5 (dd, J(C-P) = 4.0, 1.0 Hz, 4 C).  
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IR (ATR) ν~  (cm-1): 3443, 2922, 2886, 2814, 1472, 1420, 1312, 1229, 1215, 1192, 987, 898, 
815, 777, 742, 701, 680. 
MS (70 eV, EI) m/z (%): 229 (18) [M+], 186 (16), 122 (54), 95 (15), 78 (30), 44 (61). 
HRMS (EI): 229.0971 (calcd.: 229.0980). 
 
Synthesis of quinolin-2-yl N,N,N',N'-tetramethyldiamidophosphate (30a): 
 
 
 
The title compound was prepared from 2-hydroxyquinoline (2.90 g, 20 mmol) applying TP2. 
The yellow solid (5.08 g, 91%) was used without further purification.  
m.p.: 65.3 - 65.6 °C 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.1 (d, J = 8.7 Hz, 1 H), 7.9 (d, J = 8.4 Hz, 1 H), 7.8 
(m, 1 H), 7.6 (m, 1 H), 7.5 (m, 1 H), 7.2 (d, J = 8.7 Hz, 1 H), 2.8 (m, 12 H). 
13C-NMR (75 MHz, CDCl3) δ (ppm): 164.0, 156.6, 156.5, 146.5, 140.8, 140.0, 138.6, 130.5, 
129.8, 128.2, 127.6, 127.4, 126.2, 125.5, 122.5, 121.4, 119.8, 116.2, 114.0, 113.9, 36.8. 
Observed complexity due to C-P splitting, definitive assignments have not been made.  
IR (ATR) ν~  (cm-1): 3440, 2924, 2806, 2454, 1646, 1598, 1468, 1428, 1312, 1260, 1242, 
1222, 1214, 1176, 974, 946, 924, 834, 818, 776, 756, 730, 690, 680, 670, 662. 
MS (70 eV, EI) m/z (%): 280 (12) [M+]235 (51), 192 (75), 172 (10), 145 (100), 143 885), 128 
(45), 117 (15)44, 44 (14). 
HRMS (EI): 279.1130 (calcd.: 279.1137). 
 
Synthesis of quinolin-3-yl N,N,N',N'-tetramethyldiamidophosphate (30f): 
 
N
O
P(NMe2)2
O
 
 
The title compound was prepared from 3-hydroxyquinoline (2.90 g, 20 mmol) applying TP2. 
The colorless solid (5.30 g, 95%) was used without further purification.  
m.p.: 66.6 - 66.9 °C 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.7 (d, J = 2.8 Hz, 1 H), 8.0 (m, 2 H), 7.7 (m, 1 H), 7.6 
(m, 1 H), 7.5 (m, 1 H), 2.7 (d, 12 H).  
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13C-NMR (75 MHz, CDCl3) δ (ppm): 145.3, 145.2, 145.1, 145.0, 144.9, 129.1, 128.4, 128.3, 
127.5, 127.2, 123.4, 36.7, 36.6.  
Observed complexity due to C-P splitting, definitive assignments have not been made. 
IR (ATR) ν~  (cm-1): 3432, 2928, 2890, 1646, 1600, 1458, 1422, 1340, 1300, 1220, 1212, 
1188, 1178, 1154, 1140, 980, 914, 902, 850, 784, 762, 754, 738, 722, 690, 672, 656.  
MS (70 eV, EI) m/z (%): 280 (12) [M+], 235 (51), 192 (75), 172 (10), 145 (100), 143 (85), 
128 (45), 117 (15), 44 (14). 
HRMS (EI): 279.1130 (calcd.: 279.1137). 
 
Synthesis of quinolin-4-yl N,N,N',N'-tetramethyldiamidophosphate (30b): 
 
 
 
The title compound was prepared from 4-hydroxyquinoline (2.90 g, 20 mmol) applying TP2. 
The colorless oil (4.63 g, 83%) was used without further purification.  
 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.8 (d, J = 5.1 Hz, 2 H), 8.6 (d, J = 5.6 Hz, 1 H), 8.1 
(m, 1 H), 7.7 (m, 1 H), 7.6 (m, 1 H) 2.8 (m, 12 H).  
13C-NMR (75 MHz, CDCl3) δ (ppm): 154.9, 154.8, 151.3, 149.9, 129.9, 129.4, 126.3, 122.1, 
121.2, 109.1, 109.0, 44.0, 36.8, 36.7.  
Observed complexity due to C-P splitting, definitive assignments have not been made. 
IR (ATR) ν~  (cm-1): 3416, 2946, 2860, 2844, 2792, 1574, 1510, 1454, 1422, 1392, 1334, 
1296, 1230, 1188, 1134, 1098, 1046, 990, 934, 906, 830, 810, 764, 692, 664. 
MS (70 eV, EI) m/z (%): 236 (22), 193 (16), 146 (58), 135 (41), 129 (45), 118 816), 92 (35), 
44 (100). 
HRMS (EI): 279.1134 (calcd.: 279.2748). 
 
Synthesis of 2-chloroquinolin-8-yl N,N,N',N'-tetramethyldiamidophosphate (30c):  
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The title compound was prepared from 2-chloroquinolin-8-ol99 (3.59 g, 20 mmol) applying 
TP2. The brown oil (5.08 g, 81%) was used without further purification.  
 
1H-NMR (300 MHz, CDCl3) δ (ppm): 7.8 (m, 2 H), 7.5 – 7.3 (m, 3 H), 2.6 (m, 12 H). 
13C-NMR (75 MHz, CDCl3) δ (ppm): 150.3, 150.2, 146.5, 146.4, 146.4, 140.8, 140.7, 138.7, 
128.0, 127.9, 126.8, 123.4, 122.6, 122.6, 120.9, 36.7, 36.6. 
Observed complexity due to C-P splitting, definitive assignments have not been made. 
IR (ATR) ν~  (cm-1): 2928, 2894, 2810, 1588, 1566, 1492, 1460, 1420, 1300, 1252, 1224, 
1170, 1118, 1080, 1054, 984, 912, 850, 836, 814, 800, 754, 704, 686, 658. 
MS (70 eV, ESI) m/z (%): 314 (100) [M+], 280 (12), 162 (3). 
HRMS (ESI): 314.0820 (calcd.: 314.0825).  
 
Synthesis of 2-bromoquinolin-8-yl N,N,N',N'-tetramethyldiamidophosphate (30d):  
 
 
 
The title compound was prepared from 2-bromoquinolin-8-ol99 (3.59 g, 20 mmol) applying 
TP2. The brown oil (5.08 g, 81%) was used without further purification.  
 
1H-NMR (300 MHz, CDCl3) δ (ppm): 7.8 (m, 2 H), 7.5 – 7.3 (m, 3 H), 2.8 (m, 12 H). 
13C-NMR (75 MHz, CDCl3) δ (ppm): 146.6, 141.6, 138.2, 128.3, 127.3, 127.2, 126.2, 123.8, 
123.7, 121.2, 121.1, 36.9, 36.8. 
Observed complexity due to C-P splitting, definitive assignments have not been made. 
IR (ATR) ν~  (cm-1): 3466, 2926, 2894, 2810, 1582, 1564, 1488, 1460, 1420, 1296, 1252, 
1222, 1168, 1104, 1078, 984, 908, 834, 812, 754, 702, 682, 672, 656. 
MS (70 eV, EI) m/z (%): 357 (8) [M+], 324 (40), 322 (35), 294 (54), 251 (100), 248 (15), 142 
(28), 135 (24), 114 (11), 44 (33). 
HRMS (EI): 357.9771 (calcd.: 358.1701). 
                                                 
99
 a) O. Sigouin, A. L Beauchamp, Can. J. Chem. 2005, 83, 460; b) H. Gernshorn, D. D. Clarke, Monatsh. Chem. 
1991, 122, 935. 
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Synthesis of quinoxalin-2-yl N,N,N',N'-tetramethyldiamidophosphate (30e):  
 
 
 
The title compound was prepared from 2-hydroxyquinoxaline (2.92 g, 20 mmol) applying 
TP2. The brown oil (5.08 g, 81%) was used without further purification.  
 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.6 (s, 1 H), 7.9 (d, J = 8.3 Hz, 1 H), 7.8 (d, J = 8.3 Hz, 
1 H), 7.6 (m, 1 H), 7.5 (m, 1 H), 2.7 (m, 12 H)  
13C-NMR (75 MHz, CDCl3) δ (ppm): 170.9, 170.8, 152.1, 152.0, 140.2, 140.1, 139.4, 139.4, 
130.4, 128.8, 128.2, 128.1, 36.6. Observed complexity due to C-P splitting, definitive 
assignments have not been made.  
IR (ATR) ν~  (cm-1): 3476, 2930, 2894, 2812, 1570, 1494, 1458, 1404, 1296, 1268, 1232, 
1212, 1202, 1178, 1134, 1124, 982, 924, 830, 758, 688. 
MS (70 eV, EI) m/z (%): 280 (1) [M+], 236 (22), 193 (17), 146 (45), 135 (41), 129 (45), 92 
(25). 
HRMS (EI): 280.1099 (calcd.: 280.2629). 
 
4.5.2. Directed Magnesiation or Zincation and Reaction with 
Electrophiles 
  
Synthesis of 3-[4-(methylthio)phenyl]pyridin-2-yl N,N,N',N'-
tetramethyldiamidophosphate (29a):  
 
 
 
The title compound was prepared from 28a (229 mg, 1.00 mmol), TMPMgCl·LiCl (1.07 mL, 
1.4 M in THF, 1.5 mmol), 4-bromo methylthiobenzene (223 mg, 1.00 mmol), ZnCl2 (1.6 ml, 1 
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M in THF, 1.6 mmol), Pd2(dba)3 (9 mg, 1 mol%), RuPHOS (9 mg, 2 mol%) applying TP5 and 
7. Metalation conditions 0 °C, 60 min. Flash chromatography on silica (EtOAc/EtOH, 9:1) 
gave a pale yellow solid (260 mg, 74%).  
m.p.: 88.3 - 88.7 °C 
1H-NMR (600 MHz, CDCl3) δ (ppm): 8.2 (m, 1 H), 7.6 (d, J = 8.1 Hz, 1 H), 7.5 (s, 1 H), 7.4 
(d, J = 1.9 Hz, 1 H), 7.3 (d, J = 6.7 Hz, 2 H), 7.1 (dd, J = 7.4, 5.0 Hz, 1 H), 2.6 (m, 12 H), 2.5 
(s, 3 H).  
13C-NMR (150 MHz, CDCl3) δ (ppm): 155.5, 155.4, 146.8, 139.7, 138.4, 132.9, 129.7, 126.3, 
126.2, 126.1, 120.1, 36.7, 15.7. 
Observed complexity due to C-P splitting, definitive assignments have not been made.  
IR (ATR) ν~  (cm-1): 2884, 2850, 2812, 1586, 1572, 1422, 1398, 1308, 1286, 1260, 1242, 
1214, 1202, 1168, 1152, 1110, 1092, 1072, 1064, 1000, 980, 892, 840, 800, 780, 760, 736, 
716, 670. 
MS (70 eV, EI) m/z (%): 351 (1) [M+], 307 (27), 217 (100), 215 (38), 153 (6), 44 (6). 
HRMS (EI): 351.1169 (calcd.: 351.1170). 
 
Synthesis of 4-(3-{[bis(dimethylamino)phosphoryl]oxy}pyridin-4-yl)phenyl 
trifluoromethanesulfonate (29b):  
 
N
O
P(NMe2)2
O
OTf
 
 
The title compound was prepared from 28b (229 mg, 1.00 mmol), TMP2Zn·2MgCl2·2LiCl 
(1.5 mL, 0.5 M in THF, 0.75 mmol), 4-iodophenyl trifluoromethanesulfonate100 (223 mg, 1.00 
mmol), Pd(dba)2 (30 mg, 5 mol%), P(2-furyl)3 (23 mg, 10 mol%) applying TP5 and TP7. 
Metalation conditions 25 °C, 60 min. Flash chromatography on silica (EtOAc/EtOH, 9:1) 
gave a colorless oil (398 mg, 88%). 
m.p.: 78.3 - 78.5 °C 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.6 (s, 1 H), 8.4 (d, J = 4.9 Hz, 1 H) 7.6 (m, 2 H), 7.4 
(m, 2 H), 7.2 (s, 1 H), 2.5 (m, 12 H)  
13C-NMR (75 MHz, CDCl3) δ (ppm): 158.1, 149.5, 145.6, 145.3, 145.2, 144.4, 143.1, 139.2, 
                                                 
100
 I. Sapountzis, W. Lin, C. C. Kofink, C. Despotopoulou, P. Knochel, Angew. Chem. Int. Ed. 2005, 44, 1654. 
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139.1, 135.8, 131.2, 130.6, 125.1, 124.6, 123.5, 121.4, 120.3, 117.1, 115.5, 113.9, 36.4, 36.3.  
Observed complexity due to C-P & C-F splitting, definitive assignments have not been made. 
IR (ATR) ν~  (cm-1): 2926, 1478, 1420, 1406, 1312, 1296, 1272, 1246, 1202, 1170, 1134, 
1056, 1002, 984, 914, 886, 862, 842, 832, 792, 778, 764, 748, 708, 688, 672. 
MS (70 eV, EI) m/z (%): 453 (8) [M+], 365 (9), 314 (6), 134 (100), 91 (6), 44 (8). 
HRMS (EI): 453.0729 (calcd.: 453.0735). 
 
Synthesis of 4-(4-chlorophenyl)pyridin-3-yl N,N,N',N'-tetramethyldiamidophosphate 
(29c):  
 
N
O
P(NMe2)2
O
Cl
 
 
The title compound was prepared from 28b (229 mg, 1.00 mmol), TMP2Zn·2MgCl2·2LiCl 
(1.5 mL, 0.5 M in THF, 0.75 mmol), 1-chloro-4-iodobenzene (238 mg, 1.00 mmol), Pd(dba)2 
(30 mg, 5 mol%), P(2-furyl)3 (23 mg, 10 mol%) applying TP5 and TP7. Metalation 
conditions 25 °C, 60 min. Flash chromatography on silica (EtOAc/EtOH, 9:1) gave a 
colorless oil (268 mg, 79%). 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.7 (s, 1 H), 8.5 (d, J = 5.0 Hz, 1 H), 7.5 (m, 4 H), 7.3 
(d, J = 4.7 Hz, 1 H), 2.6 (m, 12 H).   
13C-NMR (75 MHz, CDCl3) δ (ppm): 145.6, 145.5, 144.6, 142.1, 140.6, 140.5, 135.0, 133.5, 
130.6, 128.7, 125.0, 36.5, 36.4. 
Observed complexity due to C-P splitting, definitive assignments have not been made. 
IR (ATR) ν~  (cm-1): 3470, 2914, 2896, 1600, 1476, 1412, 1396, 1306, 1282, 1226, 1208, 
1172, 1090, 1064, 986, 894, 822, 780, 764, 756, 740, 716, 670. 
MS (70 eV, EI) m/z (%): 339 (20) [M+], 251 (22), 231 (20), 201 (14), 135 (100), 44 (22). 
HRMS (EI): 339.0894 (calcd.: 338.0903). 
 
Synthesis of 4-(2-methylprop-2-en-1-yl)pyridin-3-yl N,N,N',N'-
tetramethyldiamidophosphate (29d):  
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The title compound was prepared from 28b (229 mg, 1.00 mmol), TMP2Zn·2MgCl2·2LiCl 
(1.5 mL, 0.5 M in THF, 0.75 mmol), 3-bromo-2-methylpropene (135 mg, 1.00 mmol), 
CuCN·2LiCl (0.1 mL, 1 M in THF, 10 mol%) applying TP5 and TP9. Metalation conditions 
25 °C, 60 min. Flash chromatography on silica (EtOAc/EtOH, 9:1) gave a colorless oil (268 
mg, 79%). 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.5 (s, 1 H), 8.3 (m, 1 H), 7.2 (m, 1 H), 4.9 (s, 1 H), 
4.7 (s, 1 H), 3.4 (s, 2 H), 2.8 (m, 12 H) 1.8 (s, 3 H).  
13C-NMR (75 MHz, CDCl3) δ (ppm): 147.4, 144.6, 142.0, 141.0, 125.4, 113.4, 37.6, 36.7, 
36.6, 22.6.  
Observed complexity due to C-P splitting, definitive assignments have not been made. 
IR (ATR) ν~  (cm-1): 3492, 2928, 2898, 1652, 1594, 1492, 1456, 1408, 1306, 1246, 1224, 
1196, 1148, 1140, 1064, 984, 924, 900, 836, 816, 770, 750, 730, 670. 
MS (70 eV, EI) m/z (%): 283 (13) [M+], 135 (57), 70 (20), 61 (25), 45 (31), 42 (100). 
HRMS (EI): 283.1444 (calcd.: 283.1450). 
 
Synthesis of 3-chloropyridin-4-yl N,N,N',N'-tetramethyldiamidophosphate (29e):  
 
 
 
The title compound was prepared from 28c (229 mg, 1.00 mmol), TMPMgCl·LiCl (1.07 mL, 
1.4 M in THF, 1.5 mmol), 1,1,2-trichlorotrifluoroethane (188 mg, 1.00 mmol) applying TP5. 
Metalation conditions 0 °C, 60 min. Flash chromatography on silica (EtOAc) gave a colorless 
oil (268 mg, 83%). 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.6 (s, 1 H), 8.4 (d, J = 5.4 Hz, 1 H), 7.5 (d, J = 5.7 Hz, 
1 H), 2.8 (m, 12 H)  
13C-NMR (75 MHz, CDCl3) δ (ppm): 154.4, 154.3, 150.7, 149.3, 115.7, 36.7, 36.6.  
Observed complexity due to C-P splitting, definitive assignments have not been made. 
IR (ATR) ν~  (cm-1): 3480, 2930, 2900, 1570, 1480, 1400, 1290, 1266, 1230, 1176, 1100, 
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1036, 988, 904, 838, 756, 702, 668. 
MS (70 eV, EI) m/z (%): 263 (16) [M+], 228 (80), 175 (17), 135 (100), 90 820), 44 (46). 
HRMS (EI): 263.0583 (calcd.: 263.0590). 
 
Synthesis of 3-(methylthio)pyridin-4-yl N,N,N',N'-tetramethyldiamidophosphate (29f):  
 
 
 
The title compound was prepared from 28c (229 mg, 1.00 mmol), TMPMgCl·LiCl (1.07 mL, 
1.4 M in THF, 1.5 mmol), S-methyl methanethiolsulfonate (127 mg, 1.00 mmol) applying 
TP5. Metalation conditions 0 °C, 60 min. Flash chromatography on silica (EtOAc) gave a 
colorless solid (217 mg, 88%). 
m.p.: 76.9 - 77.4 °C 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.4 (s, 1 H), 8.3 (d, J = 5.6 Hz, 1 H),  7.4 (d, J = 5.4 
Hz, 1 H), 2.8 (m, 12 H), 2.5 (s, 3 H). 
13C-NMR (75 MHz, CDCl3) δ (ppm): 155.7, 155.6, 147.7, 147.5, 126.6, 126.5, 113.7, 36.7, 
36.6, 14.6.   
Observed complexity due to C-P splitting, definitive assignments have not been made. 
IR (ATR) ν~  (cm-1): 2924, 1562, 1486, 1470, 1408, 1298, 1266, 1216, 1172, 1110, 1072, 
1040, 1004, 988, 906, 824, 774, 756, 724, 698, 672. 
MS (70 eV, EI) m/z (%): 275 (52) [M+], 231 (64), 228 (63), 141 (31), 135 (100), 44 (33). 
HRMS (EI): 275.0856 (calcd.: 275.0857). 
 
Synthesis of 3-(ethylthio)quinolin-2-yl N,N,N',N'-tetramethyldiamidophosphate (31a):  
 
 
 
The title compound was prepared from 30a (279 mg, 1.00 mmol), TMPMgCl·LiCl (1.07 mL, 
1.4 M in THF, 1.5 mmol), S-ethyl benzenesulfonothioate (182 mg, 0.9 mmol) applying TP5. 
Metalation conditions 0 °C, 60 min. Flash chromatography on silica (EtOAc) gave a colorless 
solid (289 mg, 85%). 
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m.p.: 82.5 - 82.8 °C 
1H-NMR (300 MHz, CDCl3) δ (ppm): 7.9 (m, 2 H), 7.7 (d, J = 8.2 Hz, 1 H), 7.6 (m, 1 H), 7.5 
(d, J = 7.9 Hz, 1 H), 3.0 (q, J = 7.4 Hz, 2 H), 2.9 (m, 12 H), 1.4 (t, J = 7.3 Hz, 3 H).  
13C-NMR (75 MHz, CDCl3) δ (ppm): 153.4, 153.3, 143.9, 140.8, 134.3, 130.5, 128.5, 128.1, 
127.7, 126.7, 126.0, 125.6, 124.3, 124.2, 122.6, 121.6, 119.8, 115.9, 36.9, 36.8, 25.6, 13.5.  
Observed complexity due to C-P splitting, definitive assignments have not been made. 
IR (ATR) ν~  (cm-1): 2924, 2850, 1638, 1456, 1404, 1248, 1222, 1190, 990, 932, 860, 812, 
772, 756, 700, 670. 
MS (70 eV, EI) m/z (%): 339 (7) [M+], 295 (27), 232 (21), 192 (74), 172 (100), 145 (10), 128 
(12). 
HRMS (EI): 339.1160 (calcd.: 339.1170). 
 
Synthesis of 3-(2,2-dimethylpropanoyl)quinolin-4-yl N,N,N',N'-
tetramethyldiamidophosphate (31b):  
 
 
 
The title compound was prepared from 30b (279 mg, 1.00 mmol), TMPMgCl·LiCl (1.07 mL, 
1.4 M in THF, 1.5 mmol), ZnCl2 (1.6 mL, 1 M in THF, 1.6 mmol), CuCN·2LiCl (0.1 mL, 1 M 
in THF, 10 mol%), pivaloyl chloride (122 mg, 1.00 mmol) applying TP5 and TP8. 
Metalation conditions 0 °C, 60 min. Flash chromatography on silica (EtOAc/EtOH, 9:1) gave 
a brown oil (225 mg, 62%). 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.8 (s, 1 H), 8.3 (m, 1 H), 8.1 (d, J=8.4 Hz, 1 H), 7.7 
(m, 1 H),  7.6 (m, 1 H),  2.7 (m, 12 H), 1.3 (s, 8 H). 
13C-NMR (75 MHz, CDCl3) δ (ppm): 208.9, 151.8, 151.7, 149.8, 147.8, 130.5, 129.3, 127.0, 
125.8, 123.4, 123.3, 45.4, 36.9, 36.8, 27.1. Observed complexicity due to C-P splitting, 
definitive assignments have not been made. 
IR (ATR) ν~  (cm-1): 2930, 1702, 1586, 1560, 1490, 1376, 1306, 1228, 1170, 1104, 990, 906, 
858, 812, 792, 756, 694. 
MS (70 eV, EI) m/z (%): 363 (1) [M+], 319 (31), 306 (100), 212 (8), 194 (6), 135 (26). 
HRMS (EI): 363.1713 (calcd.: 363.1712). 
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Synthesis of ethyl 4-(4-{[bis(dimethylamino)phosphoryl]oxy}quinolin-3-l)benzoate (31c):  
 
 
 
The title compound was prepared from 30b (279 mg, 1.00 mmol), TMPMgCl·LiCl (1.07 mL, 
1.4 M in THF, 1.5 mmol), ZnCl2 (1.6 mL, 1 M in THF, 1.6 mmol), ethyl 4-iodobenzoate (276 
mg, 1.00 mmol), Pd(dba)2 (30 mg, 5 mol%), P(2-furyl)3 (23 mg, 10 mol%) applying TP5 and 
TP7. Metalation conditions 0 °C, 60 min. Flash chromatography on silica (EtOAc/EtOH, 9:1) 
gave a colorless solid (354 mg, 83%). 
m.p.: 136.8 - 137.4 °C 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.8 (s, 1 H),  8.4 (d, J = 7.7 Hz, 1 H), 8.3 (d, J = 8.2 
Hz, 2 H), 8.2 (d, J = 8.4 Hz, 1 H), 7.8 (m, 1 H), 7.7 (m, 3 H), 4.4 (q, J = 7.1 Hz, 2 H), 2.5 (m, 
12 H), 1.4 (t, J = 7.2 Hz, 3 H).  
13C-NMR (75 MHz, CDCl3) δ (ppm): 166.2, 152.2, 152.1, 151.9, 151.8, 140.1, 130.2, 130.1, 
130.0, 129.8, 129.0, 127.1, 125.5, 125.4, 123.8, 123.7, 123.7, 61.2, 36.4, 36.4, 14.3.  
Observed complexity due to C-P splitting, definitive assignments have not been made.   
IR (ATR) ν~  (cm-1): 2932, 1702, 1306, 1290, 1276, 1226, 1170, 1116, 1100, 992, 910, 856, 
812, 792, 768, 762, 700, 692. 
MS (70 eV, EI) m/z (%): 427 (23) [M+], 353 (12), 319 (179, 247 (10), 135 (100), 44 (15). 
HRMS (EI): 427.1654 (calcd.: 427.1661). 
 
Synthesis of 2-chloro-7-(2-methylprop-2-en-1-yl)quinolin-8-yl N,N,N',N'-
tetramethyldiamidophosphate (31d):  
 
 
 
The title compound was prepared from 30c (314 mg, 1.00 mmol), TMPMgCl·LiCl (1.07 mL, 
1.4 m in THF, 1.5 mmol), ZnCl2 (1.6 mL, 1 M in THF, 1.6 mmol), CuCN·2LiCl (0.1 mL, 1 M 
in THF, 10 mol%), 3-bromo-2-methylpropene (135 mg, 1.00 mmol) applying TP5 and TP9. 
Metalation conditions 0 °C, 60 min. Flash chromatography on silica (EtOAc/EtOH, 9:1) gave 
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a colorless oil (320 mg, 87%). 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.1 (d, J = 8.5 Hz, 1 H), 7.6 (d, J = 8.5 Hz, 1 H), 7.4 
(d, J = 8.5 Hz, 1 H), 7.4 (d, J = 8.5 Hz, 1 H), 4.9 (s, 1 H), 4.6 (s, 1 H), 3.8 (s, 2 H), 2.9 (m, 12 
H), 1.8 (s, 3 H).  
13C-NMR (75 MHz, CDCl3) δ (ppm): 150.3, 144.8, 144.7, 143.8, 141.9, 141.8, 138.6, 133.8, 
133.7, 129.9, 129.8, 126.9, 126.8, 123.6, 123.5, 122.2, 112.7, 39.0, 37.0, 36.9, 22.8. 
Observed complexity due to C-P splitting, definitive assignments have not been made.   
IR (ATR) ν~  (cm-1): 2926, 1702, 1588, 1488, 1438, 1310, 1218, 1120, 1100, 1078, 990, 908, 
896, 844, 824, 800, 754, 690. 
MS (70 eV, EI) m/z (%): 367 (2) [M+], 325 (27), 323 (100), 231 (22), 228 (16), 218 (29), 214 
(17). 135 (159, 44 (12). 
HRMS (EI): 367.1209 (calcd.: 367.1216). 
 
Synthesis of 2-chloro-7-(4-chlorobenzoyl)quinolin-8-yl N,N,N',N'-
tetramethyldiamidophosphate (31e):  
 
 
 
The title compound was prepared from 30c (314 mg, 1.00 mmol), TMPMgCl·LiCl (1.07 mL, 
1.4 M in THF, 1.5 mmol), ZnCl2 (1.6 mL, 1 M in THF, 1.6 mmol), CuCN·2LiCl (0.1 mL, 1 M 
in THF, 10 mol%), 4-chloro benzoylchloride (175 mg, 1.00 mmol) applying TP5 and TP8. 
Metalation conditions 0 °C, 60 min. Flash chromatography on silica (EtOAc/EtOH, 9:1) gave 
a colorless solid (320 mg, 87 %). 
m.p.: 178.2 - 178.9 °C 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.2 (d, J = 8.7 Hz, 1 H), 7.9 (d, J = 8.5 Hz, 2 H), 7.7 
(d, J = 8.5 Hz, 1 H), 7.5 (m, 4 H), 2.6 (m, 12 H) 
13C-NMR (75 MHz, CDCl3) δ (ppm): 193.0, 151.4, 144.7, 142.0, 139.9, 138.7, 135.3, 133.1, 
133.0, 132.0, 129.1, 129.0, 128.8, 126.5, 126.4, 124.1, 123.6, 123.5, 36.7, 36.6.  
Observed complexity due to C-P splitting, definitive assignments have not been made.  
IR (ATR) ν~  (cm-1): 2926, 1666, 1586, 1486, 1438, 1424, 1326, 1310, 1262, 1224, 1200, 
1182, 1122, 1108, 1096, 1080, 992, 910, 880, 854, 844, 820, 798, 756, 746, 706, 688, 670. 
MS (70 eV, EI) m/z (%): 452 (81) [M+], 410 (51), 365 (25), 312 (100), 288 (14), 202 (12), 
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111 (14), 44 (39). 
HRMS (EI): 452.0706 (calcd.: 452.0619). 
 
Synthesis of 2-bromo-7-{4-[(triisopropylsilyl)oxy]phenyl}quinolin-8-yl N,N,N',N'-
tetramethyldiamidophosphate (31f):  
 
 
 
The title compound was prepared from 30d (358 mg, 1.00 mmol), TMPMgCl·LiCl (1.07 mL, 
1.4 M in THF, 1.5 mmol), ZnCl2 (1.6 mL, 1 M in THF, 1.6 mmol), 4-(iodophenoxy)-
(triisopropyl)silane (414 mg, 1.10 mmol), Pd(dba)2 (30 mg, 5 mol%), P(2-furyl)3 (23 mg, 10 
mol%) applying TP5 and TP7. Metalation conditions 0 °C, 60 min. Flash chromatography on 
silica (EtOAc/EtOH, 9:1) gave a pale brown oil (490 mg, 81%). 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.0 (d, J = 8.7 Hz, 1 H), 7.6 (d, J = 8.4 Hz, 1 H), 7.5 
(m, 4 H), 7.0 (d, J = 8.4 Hz, 2 H), 2.6 (m, 12 H) 1.3 (m, 3 H), 1.2 (m, 18 H). 
13C-NMR (75 MHz, CDCl3) δ (ppm): 155.8, 144.1, 144.0, 142.9, 142.9, 141.6, 138.0, 135.8, 
135.7, 131.1, 130.9, 130.6, 130.6, 127.5, 127.5, 125.9, 123.5, 123.5, 119.5, 36.7, 36.6, 18.0, 
12.8. Observed complexity due to C-P splitting, definitive assignments have not been made. 
IR (ATR) ν~  (cm-1): 2942, 2866, 1704, 1588, 1512, 1488, 1438, 1304, 1260, 1238, 1214, 
1200, 1184, 1174, 1118, 1102, 1084, 1072, 992, 908, 884, 840, 828, 800, 754, 688, 658   
MS (70 eV, EI) m/z (%): 605 (5) [M+], 563 (100), 526 (40), 498 (34), 469 (19), 455 (25), 194 
(18), 135 (40). 
HRMS (EI): 605.1845 (calcd.: 605.1838). 
 
Synthesis of ethyl 8-{[bis(dimethylamino)phosphoryl]oxy}-2-bromoquinoline-7-
carboxylate (31g):  
 
N Br
O
P(NMe2)2
O
EtO2C
 
 
The title compound was prepared from 30d (358 mg, 1.00 mmol), TMPMgCl·LiCl (1.07 mL, 
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1.4 M in THF, 1.5 mmol), ethyl cyanoformate (100 mg, 1.00 mmol) applying TP5. Metalation 
conditions 0 °C, 60 min. Flash chromatography on silica (EtOAc/EtOH, 9:1) gave a pale 
brown solid (331 mg, 77%). 
m.p.: 127.8 - 128.4 °C 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.0 (d, J = 8.7 Hz, 1 H), 7.9 (d, J = 8.7 Hz, 1 H), 7.6 
(m, 2 H), 4.5 (q, J = 7.2 Hz, 2 H), 2.8 (m, 12 H), 1.4 (t, J = 7.2 Hz, 3 H).   
13C-NMR (75 MHz, CDCl3) δ (ppm): 165.5, 165.4, 146.2, 146.1, 142.6, 142.6, 142.2, 137.9, 
129.7, 129.7, 127.8, 127.7, 127.6, 126.6, 126.5, 123.4, 123.4, 77.2, 61.6, 37.1, 37.0, 14.3.  
Observed complexity due to C-P splitting, definitive assignments have not been made. 
IR (ATR) ν~  (cm-1): 2912, 1702, 1586, 1490, 1438, 1424, 1326, 1312, 1258, 1222, 1214, 
1192, 1136, 1098, 1080, 994, 954, 906, 856, 822, 802, 756, 688, 666. 
MS (70 eV, EI) m/z (%): 430 81) [M+], 386 (24), 356 (40), 294 (54), 251 (100), 248 (15), 135 
(24), 44 (44). 
HRMS (EI): 430.0520 (calcd.: 430.0453). 
 
Synthesis of 3-(4-chlorophenyl)quinoxalin-2-yl N,N,N',N'-tetramethyldiamidophosphate 
(31h):  
 
 
 
The title compound was prepared from 30e (280 mg, 1.00 mmol), TMP2Mg·2LiCl (2.5 mL, 
0.6 M in THF, 1.5 mmol), ZnCl2 (1.6 mL, 1 M in THF, 1.6 mmol), 1-chloro-4-iodobenzene 
(238 mg, 1.00 mmol), Pd(dba)2 (30 mg, 5 mol%), P(2-furyl)3 (23 mg, 10 mol%) applying 
TP5 and TP7. Metalation conditions –30 °C, 1.5 h. Flash chromatography on silica 
(EtOAc/EtOH, 9:1) gave a pale brown solid (305 mg, 78%).  
m.p.: 148.9 - 149.4 °C 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.1 (d, J = 9.0 Hz, 1 H), 8.0 (m, 3 H), 7.7 (m, 2 H), 7.5 
(d, J = 8.5 Hz, 2 H), 2.8 (m, 12 H)  
13C-NMR (75 MHz, CDCl3) δ (ppm): 150.3, 150.2, 146.1, 146.0, 140.2, 139.8, 136.0, 134.4, 
131.0, 130.3, 129.0, 128.6, 128.5, 127.8, 36.8, 36.7.  
Observed complexity due to C-P splitting, definitive assignments have not been made. 
IR (ATR) ν~  (cm-1): 2894, 1484, 1396, 1316, 1244, 1204, 1192, 1176, 1140, 1090, 998, 978, 
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926, 866, 854, 830, 796, 766, 756, 736, 686, 668. 
MS (70 eV, EI) m/z (%): 390 (1) [M+], 254 (100), 239 (15), 228 (20), 135 (15), 90 (10), 44 
(29). 
HRMS (EI): 390.1007 (calcd.: 390.1012). 
 
Synthesis of ethyl 4-(3-{[bis(dimethylamino)phosphoryl]oxy}quinoxalin-2-yl)benzoate 
(31i):  
 
N
N O
P(NMe2)2
O
CO2Et
 
 
The title compound was prepared from 30e (280 mg, 1.00 mmol), TMP2Mg·2LiCl (2.5 mL, 
0.6 M in THF, 1.5 mmol), ZnCl2 (1.6 mL, 1 M in THF, 1.6 mmol), ethyl 4-iodobenzoate (276 
mg, 1.00 mmol), Pd(dba)2 (30 mg, 5 mol%), P(2-furyl)3 (23 mg, 10 mol%) applying TP5 and 
TP7. Metalation conditions –30 °C, 1.5 h. Flash chromatography on silica (EtOAc/EtOH, 9:1) 
gave a pale brown solid (338 mg, 78%).  
m.p.: 135.7 - 136.1 °C 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.2 (m, 2 H), 8.1 (m, 3 H), 8.0 (m, 1 H), 7.7 (m, 2 H), 
4.4 (q, J = 7.0 Hz, 2 H), 2.8 (m, 12 H), 1.5 (t, J = 7.0 Hz, 3 H).  
13C-NMR (75 MHz, CDCl3) δ (ppm): 166.2, 150.4, 150.3, 146.3, 146.2, 140.2, 140.1, 139.9, 
131.3, 130.5, 129.7, 129.4, 129.1, 128.6, 127.9, 61.2, 36.8, 36.8, 14.3.   
Observed complexity due to C-P splitting, definitive assignments have not been made. 
IR (ATR) ν~  (cm-1): 2928, 2900, 1716, 1400, 1308, 1294, 1272, 1228, 1204, 1138, 1124, 
1112, 1106, 992, 928, 858, 846, 806, 796, 778, 764, 740, 704, 690. 
MS (70 eV, EI) m/z (%): 428 (1) [M+], 384 (12), 292 (100), 266 (17), 249 (17), 219 (47), 135 
(17), 90 (10), 44 (28). 
HRMS (EI): 428.1597 (calcd.: 428.1613). 
 
Synthesis of 3-(2-methylprop-2-en-1-yl)quinoxalin-2-yl N,N,N',N'-
tetramethyldiamidophosphate (31j):  
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The title compound was prepared from 30e (280 mg, 1.00 mmol), TMP2Mg·2LiCl (2.5 mL, 
0.6 M in THF, 1.5 mmol), ZnCl2 (1.6 mL, 1 M in THF, 1.6 mmol), CuCN·2LiCl (0.1 mL, 1 M 
in THF, 10 mol%), 3-bromo-2-methylpropene (135 mg, 1.00 mmol) applying TP5 and TP9. 
Metalation conditions –30 °C, 1.5 h. Flash chromatography on silica (EtOAc/EtOH, 9:1) gave 
a pale brown oil (237 mg, 71%). 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.0 (m, 1 H), 7.9 (m, 1 H), 7.6 (m, 2 H), 4.9 (s, 1 H), 
4.6 (s, 1 H), 3.8 (s, 2 H), 2.8 (m, 12 H), 1.9 (s, 3 H).  
13C-NMR (75 MHz, CDCl3) δ (ppm): 151.4, 151.3, 148.6, 148.5, 147.5, 145.9, 145.1, 143.5, 
141.7, 140.0, 139.7, 138.7, 129.5, 129.0, 128.5, 128.0, 127.9, 127.8, 127.7, 118.0, 112.8, 41.8, 
36.8, 36.7, 23.1.  
Observed complexity due to C-P splitting, definitive assignments have not been made. 
IR (ATR) ν~  (cm-1): 3074, 2932, 1668, 1648, 1580, 1446, 1402, 1332, 1300, 1232, 1222, 
1212, 1160, 1136, 1066, 988, 930, 872, 824, 794, 770, 758, 710, 684, 666. 
MS (70 eV, EI) m/z (%): 334 (41) [M+], 289 (63), 245 (66), 198 (100), 185 (42), 183 (79), 
135 842), 44 (34). 
HRMS (EI): 334.1563 (calcd.: 334.1559). 
 
4.5.3. Synthesis of Etoricoxib:  
 
Synthesis of 3-[4-(methylsulfonyl)phenyl]pyridin-2-yl N,N,N',N'-
tetramethyldiamidophosphate (29g):  
 
 
 
The title compound was prepared from 28a (2.29 g, 10.0 mmol), TMPMgCl·LiCl (10.7 mL, 
1.4 M in THF, 15.0 mmol), 4-bromophenyl methylsulfone (2.35 g, 10.0 mmol), ZnCl2 (16 ml, 
1 M in THF, 16.0 mmol), Pd2(dba)3 (90 mg, 1 mol%), RuPHOS (90 mg, 2 mol%) applying 
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TP5 and TP7. Metalation conditions 0 °C, 60 min. Flash chromatography on silica 
(EtOAc/EtOH, 9:1 then 4:1) gave a highly viscious yellow oil (3.37 g, 88%).  
1H-NMR (600 MHz, CDCl3) δ (ppm): 8.4 (m, 1 H), 8.0 (d, J = 8.5 Hz, 2 H), 7.7 (m, 3 H), 7.2 
(m, 1 H), 3.1 (s, 3 H), 2.6 (m, 12 H).  
13C-NMR (150 MHz, CDCl3) δ (ppm): 155.1, 155.0, 148.1, 141.5, 140.5, 140.1, 130.3, 129.4, 
127.4, 127.3, 125.4, 125.3, 120.7, 44.5, 36.6, 36.5.  Observed complexity due to C-P splitting, 
definitive assignments have not been made. 
IR (ATR) ν~  (cm-1): 2886, 2814, 1576, 1426, 1386, 1306, 1298, 1246, 1218, 1202, 1148, 
1092, 1002, 982, 896, 804, 792, 782, 762, 736, 720. 
MS (70 eV, EI) m/z (%): 383 (1) [M+], 340 (10), 296 (15), 249 (100), 152 (12), 44 (20). 
HRMS (EI): 383.1088 (calcd.: 383.1069). 
 
Synthesis of 3-[4-(methylsulfonyl)phenyl]pyridin-2(1H)-one (32):  
 
 
 
29g (1.91 g, 5.0 mmol) was dissolved in a 1:1 mixture of 2 M HCl and dioxane and stirred at 
25 °C for 24 h. The formed white precipitate was collected by filtration (P4, 300 mbar) 
washed with water (3 x 25 ml) and oven dried overnight (1.24 g, quant.). 
m.p.: 273 °C (decomp.) 
1H-NMR (400 MHz, DMSO) δ (ppm): 11.9 (s, 1 H), 8.0 (m, 2 H), 7.9 (d, J = 8.6 Hz, 2 H), 
7.8 (dd, J = 6.9, 1.9 Hz, 1 H), 7.5 (dd, J = 6.3, 1.9 Hz, 1 H), 6.3 (t, J = 6.6 Hz, 1 H), 3.2 (s, 3 
H). 
13C-NMR (100 MHz, DMSO) δ (ppm): 161.4, 142.3, 140.6, 139.5, 136.6, 129.2, 128.3, 
127.0, 106.0, 44.0.   
IR (ATR) ν~  (cm-1): 2926, 1638, 1426, 1388, 1298, 1264, 1246, 1218, 1202, 1192, 1176, 
1148, 1110, 1092, 1066, 1002, 982, 896, 806, 790, 780, 762, 736, 722. 
MS (70 eV, ESI) m/z (%): 248 (100) [M+]. 
HRMS (ESI): 267.0790 (calcd.: 267.0798 +NH4+). 
 
Synthesis of 5-chloro-3-[4-(methylsulfonyl)phenyl]pyridin-2(1H)-one (33): 
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32 (996 mg, 4.00 mmol) was dissolved in 4 mL conc. HCl and warmed to 50 °C. To the clear 
solution was added KClO3 (172 mg, 1.4 mmol) in 2.4 mL water. The mixture was stirred at 50 
°C for 15 min. and then cooled to 0 °C. Formed precipitate is filtered off (P4, 300 mbar) 
washed with water (3 x 25 mL) and oven dried overnight. 33 remains as colorless solid (1.12 
g, quant.) 
m.p.: 213 °C (decomp.) 
1H-NMR (400 MHz, CDCl3) δ (ppm): 12.3 (s, 1 H), 8.0 (m, 2 H), 7.9 (d, J = 8.6 Hz, 2 H), 
7.8 (d, J = 2.9 Hz, 1 H), 7.7 (d, J = 2.7 Hz, 1 H), 3.2 (s, 3 H).  
13C-NMR (100 MHz, CDCl3) δ (ppm): 160.1, 140.9, 140.4, 140.2, 137.0, 129.6, 127.0, 126.6, 
107.9, 43.9. 
IR (ATR) ν~  (cm-1): 2926, 1640, 1426, 1388, 1304, 1246, 1218, 1150, 1108, 1092, 1002, 982, 
894, 806, 790, 782, 760, 736, 722. 
MS (70 eV, EI) m/z (%): 283 [M+] (100), 267 (12), 248 (12), 206 (14), 204 (41), 169 (17), 
141 (10). 
HRMS (EI): 283.0065 (calcd.: 283.0070). 
 
Synthesis of 5-chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2,3'-bipyridine (Etoricoxib; 
26): 
 
 
 
The title compound was prepared according to a literature101 proceedure starting from 33. A 
white solid was obtained. 
 
1H-NMR (400 MHz, d6-DMSO) δ (ppm): 8.5 (s, 1 H), 8.0 (d, J = 8.2 Hz, 2 H), 7.9 (m, 3 H), 
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7.8 (d, J = 2.1 Hz, 1 H), 7.7 (s, 1 H), 7.2 (d, J = 8.2 Hz, 1 H), 3.2 (s, 3 H), 2.4 (s, 3 H). 
13C-NMR (100 MHz, d6-DMSO) δ (ppm): 160.1, 157.3, 149.9, 140.9, 140.4, 140.1, 139.3, 
135.0, 129.6, 129.2, 127.0, 125.6, 117.7, 44.0, 23.8. 
NMR data matches published data102 
 
4.5.4. Synthesis of Talnetant and the P-Selectin Antagonist:  
 
Synthesis of ethyl 2-phenylquinolin-3-yl N,N,N',N'-tetramethyldiamidophosphate (31k):  
 
 
 
The title compound was prepared from 30f (2.79 g, 10.0 mmol), TMP2Mg·2LiCl (25 mL, 0.6 
M in THF, 15.0 mmol), ZnCl2 (16 mL, 1 M in THF, 16.0 mmol), iodobenzene (2.04 g, 10.0 
mmol), Pd(dba)2 (300 mg, 5 mol%), P(2-furyl)3 (230 mg, 10 mol%) applying TP5 and TP7. 
Metalation conditions –50 °C, 1 h. Flash chromatography on silica (EtOAc/CH2Cl2, 1:1) gave 
a brown solid (2.87 g, 81%).   
m.p.: 87.3 - 87.8 °C 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.3 (s, 1 H), 8.1 (d, J = 8.4 Hz, 1 H), 7.9 (m, 3 H), 7.7 
(m, 1 H), 7.5 (m, 4 H), 2.6 (m, 12 H). 
13C-NMR (75 MHz, CDCl3) δ (ppm): 153.1, 153.0, 144.8, 143.5, 143.4, 129.7, 129.2, 128.9, 
128.6, 128.2, 128.1, 127.2, 127.0, 124.5, 124.4, 77.5, 77.1, 76.6, 36.5, 36.4. 
Observed complexity due to C-P splitting, definitive assignments have not been made. 
IR (ATR) ν~  (cm-1): 2894, 1596, 1488, 1418, 1306, 1300, 1226, 1156, 1140, 996, 980, 918, 
908, 868, 850, 802, 788, 762, 746, 726, 714, 698, 680, 656. 
MS (70 eV, EI) m/z (%): 355 (100) [M+], 268 (41), 247 (40), 221 (40), 165 (13), 135 (83), 92 
(11), 44 (37). 
HRMS (EI): 355.1451 (calcd.: 355.1450). 
 
Synthesis of ethyl 3-{[bis(dimethylamino)phosphoryl]oxy}-2-phenylquinoline-4-
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carboxylate (35a):  
 
 
 
The title compound was prepared from 31k (1.78 g, 5.0 mmol), TMPMgCl·LiCl (5.4 mL, 1.4 
M in THF, 7.5 mmol), ethyl cyanoformiate (495 mg, 5.00 mmol) applying TP5. Metalation 
conditions 25 °C, 1 h. Flash chromatography on silica (EtOAc/EtOH, 9:1) gave a yellow solid 
(1.69 g, 79%).   
m.p.: 124.1 - 124. 9 °C 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.1 (dd, J = 17.4, 8.4 Hz, 2 H), 7.8 (d, J = 7.4 Hz, 2 H), 
7.7 (t, J = 7.5 Hz, 1 H),  7.6 (t, J = 7.7 Hz, 1 H),  7.5 (t, J = 7.7 Hz, 2 H), 7.4 (t, J = 7.4 Hz, 1 
H), 4.6 (q, J = 7.1 Hz, 2 H), 2.3 (m, 12 H), 1.5 (t, J = 7.1 Hz, 3 H).   
13C-NMR (75 MHz, CDCl3) δ (ppm): 165.1, 165.1, 154.8, 154.8, 145.2, 145.2, 139.7, 139.6, 
138.2, 131.2, 131.2, 129.8, 129.6, 128.9, 128.9, 128.3, 127.6, 125.2, 124.8, 124.8, 62.1, 36.2, 
36.1, 14.2. 
Observed complexity due to C-P splitting, definitive assignments have not been made. 
IR (ATR) ν~  (cm-1): 2934, 1724, 1598, 1486, 1422, 1348, 1310, 1280, 1242, 1168, 1142, 
1094, 992, 970, 920, 858, 820, 756, 688. 
MS (70 eV, EI) m/z (%): 427 (3) [M+], 383 (100), 355 (63), 274 (119, 248 (36), 219 (15), 135 
(76), 44 (22). 
HRMS (EI): 428.1647 (calcd.: 427.1661). 
 
Synthesis of 3-hydroxy-2-phenylquinoline-4-carboxylic acid:  
 
 
 
35a (854 mg, 2.00 mmol), was dissovled in 20 mL of a 1:1 mixture of 2 M HCl and dioxane 
then heated to reflux for 36 h. The mixture was cooled to 25 °C. The formed yellow 
precipitate was collected by filtration washed with water (3 x 20 ml) and oven dried overnight 
(530 mg, quant.).   
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1H-NMR (300 MHz, CDCl3) δ (ppm): 10.1 (br, 2 H), 8.7 (d, J = 8.0 Hz, 1 H), 8.1 (m, 1 H), 
7.9 (m, 2 H), 7.6 (m, 2 H), 7.5 (m, 3 H). 
13C-NMR (75 MHz, CDCl3) δ (ppm): 171.2, 151.9, 130.2, 129.0, 128.5, 127.2, 125.8, 125.1. 
NMR data matches published data.31 
 
Synthesis of 3-hydroxy-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide 
(Talnetant; 25):  
 
 
 
This compound was prepared from 3-hydroxy-2-phenylquinoline-4-carboxylic acid (265 mg, 
1.00 mmol) by applying a known procedure.103 Crystallization from acetone gave colorless 
crystals (329 mg, 86 %). 
 
1H-NMR (300 MHz, CDCl3) δ (ppm): 11.2 (br, 2 H), 8.2 (s, 1 H), 8.1 (d, J = 6.9 Hz, 2 H), 
8.0 (m, 1 H), 7.5 - 7.3 (m, 10 H), 5.2 (q, J = 7.5 Hz, 2 H), 2.0 (m, 1 H), 1.0 (t, J = 7.3 Hz, 3 H).  
13C-NMR (75 MHz, CDCl3) δ (ppm): 167.5, 151.8, 150.8, 140.8, 129.8, 129.6, 129.0, 128.5, 
128.2, 127.9, 126.7, 123.8, 121.8, 56.3, 29.1, 10.9.  
NMR data matches published data.31 
 
Synthesis of 2-(4-chlorophenyl)quinolin-3-yl N,N,N',N'-tetramethyldiamidophosphate 
(31l): 
 
 
 
The title compound was prepared from 30f (2.79 g, 10.0 mmol), TMP2Mg·2LiCl (25 mL, 0.6 
M in THF, 15.0 mmol), ZnCl2 (16 mL, 1 M in THF, 16.0 mmol), 4-chloro-1-iodobenzene 
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(2.38 g, 10.0 mmol), Pd(dba)2 (300 mg, 5 mol%), P(2-furyl)3 (230 mg, 10 mol%) applying 
TP5 and TP7. Metalation conditions –50 °C, 1 h. Flash chromatography on silica 
(EtOAc/CH2Cl2, 1:1) gave a brown solid (3.04 g, 78%).  
m.p.: 104.5 - 104.9 °C  
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.3 (s, 1 H), 8.1 (d, J = 8.4 Hz, 1 H), 7.8 (m, 3 H), 7.7 
(m, 1 H), 7.6 (m, 2 H), 7.5 (m, 1 H), 2.6 (m, 12 H). 
13C-NMR (75 MHz, CDCl3) δ (ppm): 151.6, 151.5, 144.8, 143.4, 143.3, 136.1, 135.0, 131.1, 
129.2, 128.7, 128.3, 127.2, 127.1, 124.5, 124.4, 36.6, 36.5. 
Observed complexity due to C-P splitting, definitive assignments have not been made. 
IR (ATR) ν~  (cm-1): 2934, 1592, 1486, 1422, 1308, 1242, 1168, 1142, 1086, 1008, 992, 972, 
918, 874, 860, 842, 830, 794, 784, 756, 740, 708, 688, 660. 
MS (70 eV, EI) m/z (%): 389 (60) [M+], 302 (20), 281 (25), 255 (24), 135 (100), 91 (12), 43 
(41). 
HRMS (EI): 389.1052 (calcd.: 389.1060). 
 
Synthesis of ethyl 3-{[bis(dimethylamino)phosphoryl]oxy}-2-(4-chlorophenyl)quinoline-
4-carboxylate (35b):  
 
N
O
Cl
CO2Et
P(NMe2)2
O
 
 
The title compound was prepared from 31l (1.95 g, 5.0 mmol), TMPMgCl·LiCl (5.4 mL, 1.4 
M in THF, 7.5 mmol), ethyl cyanoformiate (495 mg, 5.00 mmol) applying TP5. Metalation 
conditions 25 °C, 1 h. Flash chromatography on silica (EtOAc/EtOH, 9:1) gave a yellow solid 
(1.87 g, 81 %).   
m.p.: 109.5 - 109.8 °C 
1H-NMR (300 MHz, DMSO) δ (ppm): 8.2 (d, J = 8.2 Hz, 1 H), 8.1 (d, J = 8.5 Hz, 1 H),  7.8 
(d, J = 8.5 Hz, 2 H), 7.7 (t, J = 7.5 Hz, 1 H), 7.6 (t, J = 7.5 Hz, 1 H), 7.5 (d, J = 8.5 Hz, 2 H), 
4.6 (q, J = 7.1 Hz, 2 H), 2.4 (m, 12 H), 1.5 (t, J = 7.1 Hz, 3 H) 
13C-NMR (75 MHz, DMSO) δ (ppm): 164.8, 153.3, 153.2, 144.7, 139.6, 139.5, 135.4, 131.3, 
129.4, 129.2, 128.6, 128.0, 125.2, 124.9, 124.8, 62.2, 36.5, 36.4, 36.3, 36.2, 14.2. 
Observed complexity due to C-P splitting, definitive assignments have not been made. 
IR (ATR) ν~  (cm-1): 2932, 1728, 1592, 1488, 1456, 1422, 1348, 1308, 1294, 1288, 1230, 
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1218, 1206, 1170, 1140, 1090, 990, 972, 918, 872, 860, 844, 830, 818, 794, 786, 760, 740, 
708, 702, 690, 658. 
MS (70 eV, EI) m/z (%): 461 (2) [M+], 417 (61), 389 (48), 354 (10), 282 (19), 190 (10), 135 
(100), 44 (22). 
HRMS (EI): 461.1261 (calcd.: 461.1271). 
 
Synthesis of ethyl 3-{[bis(dimethylamino)phosphoryl]oxy}-2-(4-chlorophenyl)-8-
phenylquinoline-4-carboxylate (36):  
 
 
 
The title compound was prepared from 35b (1.38 g, 3.00 mmol), TMP2Mg·2LiCl (7.5 mL, 0.6 
M in THF, 4.5 mmol), ZnCl2 (4.8 mL, 1 M in THF, 4.8 mmol), iodobenzene (612 mg, 3.0 
mmol), Pd(dba)2 (90 mg, 5 mol%), P(2-furyl)3 (69 mg, 10 mol%) applying TP5 and TP7. 
Metalation conditions –40 °C, 20 h. Flash chromatography on silica (EtOAc/EtOH, 9:1) gave 
a brown oil (1.22 g, 81%).   
1H-NMR (600 MHz, CDCl3) δ (ppm): 8.1 (d, J = 8.2 Hz, 1 H), 8.1 (d, J = 8.5 Hz, 1 H), 7.9 
(d, J = 2.2 Hz, 1 H), 7.8 (dd, J =8.2, 2.2 Hz, 1 H), 7.7 (t, J = 7.8 Hz, 1 H), 7.6 (d, J = 8.2 Hz, 1 
H), 7.6 (t, J = 7.7 Hz, 1 H), 7.4 (m, 5 H), 4.6 (q, J = 7.1 Hz, 2 H), 2.4 (m, 12 H), 1.5 (t, J = 7.1 
Hz, 3 H). 
13C-NMR (150 MHz, CDCl3) δ (ppm): 164.8, 153.2, 153.1, 145.0, 140.5, 140.1, 139.5, 139.4, 
139.0, 138.9, 136.9, 136.5, 133.5, 133.1, 132.8, 131.3, 131.2, 131.0, 130.9, 130.0, 129.9, 
129.8, 129.7, 129.4, 129.3, 128.6, 128.3, 128.2, 128.1, 128.0, 127.9, 127.8, 127.7, 127.3, 
125.2, 124.9, 124.8, 62.2, 36.3, 36.3, 14.2.   
Observed complexity due to C-P splitting, definitive assignments have not been made. 
IR (ATR) ν~  (cm-1): 2926, 2854, 1726, 1376, 1352, 1300, 1286, 1222, 1176, 1138, 994, 974, 
826, 760, 742, 716, 698. 
MS (70 eV, EI) m/z (%): 537 (2) [M+], 493 (100), 465 (62), 430 (12), 360 (13), 329 (14), 135 
(86), 44 (33). 
HRMS (EI): 537.1573 (calcd.: 537.1584). 
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Synthesis of 2-(4-chlorophenyl)-3-hydroxy-8-phenylquinoline-4-carboxylic acid (37):  
 
 
 
36 (538 mg, 1.00 mmol), was dissovled in 10 mL of a 1:1 mixture of 2 M HCl and dioxane 
then heated to reflux for 36 h. The mixture was cooled to 25 °C. The formed yellow 
precipitate was collected by filtration washed with water (3 x 20 ml) and oven dried overnight 
(375 mg, quant.).   
1H-NMR (400 MHz, DMSO) δ (ppm): 10.9 (br, 2 H), 8.6 (d, J = 8.2 Hz, 1 H), 8.0 (m, 4 H), 
7.7 (dd, J = 9.1, 6.5 Hz, 1 H), 7.6 (m, 2 H), 7.5 (m, 4 H). 
13C-NMR (100 MHz, DMSO3) δ (ppm): 171.5, 167.1, 150.9, 150.4, 147.6, 142.3, 139.8, 
139.0, 136.7, 130.0, 129.8, 129.7, 128.8, 128.4, 127.6, 127.2, 124.0, 120.8, 116.3.  
NMR data matches published data.104 
 
4.6. Alternative Amines for the Preparation of Mixed 
Li/Mg- an Li/Mg/Zn-amide bases 
 
Directed Metalations and Reactions with Electrophiles 
 
Synthesis of ethyl-3,5-dichloro-2-(2-methylallyl)benzoate (41a): 
 
 
 
The title compound was prepared according to TP5 and TP9 from ethyl 3,5-di-chloro 
benzoate (436 mg, 2.00 mmol), Mg-base 10b or 10c (1.51 mL, 1.45 M in THF, 2.20 mmol), 3-
bromo-2-methylpropene (327 mg, 0.35 mL, 2.40 mmol) and CuCN·2LiCl (0.2 mL, 1 M in 
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THF, 0.1 mmol). Metalation conditions 0 °C, 1 h. Flash chromatography on silica (n-
pentane/Et2O 20:1) gave a light yellow oil (465 mg, 85% with base 10c; 506 mg, 93% with 
base 10b).  
 1H-NMR (300 MHz, CDCl3) δ: 7.7 (s, 1 H), 7.6 (s, 1 H), 4.8 (s, 1 H,) 4.3 (q, J = 7.0 Hz, 2 H), 
4.2 (s, 1 H), 3.8 (s, 2 H), 1.8 (s, 3 H), 1.4 (t, J = 7.2 Hz, 3 H). 
13C-NMR (75 MHz, CDCl3) δ: 166.0, 143.1, 137.1, 136.9, 134.3, 132.3, 132.2, 128.8, 110.5, 
61.6, 37.1, 23.3, 14.1. 
IR (ATR) ν~  (cm-1): 2979, 1726, 1581, 1556, 1444, 1387, 1374, 1365, 1291, 1249, 1219, 
1198, 1162, 1139, 1082, 1038, 1021, 935, 885, 873, 843, 792, 782, 769, 750, 727.  
MS (70 eV, EI) m/z (%): 272 (88) [M+], 257 (48), 231 (49), 229 (100), 228 (49), 227 (66), 
226 (64), 191 (60), 163 (40), 128 (34). 
HRMS (EI): 272.0375 (calcd. 272.0371). 
 
Synthesis of ethyl 4-bromo-3-(4-methoxyphenyl)-1-oxo-1,3-dihydro-2-benzofuran-5-
carboxylate (41d): 
 
 
 
The title compound was prepared according to TP5 from diethyl 2-bromoterephthalate (603 
mg, 2.00 mmol), Mg-base 10b or 10c (2.07 mL, 1.45 M in THF, 3.00 mmol), anisaldehyde 
(409 mg, 0.37 mL, 3.00 mmol). Metalation conditions –30 °C, 0.5 h. Flash chromatography 
on silica (n-pentane/Et2O 1:1) gave a yellow oil (703 mg, 90% with base 10c; 750 mg, 96% 
with base 10b).  
1H-NMR (600 MHz, CDCl3) δ: 8.0 (d, J = 7.9 Hz, 1 H), 7.9 (d, J = 7.8 Hz, 1 H), 7.1 (d, J = 
8.7 Hz, 2 H), 6.9 (d, J = 9.0 Hz, 2 H), 6.3 (s, 1 H), 4.4 (q, J = 7.2 Hz, 2 H), 3.8 (s, 3 H), 1.4 (t, 
J = 7.1 Hz, 3 H).  
13C-NMR (150 MHz, CDCl3) δ: 168.3, 165.4, 160.6, 149.7, 138.6, 132.2, 130.1, 129.9, 125.7, 
124.2, 117.3, 114.3, 84.0, 62.4, 55.3, 14.1. 
IR (ATR) ν~  (cm-1): 2981, 2937, 1767, 1725, 1609, 1586, 1514, 1457, 1444, 1407, 1392, 
1368, 1320, 1297, 1273, 1248, 1200, 1176, 1139, 1113, 1064, 1026, 966, 861, 852, 833, 820, 
774, 746, 726, 648, 644, 632, 606, 575. 
MS (70 eV, EI) m/z (%): 436 (1) [M+], 393 (48), 392 (41), 391 (51), 347 (39), 345 (39), 275 
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(93), 273 (95), 267 (100), 239 (88), 135 (64). 
HRMS (EI): 436.0536 (calcd. 436.0522). 
 
Synthesis of 2,6-dichloro-4-iodopyridine (46): 
 
N ClCl
I
 
 
The title compound was prepared according to TP5 from 2,6-dichloropyridine (296 mg, 2.00 
mmol), 10c (2.07 mL, 1.45 M in THF, 3.00 mmol), iodine (558 mg, 2.20 mmol), metalation 
conditions 25 °C, 10 min. Flash chromatographical purification on silica (n-pentane/Et2O 20:1) 
gave a colorless solid (465 mg, 85%).  
m.p.: 157 - 158.8 °C (decomp.). 
 1H-NMR (300 MHz, CDCl3) δ: 7.7 (br, 2 H). 
13C-NMR (75 MHz, CDCl3) δ: 150.6, 131.5, 107.6.   
IR (ATR) ν~  (cm-1): 2970, 1738, 1536, 1521, 1360, 1217, 1159, 1146, 848, 807, 740.  
MS (70 eV, EI) m/z (%): 272 (100) [M+], 147 (27), 109 (18), 75 (15), 50 (12). 
HRMS (EI): 272.8599 (calcd. 272.8609). 
  
Synthesis of 2,6-dibromo-4-iodopyridine (47): 
 
 
 
The title compound was prepared according to TP5 from 2,6-dibromopyridine (474 mg, 2.00 
mmol), 10c (2.07 mL, 1.45 M in THF, 3.00 mmol), iodine (558 mg, 2.20 mmol), metalation 
conditions –30 °C, 30 min. Flash chromatographical purification on silica (n-pentane/Et2O  
9:1) gave a colorless solid (631 mg, 87%).  
m.p.: 180.7 - 181.6 °C (decomp.). 
 1H-NMR (300 MHz, CDCl3) δ: 7.9 (s, 2 H). 
13C-NMR (75 MHz, CDCl3) δ: 140.9, 135.4, 107.4. 
IR (ATR) ν~  (cm-1): 3090, 2970, 1739, 1531, 1510, 1365, 1342, 1228, 1221, 1156, 1086, 850, 
758, 719, 701. 
MS (70 eV, EI) m/z (%): 362 (100) [M+], 360 (51), 283 (559, 281 (58), 156 (11), 154 (11), 
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126 (12), 76 (28). 50 (19).  
HRMS (EI): 360.7574 (calcd. 360.7599). 
 
Synthesis of 1-(1,3-benzothiazol-2-yl)-2,2-dimethylpropan-1-ol (41l): 
 
 
 
The title compound was prepared according to TP5 from benzothiazole (270 mg, 0.22 mL, 
2.00 mmol), Mg-base 10b or 10c (2.07 mL, 1.45 M in THF, 3.00 mmol) and pivaldehyde (233 
mg, 0.30 mL, 2.20 mmol). Metalation conditions 25 °C, 0.2 h. Flash chromatography on silica 
(n-pentane/Et2O 3:1) gave yellow solid (402 mg, 91% with base 10c; 380 mg, 86% with base 
10b).  
m.p.: 107.0 - 109.3 °C. 
 1H-NMR (600 MHz, CDCl3) δ: 8.0 (d, J = 8.1 Hz, 1 H), 7.9 (d, J = 7.9 Hz, 1 H), 7.5 (t, J = 
7.7 Hz, 1 H), 7.4 (t, J = 7.6 Hz, 1 H), 4.7 (s, 1 H), 3.4 (s, 1 H), 1.1 (s, 9 H).  
13C-NMR (150 MHz, CDCl3) δ: 173.6, 152.1, 134.8, 125.9, 125.0, 122.9, 121.5, 80.0, 36.1, 
25.8. 
IR (ATR) ν~  (cm-1): 3422, 3060, 2972, 2961, 2951, 2929, 2867, 1510, 1500, 1475, 1464, 
1453, 1436, 1390, 1368, 1360, 1329, 1313, 1284, 1236, 1218, 1187, 1168, 1153, 1125, 1086, 
1075, 1060, 1015, 900, 862, 764, 757, 731, 709, 687. 
MS (70 eV, EI) m/z (%): 221 (6) [M+], 167 (10), 165 (100), 136 (10), 57 (10). 
HRMS (EI): 221.0860 (calcd. 221.0874). 
 
Synthesis of ethyl-3,5-dichloro-2-iodobenzoate (41b): 
 
 
 
The title compound was prepared according to TP5 from 3,5-di-chloro ethylbenzoate (436 mg, 
2.00 mmol), Mg-base 10b (1.51 mL, 1.45 M in THF, 2.20 mmol) and iodine (611 mg, 2.40 
mmol). Metalation conditions 0 °C, 1 h. Flash chromatography on silica (n-pentane/Et2O 60:1) 
gave a pale brown oil (556 mg, 81%).  
 1H-NMR (300 MHz, CDCl3) δ: 7.6 (d, J = 2.4 Hz, 1 H), 7.5 (d, J = 2.4 Hz, 1 H), 4.4 (q, J = 
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7.2 Hz, 2 H), 1.4 (t, J = 7.0 Hz, 3 H).  
13C-NMR (75 MHz, CDCl3) δ: 166.1, 141.6, 141.3, 135.0, 130.8, 127.7, 95.7, 62.5, 14.1. 
IR (ATR) ν~  (cm-1): 2979, 1728, 1564, 1546, 1464, 1443, 1404, 1390, 1379, 1363, 1266, 
1236, 1184, 1140, 1112, 1093, 1012, 907, 897, 868, 858, 816, 797, 770, 734, 725, 701. 
MS (70 eV, EI) m/z (%): 344 (81) [M+], 318 (25), 315 (38), 301 (62), 271 (20), 254 (16), 144 
(22), 109 (17), 44 (24). 
HRMS (EI): 272.0375 (calcd. 272.0371). 
 
Synthesis of diethyl-5-(tert-butoxycarbonyloxy)-4-(cyclohex-2- enyl)isophthalate (41c): 
 
 
 
The title compound was prepared according to TP5 and TP9 from diethyl 5-[(tert-
butoxycarbonyl)oxy]isophthalate (678 mg, 2.00 mmol), Mg-base 10b (1.51 mL, 1.45 M in 
THF, 2.20 mmol), 3-bromocyclohexene (355 mg, 0.28 mL, 2.40 mmol) and CuCN·2LiCl (0.2 
mL, 1 M in THF, 0.2 mmol). Metalation conditions 0 °C, 1 h. Flash chromatography on silica 
(n-pentane/Et2O 1:1) gave a yellow solid (778 mg, 93%).  
m.p.: 70.3 - 73.1 °C. 
 1H-NMR (600 MHz, CDCl3) δ: 8.1 (d, J = 1.9 Hz, 1 H), 7.8 (d, J = 1.7 Hz, 1 H), 5.8 (m, 1 
H), 5.5 (d, J = 9.8 Hz, 1 H), 4.3-4.5 (m, 4 H), 4.0 (m, 1 H), 2.1-2.2 (m, 1 H), 2.0-2.1 (m, 1 H), 
1.9-2.0 (m, 2 H), 1.6 (m, 2 H), 1.5 (s, 9 H), 1.2-1.5 (m, 6 H). 
13C-NMR (150 MHz, CDCl3) δ: 167.6, 164.9, 151.4, 150.3, 142.8, 134.3, 129.4, 128.2, 127.9, 
127.4, 127.1, 83.6, 61.6, 61.4, 37.5, 28.5, 27.7, 27.4, 24.4, 22.7, 14.3, 14.2. 
IR (ATR) ν~  (cm-1): 2980, 2935, 1758, 1719, 1457, 1448, 1394, 1368, 1319, 1277, 1266, 
1238, 1218, 1174, 1144, 1100, 1060, 1024, 984, 951, 927, 907, 898, 866, 843, 821, 787, 764, 
719, 639. 
MS (70 eV, EI) m/z (%): 418 (2) [M+], 362 (43), 318 (26), 317 (11), 273 (31), 272 (100), 271 
(15), 244 (13), 243 (11), 238 (13), 199 (14), 193 (12), 57 (66), 44 (26), 41 (18). 
HRMS (EI):418.1995 (calcd. 418.1992). 
 
Synthesis of ethyl 6-bromo-1-(4-methoxyphenyl)-3-oxo-1,3-dihydro-2-benzofuran-5-
carboxylate (41e) 
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The title compound was prepared according to TP5 from 4-bromo diethylisophthalate (603 
mg, 2.00 mmol), Mg-base 10b (2.07 mL, 1.45 M in THF, 3.00 mmol), anisaldehyde (409 mg, 
0.37 mL 3.00 mmol). Metalation conditions–30 °C, 0.5 h. Flash chromatography on silica (n-
pentane/Et2O 1:1) gave a colorless solid (671 mg, 86%).  
m.p.: 130.2 - 132.3 °C. 
 1H-NMR (600 MHz, CDCl3) δ: 8.3 (s, 1 H), 7.6 (s, 1 H), 7.1 (d, J = 8.8 Hz, 2 H), 6.9 (d, J = 
8.8 Hz, 2 H), 6.3 (s, 1 H), 4.4 (q, J = 7.2 Hz, 2 H), 3.8 (s, 3 H), 1.4 (t, J = 7.2 Hz, 3 H).   
13C-NMR (150 MHz, CDCl3) δ: 168.6, 164.9, 160.8, 152.7, 134.2, 129.1, 128.8, 128.4, 128.1, 
126.8, 125.2, 114.6, 82.1, 62.3, 55.4, 14.1. 
IR (ATR) ν~  (cm-1): 2990, 2967, 2955, 1757, 1727, 1616, 1579, 1514, 1468, 1460, 1449, 
1443, 1428, 1392, 1365, 1325, 1307, 1290, 1283, 1248, 1200, 1178, 1159, 1114, 1105, 1078, 
1028, 1020, 969, 932, 924, 893, 878, 867, 843, 834, 821, 802, 781, 754, 734, 726, 681, 658. 
MS (70 eV, EI) m/z (%): 392 (95), 391 (23) [M+], 390 (100), 275 (20), 273 (21), 267 (20), 
256 (27), 254 (24), 135 (61). 
HRMS (EI): 391.0087 (calcd. 391.0181). 
 
Synthesis of 3-Bromoquinoline-2-carbaldehyde (41f): 
 
 
 
The title compound was prepared according to TP5 from 3-bromoquinoline (415 mg, 2.00 
mmol), Mg-base 10b (2.0 mL, 1.45 M in THF, 3.00 mmol) and dry DMF (257 mg, 0.27 mL, 
3.50 mmol). Metalation conditions –25 °C, 0.3 h. Flash chromatography on silica (n-
pentane/Et2O 3:1) gave a yellow solid (304 mg, 65 %).  
m.p.: 104.8 - 106.4 °C. 
 1H-NMR (300 MHz, CDCl3) δ: 10.4 (s, 1 H) 8.5 (s, 1 H) 8.3 (d, J = 8.3 Hz, 1 H) 7.8-7.9 (m, 
2 H) 7.7-7.8 (m, 1 H).  
13C-NMR (75 MHz, CDCl3) δ: 191.2, 147.8, 146.4, 141.5, 130.9, 130.5, 130.3, 130.1, 126.7, 
114.7. 
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IR (ATR) ν~  (cm-1): 2857, 1713, 1677, 1661, 1632, 1611, 1582, 1566, 1544, 1485, 1444, 
1403, 1392, 1361, 1315, 1298, 1254, 1227, 1192, 1145, 1133, 995, 985, 964, 912, 893, 874, 
783, 757, 637, 611. 
MS (70 eV, EI) m/z (%): 235 (57) [M+], 209 (75), 208 (22), 207 (77), 206 (14), 128 (100), 
127 (46), 101 (29), 75 (14), 44 (19). 
HRMS (EI): 234.9626 (calcd. 234.9633). 
 
Synthesis of 2,6-dichloro-4-(4-methoxyphenyl)pyridine (41g): 
 
N ClCl
OMe
 
 
The title compound was prepared according to TP5 and TP7 from 2,6-dichloropyridine (296 
mg, 2.00 mmol), Mg-base 10b (2.07 mL, 1.45 M in THF, 3.00 mmol), ZnCl2 (3.1 mL, 1 M in 
THF, 3.1 mmol) 4-iodoanisole (515 mg, 2.20 mmol), Pd(dba)2 (56 mg, 5 mol%), P(2-furyl)3 
(46 mg, 10 mol%), metalation conditions 25 °C, 10 min. Flash chromatographical purification 
on silica (n-pentane/Et2O 19:1) gave a colorless solid (437 mg, 85%).  
m.p.: 68.7 - 70.1 °C. 
1H-NMR (300 MHz, CDCl3) δ: 7.6 (d, J = 9.0 Hz, 2 H), 7.4 (s, 2 H), 7.0 (d, J = 9.0 Hz, 2 H), 
3.9 (s, 3 H). 
13C-NMR (75 MHz, CDCl3) δ: 161.4, 153.4, 151.0, 120.0, 114.8, 113.9, 55.5.  
IR (ATR) ν~  (cm-1): 2970, 2937, 2839, 1739, 1607, 1580, 1515, 1417, 1371, 1289, 1255, 
1232, 1184, 1173, 1113, 1065, 1036, 985, 866, 821, 808, 767. 
MS (70 eV, EI) m/z (%): 253 (100) [M+], 239 (10), 237 (16), 209 (22), 114 (11).  
HRMS (EI): 253.0070 (calcd. 253.0061). 
 
Synthesis of 1-(2,6-dichloropyridin-4-yl)-2,2-dimethylpropan-1-one (41h): 
 
N ClCl
tBuO
 
 
The title compound was prepared according to TP5 and TP8 from 2,6-dichloropyridine (296 
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mg, 2.00 mmol), Mg-base 10b (2.07 mL, 1.45 M in THF, 3.00 mmol), ZnCl2 (3.1 mL, 1 M in 
THF, 3.1 mmol), pivaloyl chloride (724 mg, 6.00 mmol), Pd(PPh3)4 (46 mg, 2 mol%), 25 °C, 
10 min. Flash chromatographical purification on silica (n-pentane/Et2O 20:1) gave a colorless 
solid (399 mg, 86%).  
m.p.: 58.6 - 60.2 °C. 
1H-NMR (300 MHz, CDCl3) δ: 7.3 (s, 2 H), 1.3 (s, 9 H).  
13C-NMR (75 MHz, CDCl3) δ: 206.2, 151.4, 150.9, 120.4, 44.6, 27.0. 
IR (ATR) ν~  (cm-1): 3072, 2979, 2938, 1738, 1688, 1577, 1521, 1481, 1460, 1395, 1364, 
1284, 1211, 1168, 1048, 1002, 879, 831, 818, 764, 753, 721, 632. 
MS (70 eV, EI) m/z (%): 233 (2) [M+], 231 (3), 177 (17), 175 (26), 149 (18), 147 (25), 57 
(100), 41 (23). 
HRMS (EI): 231.0221 (calcd. 231.0218). 
 
Synthesis of 1-(2,6-dibromopyridin-4-yl)-2,2-dimethylpropan-1-ol (41i): 
N BrBr
tBuHO
 
 
The title compound was prepared according to TP5 from 2,6-dibromo pyridine (475 mg, 2.00 
mmol), Mg-base 10b (2.0 mL, 1.45 M in THF, 3.00 mmol), pivaldehyde (277 mg, 2.20 mmol). 
Metalation conditions –50 °C, 0.5 h. Flash chromatography on silica (n-pentane/Et2O 40:1) 
gave a colorless solid (544 mg, 84%).  
m.p.:167.8 - 169.7 °C. 
1H-NMR (300 MHz, CDCl3) δ: 7.4 (s, 2 H), 4.3 (s, 1 H), 2.1 (s, 1 H), 1.0 (s, 9 H).  
13C-NMR (150 MHz, CDCl3) δ: 156.6, 140.4, 126.3, 80.3, 36.1, 25.9. 
IR (ATR) ν~  (cm-1): 3432, 2968, 2962, 2931, 2866, 1575, 1528, 1480, 1402, 1373, 1364, 
1325, 1295, 1236, 1217, 1201, 1175, 1158, 1087, 1072, 1015, 985, 938, 927, 897, 884, 860, 
774, 752, 681, 615. 
MS (70 eV, EI) m/z (%): 321 (1) [M+], 269 (97), 268 (18), 267 (88), 265 (100), 186 (9), 158 
(10), 156 (9), 57 (50), 41 (9). 
HRMS (EI): 320.9370 (calcd. 320.9364). 
 
Synthesis of 1,3-benzothiazol-2-yl(2-chloropyridin-3-yl)methanone (41k): 
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The title compound was prepared according to TP5 and TP8 from benzothiazole (270 mg, 
2.00 mmol), Mg-base 10b (2.07 mL, 1.45 M in THF, 3.00 mmol), ZnCl2 (3.1 mL, 1 M in THF, 
3.1 mmol), 3-chloro nicotinylchloride (1.06 g, 6.00 mmol), Pd(PPh3)4 (46 mg, 2 mol%), 25 °C, 
10 min. Flash chromatographical purification on silica (n-pentane/Et2O 20:1) gave a colorless 
solid (456 mg, 83%).  
m.p.: 142.2 - 143.7 °C. 
1H-NMR (600 MHz, CDCl3) δ: 8.6 (m, 1 H), 8.2 (m, 1 H), 8.1 (dd, J = 7.6, 1.9 Hz, 1 H), 8.0 
(m, 1 H), 7.6 (m, 2 H), 7.4 (dd, J = 7.4, 5.0 Hz, 1 H) . 
13C-NMR (150 MHz, CDCl3) δ: 186.2, 165.1, 153.6, 151.5, 148.8, 139.4, 137.5, 132.6, 128.3, 
127.3, 126.0, 122.4, 121.9. 
IR (ATR) ν~  (cm-1): 3094, 2989, 2970, 1739, 1674, 1575, 1554, 1486, 1456, 1424, 1397, 
1324, 1291, 1278, 1230, 1137, 1126, 1080, 1052, 954, 890, 843, 809, 755, 726, 702, 652, 602. 
MS (70 eV, EI) m/z (%): 274 (5) [M+], 246 (11), 240 (50), 239 (62), 238 (55), 141 (28), 139 
(100), 113 (16), 111 (54), 76 (16). 
HRMS (EI): 273.9962 (calcd. 273.9968). 
 
Synthesis of 1-benzothien-2-yl(phenyl)methanol (41l): 
 
 
 
The title compound was prepared according to TP5 from benzothiophene (266 mg, 0.23 mL, 
2.00 mmol), Mg-base 10b (2.07 mL, 1.45 M in THF, 3.00 mmol) and benzaldehyde (233 mg, 
0.22 mL, 2.20 mmol). Metalation conditions 0 °C, 12 h. Flash chromatography on silica (n-
pentane/Et2O 4:1) gave a colorless solid (338 mg, 71%).  
mp.: 87.4 - 88.0 °C. 
 1H-NMR (600 MHz, CDCl3) δ: 7.8 (d, J = 7.2 Hz, 1 H) 7.7 (d, J = 8.3 Hz, 1 H) 7.5 (d, J = 
7.6 Hz, 2 H) 7.4 (t, J = 7.5 Hz, 2 H) 7.3 (s, 2 H) 7.3 (s, 1 H) 7.1 (s, 1 H) 6.1 (d, J = 3.1 Hz, 1 
H) 2.5 (d, J = 4.1 Hz, 1 H).  
13C-NMR (150 MHz, CDCl3) δ: 148.6, 142.5, 139.9, 139.4, 128.6, 128.3, 126.4, 124.3, 124.2, 
123.6, 122.4, 121.2, 73.0. 
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IR (ATR) ν~  (cm-1): 3143, 3058, 3028, 1492, 1455, 1434, 1327, 1306, 1295, 1247, 1197, 
1177, 1154, 1103, 1031, 1021, 1010, 1001, 818, 786, 769, 749, 728, 722, 699, 666, 627. 
MS (70 eV, EI) m/z (%): 240 (79) [M+], 223 (15), 221 (16), 161 (16), 136 (12), 135 (100), 
105 (50), 91 (12), 77 (17), 44 (11). 
HRMS (EI): 240.0595 (calcd. 240.0609). 
 
Synthesis of tert-butyl 2-(2-methylprop-2-en-1-yl)benzoate (42a): 
 
 
 
The title compound prepared according to TP5 and TP9 from tert-butyl benzoate (356 mg, 
2.00 mmol), Mg-base 14c (2.59 mL, 0.85 M in THF, 2.20 mmol), ZnCl2 (2.4 mL, 1 M in THF, 
2.4 mmol), CuCN·2LiCl (0.2 ml, 1.0 M in THF, 10 mol%), 3-bromo-2-methylpropene (297 
mg, 2.20 mmol), metalation conditions 25 °C, 1 h. Flash chromatographical purification on 
silica (n-pentane/Et2O 9:1) gave a colorless oil (422 mg, 91%).  
1H-NMR (300 MHz, CDCl3) δ: 7.8 (m, 1 H), 7.4 (m, 1 H), 7.3 (m, 2 H), 4.8 (s, 1 H), 4.5 (s, 1 
H), 3.7 (s, 2 H), 1.8 (s, 3 H), 1.6 (s, 9 H). 
13C-NMR (75 MHz, CDCl3) δ: 167.5, 145.2, 139.9, 132.8, 131.0, 131.0, 130.0, 126.0, 111.7, 
81.1, 41.6, 28.2, 22.8. 
IR (ATR) ν~  (cm-1): 2970, 2938, 1738, 1716, 1447, 1366, 1293, 1275, 1252, 1229, 1217, 
1172, 1129, 1077, 1049, 890, 849, 738, 711. 
MS (70 eV, EI) m/z (%): 232 (0.04) [M+], 177 (29), 176 (100), 162 (35), 161 (74), 159 (94), 
158 (91), 143 (15), 134 (24). 
HRMS (EI): 232.1444 (calcd. 232.1463). 
 
Synthesis of tert-butyl 2-(4-chlorobenzoyl)benzoate (42b): 
 
 
 
The title compound was prepared according to TP5 and TP8 from tert-butyl benzoate (356 
mg, 2.00 mmol), Mg-base 33 (2.59 mL, 0.85 M in THF, 2.20 mmol), ZnCl2 (2.4 mL, 1 M in 
THF, 2.4 mmol), 4-chloro benzoylchloride (385 mg, 2.20 mmol), Pd(PPh3)4 (46 mg, 2 mol%), 
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metalation conditions 25 °C, 1 h. Flash chromatographical purification on silica (n-
pentane:Et2O = 5:1) gave a colorless solid (422 mg, 91%).  
m.p.: 65.8 -  67.3 °C  
1H-NMR (300 MHz, CDCl3) δ: 8.0 (m, 1 H), 7.7 (d, J = 8.7 Hz, 2 H), 7.6 (m, 2 H), 7.4 (d, J 
= 8.7 Hz, 2 H), 7.3 (m, 1 H), 1.3 (s, 9 H).  
13C-NMR (75 MHz, CDCl3) δ: 195.6, 165.0, 140.6, 139.5, 135.7, 132.0, 131.1, 130.9, 130.1, 
129.7, 128.8, 127.4, 82.7, 27.6. 
IR (ATR) ν~  (cm-1): 2972, 2933, 1737, 1706, 1666, 1583, 1571, 1485, 1455, 1441, 1396, 
1366, 1301, 1286, 1267, 1173, 1138, 1082, 1011, 969, 930, 896, 866, 849, 775, 762, 748, 737, 
712, 676, 645. 
MS (70 eV, EI) m/z (%): 316 (5) [M+], 261 (34), 260 (23), 245 (27), 243 883), 181 8100), 
152 (28), 149 (17), 139 (32), 111 (11), 57 (21). 
HRMS (EI): 318.0869 (calcd. 316.0866). 
 
Synthesis of tert-butyl 4'-methylbiphenyl-2-carboxylate (42c): 
 
 
 
The title compound was prepared according to TP5 and TP7 from tert-butyl benzoate (356 
mg, 2.00 mmol), Mg-base 14c (2.59 mL, 0.85 M in THF, 2.20 mmol), ZnCl2 (2.4 mL, 1 M in 
THF, 2.4 mmol) 4-iodotoluene (480 mg, 2.20 mmol), Pd(dba)2 (56 mg, 5 mol%), P(2-furyl)3 
(46 mg, 10 mol%), metalation conditions 25 °C, 1 h. Flash chromatographical purification on 
silica (n-pentane/Et2O 20:1) gave a colorless oil (440 mg, 82%).  
1H-NMR (300 MHz, CDCl3) δ: 7.8 (m, 1 H), 7.5 (m, 1 H), 7.4 (m, 1 H), 7.3 (m, 1 H), 7.2 (s, 
4 H), 2.4 (s, 3 H), 1.3 (s, 9 H). 
13C-NMR (75 MHz, CDCl3) δ: 168.2, 142.0, 138.9, 136.7, 133.0, 130.6, 130.5, 129.5, 128.6, 
128.5, 126.9, 81.2, 27.6, 21.2. 
IR (ATR) ν~  (cm-1): 2970, 2928, 1706, 1599, 1477, 1444, 1366, 1298, 1247, 1217, 1172, 
1126, 1087, 1047, 848, 819, 755, 705. 
MS (70 eV, EI) m/z (%): 268 (6) [M+], 213 (13), 212 (100), 195 (37), 165 (16), 152 (11). 
HRMS (EI) 268.1458 (calcd. 268.1463). 
 
Synthesis of tert-butyl 4'-[(triisopropylsilyl)oxy]biphenyl-2-carboxylate (42d): 
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The title compound was prepared according to TP5 and TP7 from tert-butyl benzoate (356 
mg, 2.00 mmol), Mg-base 14c (2.59 mL, 0.85 M in THF, 2.20 mmol), ZnCl2 (2.4 mL, 1 M in 
THF, 2.4 mmol) (4-iodophenoxy)(triisopropyl)silane (850 mg, 2.20 mmol), Pd(dba)2 (56 mg, 
5 mol%), P(2-furyl)3 (46 mg, 10 mol%), metalation conditions 25 °C, 1 h. Flash 
chromatographical purification on silica (n-pentane/Et2O 20:1) gave a colorless oil (758 mg, 
89%).  
1H-NMR (300 MHz, CDCl3) δ: 7.7 (m, 1 H), 7.5 (m, 1 H), 7.4 (m, 2 H), 7.2 (d, J = 8.7 Hz, 2 
H), 6.9 (d, J = 8.7 Hz, 2 H), 1.3 (s, 9 H), 1.1 (m, 21 H). 
13C-NMR (75 MHz, CDCl3) δ: 168.6, 155.4, 141.4, 134.4, 133.3, 130.5, 130.4, 129.6, 129.3, 
126.7, 119.3, 81.2, 27.7, 18.0, 12.7. 
IR (ATR) ν~  (cm-1): 2970, 2944, 2867, 1737, 1712, 1607, 1515, 1477, 1444, 1366, 1301, 
1260, 1232, 1217, 1172, 1126, 1047, 911, 882, 837, 762, 686, 652. 
MS (70 eV, EI) m/z (%): 427 (12), 426 (36) [M+], 328 (25), 327 (100), 309 (22), 299 (28), 
281 (22), 255 (10), 254 (11), 253 (53), 239 (279, 127 (14), 75 (11), 57 (14). 
HRMS (EI): 426.2586 (calcd. 426.2590). 
 
Synthesis of tert-butyl 2-(4-chlorophenyl)-1-naphthoate (42e): 
 
 
 
The title compound was prepared according to TP5 and TP7 from tert-butyl 1-naphthoate 
(456 mg, 2.00 mmol), Mg-base 14c (2.59 mL, 0.85 M in THF, 2.20 mmol), ZnCl2 (2.4 mL, 1 
M in THF, 2.4 mmol) 4-iodo-1-chlorobenzene (525 mg, 2.20 mmol), Pd(dba)2 (56 mg, 5 
mol%), P(2-furyl)3 (46 mg, 10 mol%), metalation conditions 25 °C, 3 h. Trituration with n-
pentane gave a brown solid (657 mg, 97%).  
m.p.: 95.6 - 97.1 °C (decomp.). 
1H-NMR (300 MHz, CDCl3) δ: 8.0 (m, J = 8.3 Hz, 1 H), 7.9 (m, 2 H), 7.6 (m, 2 H), 7.4 (m, 5 
H), 1.4 (s, 9 H). 
13C-NMR (75 MHz, CDCl3) δ: 168.3, 139.5, 136.0, 133.6, 132.5, 131.7, 130.4, 129.8, 129.4, 
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129.0, 128.2, 128.1, 127.1, 126.4, 125.0, 82.4, 27.9. 
IR (ATR) ν~  (cm-1): 2971, 2930, 1737, 1711, 1597, 1491, 1364, 1286, 1274, 1243, 1175, 
1162, 1135, 1109, 1091, 1014, 1009, 959, 890, 859, 849, 814, 795, 748, 723, 676, 664. 
MS (70 eV, EI) m/z (%): 338 (10) [M+], 284 (27), 282 (100), 265 (28), 202 (26). 
HRMS (EI): 338.1075 (calcd. 338.1074). 
 
Synthesis of tert-butyl 2-(2-methylprop-2-en-1-yl)-1-naphthoate (42f): 
 
 
 
The title compound was prepared according to TP5 and TP9 from tert-butyl 1-naphthoate 
(456 mg, 2.00 mmol), Mg-base 14c (2.59 mL, 0.85 M in THF, 2.20 mmol), ZnCl2 (2.4 mL, 1 
M in THF, 2.4 mmol), CuCN·2LiCl (0.2 ml, 1.0 M in THF, 10 mol%), 3-bromo-2-
methylpropene (297 mg, 2.20 mmol), metalation conditions 25 °C, 3 h. Flash 
chromatographical purification on silica (n-pentane/Et2O 50:1) gave a colorless oil (496 mg, 
88%).  
 
1H-NMR (300 MHz, CDCl3) δ: 7.8 (m, 3 H), 7.5 (m, 2 H), 7.4 (d, J = 8.5 Hz, 1 H), 4.9 (s, 1 
H), 4.7 (s, 1 H), 3.6 (s, 2 H), 1.8 (s, 3 H), 1.7 (s, 9 H). 
13C-NMR (75 MHz, CDCl3) δ: 168.9, 144.1, 133.8, 132.3, 132.0, 129.9, 129.0, 128.0, 127.4, 
126.8, 125.6, 124.7, 112.8, 82.4, 41.7, 28.3, 22.4. 
IR (ATR) ν~  (cm-1): 2970, 2942, 1738, 1718, 1508, 1455, 1366, 1283, 1248, 1227, 1222, 
1171, 1152, 1132, 1044, 1023, 891, 847, 807, 755, 735. 
MS (70 eV, EI) m/z (%): 282 (1) [M+], 226 (45), 211 (100), 209 (15), 181 (23), 165 (19). 
HRMS (EI): 282.1606 (calcd. 282.1620). 
 
Synthesis of tert-butyl 2-(2,2-dimethylpropanoyl)-1-naphthoate (42g): 
 
 
 
The title compound was prepared according to TP5 and TP8 from tert-butyl 1-naphthoate 
(456 mg, 2.00 mmol), Mg-base 14c (2.59 mL, 0.85 M in THF, 2.20 mmol), ZnCl2 (2.4 mL, 1 
M in THF, 2.4 mmol), pivaloyl chloride (385 mg, 2.20 mmol), Pd(PPh3)4 (46 mg, 2 mol%), 
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metalation conditions 25 °C, 3 h. Flash chromatographical purification on silica (n-
pentane/Et2O 9:1) gave a colorless solid (518 mg, 83 %).  
m.p.: 76.1 - 78.0 °C. 
1H-NMR (300 MHz, CDCl3) δ: 8.2 (m, 1 H), 7.9 (m, 2 H), 7.6 (m, 2 H), 7.5 (d, J = 8.7 Hz, 1 
H), 1.7 (s, 9 H), 1.4 (s, 9 H).  
13C-NMR (75 MHz, CDCl3) δ: 221.3, 167.6, 138.7, 133.4, 130.9, 130.0, 129.4, 128.2, 127.6, 
127.0, 125.9, 122.0, 83.0, 44.4, 28.2, 27.9. 
IR (ATR) ν~  (cm-1): 2970, 2932, 2871, 1737, 1711, 1683, 1622, 1567, 1475, 1458, 1395, 
1380, 1366, 1266, 1248, 1159, 1133, 1069, 1026, 997, 882, 864, 852, 842, 822, 802, 790, 762, 
741, 727, 682, 624. 
MS (70 eV, EI) m/z (%): 312 (0.1) [M+], 254 (5), 199 (12), 198 (100), 126 (4), 57 (11). 
HRMS (EI): 312.1710 (calcd. 312.1725). 
 
Synthesis of 1-tert-butyl 2-ethyl naphthalene-1,2-dicarboxylate (42h): 
 
 
The title compound was prepared according to TP5 and TP8 from tert-butyl naphthoate (456 
mg, 2.00 mmol), Mg-base 14c (2.59 mL, 0.85 M in THF, 2.20 mmol), ZnCl2 (2.4 mL, 1 M in 
THF, 2.4 mmol), ethyl chloroformate (1.08 g, 10.0 mmol), Pd(PPh3)4 (46 mg, 2 mol%), 
metalation conditions 25 °C, 3 h. Flash chromatographical purification on silica (n-
pentane/Et2O 9:1) gave a colorless solid (498 mg, 83 %).  
m.p.: 103.8 -105.6 °C. 
1H-NMR (300 MHz, CDCl3) δ: 8.0 (m, 2 H), 7.9 (m, 2 H), 7.6 (m, 2 H),  4.5 (q, J = 7.2 Hz, 2 
H), 1.7 (s, 9 H), 1.4 (t, J = 7.2 Hz, 3 H).  
13C-NMR (75 MHz, CDCl3) δ: 167.9, 165.8, 136.0, 135.1, 129.5, 128.9, 128.1, 128.1, 127.5, 
126.0, 125.1, 124.7, 82.8, 61.4, 28.2, 14.4. 
IR (ATR) ν~  (cm-1): 2980, 2970, 1738, 1722, 1712, 1467, 1438, 1364, 1289, 1265, 1241, 
1217, 1173, 1158, 1133, 1116, 1042, 1018, 867, 850, 828, 796, 766, 752, 730, 669. 
MS (70 eV, EI) m/z (%): 300 (32) [M+], 245 (16), 244 (100), 227 (25), 200 (30), 199 (90), 
172 (27), 155 (73), 127 (29), 115 (19), 57 (17). 
HRMS (EI): 300.1354 (calcd. 300.1262).  
 
Synthesis of tri-tert-butyl benzene-1,2,4-tricarboxylate (42i): 
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The title compound was prepared according to TP5 from di-tert-butyl isophtalate (556 mg, 
2.00 mmol), Mg-base 14c (2.59 mL, 0.85 M in THF, 2.20 mmol), Boc2O (1.08 g, 5.00 mmol), 
metalation conditions 25 °C, 6 h. Flash chromatographical purification on silica (n-
pentane/Et2O 9:1) gave a pale green oil (685 mg, 90%).  
1H-NMR (300 MHz, CDCl3) δ: 8.2 (d, J = 1.2 Hz, 1 H), 8.1 (dd, J = 8.0, 1.7 Hz, 1 H), 7.6 (d, 
J = 8.0, 1 H), 1.6 (m, 23 H), 1.5 (m, 4 H).  
13C-NMR (75 MHz, CDCl3) δ: 166.4, 166.0, 164.3, 137.4, 133.6, 133.6, 131.2, 129.8, 128.6, 
85.2, 83.9, 82.4, 81.9, 28.0, 27.6, 27.4. 
IR (ATR) ν~  (cm-1): 2970, 2941, 1736, 1718, 1455, 1393, 1367, 1293, 1273, 1245, 1217, 
1157, 1113, 1066, 935, 869, 841, 763, 741. 
MS (70 eV, EI) m/z (%): 378 (0.02) [M+], 305 (47), 267 (36), 249 (24), 211 (51), 194 (37), 
193 (23), 175 (19), 167 (80), 148 (47), 57 (38), 56 (100). 
HRMS (EI): 378.2047 (calcd. 378.2842). 
 
Synthesis of di-tert-butyl 4-(2-methylprop-2-en-1-yl)isophthalate (42j): 
 
 
 
The title compound was prepared according to TP5 and TP9 from di-tert-butyl isophtalate 
(556 mg, 2.00 mmol), Mg-base 14c (2.59 mL, 0.85 M in THF, 2.20 mmol), ZnCl2 (2.4 mL, 1 
M in THF, 2.4 mmol), CuCN·2LiCl (0.2 ml, 1 M in THF, 10 mol%), 3-bromo-2-
methylpropene (297 mg, 2.20 mmol), metalation conditions 25 °C, 6 h. Flash 
chromatographical purification on silica (n-pentane/Et2O 20:1) gave a colorless oil (680 mg, 
90%).  
1H-NMR (300 MHz, CDCl3) δ: 8.4 (d, J = 1.7 Hz, 1 H), 8.2 (dd, J = 7.7, 1.7 Hz, 1 H), 7.9 
(dd, J = 8.0, 1.9 Hz, 1 H), 4.8 (s, 1 H), 4.5 (s, 1 H), 3.8 (s, 2 H), 1.6 (m, 21 H). 
13C-NMR (75 MHz, CDCl3) δ: 166.8, 165.1, 144.6, 133.2, 132.9, 132.2, 131.6, 131.1, 130.4, 
130.0, 128.2, 112.1, 81.6, 81.5, 81.2, 28.2, 28.1, 22.8. 
IR (ATR) ν~  (cm-1): 2970, 2938, 1738, 1715, 1608, 1452, 1393, 1366, 1315, 1290, 1247, 
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1217, 1156, 1140, 1117, 1075, 939, 891, 849, 768, 756, 732. 
MS (70 eV, EI) m/z (%): 332 (0.02) [M+], 276 (52), 259 (16), 220 (59), 205 (100), 203 (28), 
202 (16), 149 (7), 57 (25). 
HRMS (EI): 332.1976 (calcd. 332.1988). 
 
Synthesis of tert-butyl 3-phenylisonicotinate (42k): 
 
 
 
The title compound was prepared according to TP5 and TP7 from tert-butyl isonicotinate 
(358 mg, 2.00 mmol), Mg-base 14c (3.53 mL, 0.85 M in THF, 3.00 mmol), ZnCl2 (3.2 mL, 1 
M in THF, 3.2 mmol) iodobenzene (449 mg, 2.20 mmol), Pd(dba)2 (56 mg, 5 mol%), P(2-
furyl)3 (46 mg, 10 mol%), metalation conditions –40 °C, 12 h. Flash chromatographical 
purification on silica (n-pentane/Et2O 1:1) gave a red oil (347 mg, 68%).  
1H-NMR (300 MHz, CDCl3) δ: 8.7 (d, J = 5.1 Hz, 1 H), 8.6 (s, 1 H), 7.6 (d, J = 5.6 Hz, 1 H), 
7.4 (m, 3 H), 7.3 (m, 2 H), 1.3 (s, 9 H). 
13C-NMR (75 MHz, CDCl3) δ: 166.2, 151.0, 148.7, 140.0, 137.7, 135.9, 128.8, 127.9, 122.5, 
99.4, 82.8, 27.5. 
IR (ATR) ν~  (cm-1): 2970, 1736, 1715, 1477, 1445, 1397, 1368, 1316, 1296, 1217, 1159, 
1119, 1075, 1006, 856, 837, 761, 717, 699, 672. 
MS (70 eV, EI) m/z (%): 255 (3) [M+], 200 (16), 199 (100), 198 (19), 182 (30), 154 (9), 127 
(10), 57 (11). 
HRMS (EI): 255.1264 (calcd. 255.1259). 
 
Synthesis of 4-(3-methylphenyl)-2-(methylthio)pyrimidine (42l): 
 
 
 
The title compound was prepared according to TP5 and TP7 from 2(methylthio)pyrimidine 
(252 mg, 2.00 mmol), Mg-base 14c (3.53 mL, 0.85 M in THF, 3.00 mmol), ZnCl2 (3.2 mL, 1 
M in THF, 3.2 mmol) 3-iodotoluene (480 mg, 2.20 mmol), Pd(dba)2 (56 mg, 5 mol%), P(2-
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furyl)3 (46 mg, 10 mol%), metalation conditions –40 °C, 12 h. Flash chromatographical 
purification on silica (n-pentane/Et2O 1:4) gave a colorless solid (328 mg, 76%). 
m.p.: 55.2 - 56.3 °C. 
1H-NMR (300 MHz, CDCl3) δ: 8.5 (d, J = 5.3 Hz, 1 H), 7.9 (s, 1 H), 7.8 (d, J = 8.0 Hz, 1 H), 
7.4 (m, 3 H), 2.7 (s, 3 H), 2.5 (s, 3 H). 
13C-NMR (75 MHz, CDCl3) δ: 172.7, 164.1, 157.4, 138.6, 136.3, 131.9, 128.8, 127.8, 124.4, 
112.0, 21.5, 14.2. 
IR (ATR) ν~  (cm-1): 3058, 2970, 2925, 1739, 1561, 1542, 1492, 1415, 1348, 1315, 1301, 
1208, 1194, 1185, 1126, 1080, 969, 918, 890, 850, 796, 768, 693, 654, 628. 
MS (70 eV, EI) m/z (%): 217 (14), 216 (100) [M+], 215 (30, 170 (37), 169 (22), 155 (14), 115 
(12). 
HRMS (EI): 216.0708 (calcd. 216.0721). 
 
Synthesis of 4'-methoxybiphenyl-2-carbonitrile (42m): 
 
CN
OMe
 
 
The title compound was prepared according to TP5 and TP9 from benzonitrile (206 mg, 2.00 
mmol), Mg-base 14c (2.59 mL, 0.85 M in THF, 2.20 mmol), ZnCl2 (2.4 mL, 1 M in THF, 2.40 
mmol) 3-iodoanisole (480 mg, 2.20 mmol), Pd(dba)2 (56 mg, 5 mol%), P(2-furyl)3 (46 mg, 10 
mol%), metalation conditions –30 °C, 3 h. Flash chromatographical purification on silica (n-
pentane/Et2O 9:1) gave a colorless solid (328 mg, 76%). 
m.p.: 77.1 - 79.1 °C. 
1H-NMR (300 MHz, CDCl3) δ: 7.8 (m, 1 H), 7.6 (m, 1 H), 7.5 (d, J = 9.0 Hz, 2 H), 7.4 (m, 2 
H), 7.0 (d, J = 9.0 Hz, 2 H) 3.9 (s, 3 H).  
13C-NMR (75 MHz, CDCl3) δ: 160.1, 133.7, 132.7, 130.5, 130.0, 129.9, 129.0, 128.4, 127.0, 
114.2, 77.4, 76.6, 55.4. 
IR (ATR) ν~  (cm-1): 2994, 2970, 2224, 1739, 1611, 1598, 1516, 1480, 1443, 1435, 1370, 
1300, 1270, 1248, 1184, 1035, 833, 820, 750, 696. 
MS (70 eV, EI) m/z (%): 209 (100) [M+], 194 (17), 166 (30), 140 (12).  
HRMS (EI): 209.0841 (calcd. 209.0841). 
 
Synthesis of 4-fluoro-2-(2-methylprop-2-en-1-yl)benzonitrile (45d): 
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The title compound was prepared according to TP6 and TP9 from 4-fluoro benzonitrile (242 
mg, 2.00 mmol), Zn-base 12b (2.4 mL, 0.5 M in THF, 1.2 mmol), CuCN·2LiCl (0.2 ml, 1 M in 
THF 10 mol%), 3-bromo-2-methylpropene (297 mg, 2.20 mmol), metalation conditions 100 
°C, 2 h. Flash chromatographical purification on silica (n-pentane/Et2O 19:1) gave a colorless 
oil (283 mg, 81%).  
1H-NMR (300 MHz, CDCl3) δ: 7.6 (dd, J = 4.7, 2.1 Hz, 1 H), 7.5 (m, 1 H), 7.1 (t, J = 9.1 Hz, 
1 H), 4.9 (s, 1 H), 4.7 (s, 1 H), 3.4 (s, 2 H), 1.7 (s, 3 H).  
13C-NMR (75 MHz, CDCl3) δ: 165.2, 161.9, 142.1, 135.4, 135.3, 132.5, 132.3, 128.9, 128.7, 
118.2, 116.8, 116.5, 113.3, 108.4, 108.4, 36.5, 36.5, 22.1. Observed complexity due to C-F 
splitting, definitive assignments have not been made. 
IR (ATR) ν~  (cm-1): 2970, 2942, 2920, 2231, 1739, 1653, 1590, 1493, 1443, 1376, 1247, 
1230, 1217, 1103, 1066, 895, 829, 780, 728, 682. 
MS (70 eV, EI) m/z (%): 175 (66) [M+], 161 (10), 160 (100), 158 (10), 147 (13), 135 (12), 
134 (30), 133 (11), 107 (11), 57 (13), 43 (59). 
HRMS (EI): 175.0790 (calcd. 175.0797). 
 
Synthesis of 3-fluoro-4'-[(triisopropylsilyl)oxy]biphenyl-2-carbonitrile (45e): 
 
 
 
The title compound was prepared according to TP6 and TP7 from 2-fluoro benzonitrile (242 
mg, 2.00 mmol), Zn-base 12b (2.4 mL, 0.5 M in THF, 1.2 mmol), (4-
iodophenoxy)(triisopropyl)silane (850 mg, 2.20 mmol), Pd(dba)2 (56 mg, 5 mol%), P(2-
furyl)3 (46 mg, 10 mol%), metalation conditions 140 °C, 2 h. Flash chromatographical 
purification on silica (n-pentane/Et2O 9:1) gave a colorless solid (610 mg, 83%). 
m.p.: 81.7-82.9 °C. 
1H-NMR (300 MHz, CDCl3) δ: 7.7 (td, J = 7.7, 1.7 Hz, 1 H), 7.6 (m, 1 H), 7.4 (dd, J = 6.7, 
1.8, 1.7 Hz, 2 H), 7.0 (m, 3 H), 1.3 (m, 3 H), 1.1 (d, J = 7.0 Hz, 18 H).  
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13C-NMR (75 MHz, CDCl3) δ: 161.9, 158.4, 156.7, 135.3, 135.3, 131.6, 130.4, 130.2, 130.0, 
130.0, 126.1, 126.1, 124.9, 124.8, 120.2, 114.2, 114.2, 102.4, 102.1, 17.9, 12.7 (observed 
complexity due to C-F splitting, definitive assignments have not been made). 
IR (ATR) ν~  (cm-1): 2946, 2867, 2231, 1739, 1604, 1513, 1457, 1403, 1384, 1366, 1304, 
1264, 1235, 1171, 1110, 1074, 1014, 993, 909, 883, 847, 822, 791, 740, 721, 688, 650, 625. 
MS (70 eV, EI) m/z (%): 369 (57) [M+], 326 (28), 298 (41), 271 (64), 257 (29), 196 (24), 135 
(100) 128 (22), 77 (20).  
HRMS (EI): 369.1916 (calcd. 369.1924). 
 
Synthesis of 1-(1-benzothien-2-yl)-2,2-dimethylpropan-1-one (45f): 
 
 
 
The title compound was prepared according to TP6 and TP8 from benzothiophene (268 mg, 
2.00 mmol), Zn-base 12b (2.4 mL, 0.5 M in THF, 1.2 mmol), pivaloyl chloride (385 mg, 2.20 
mmol), CuCN·2LiCl (0.2 ml, 1 M in THF, 10 mol%), metalation conditions 140 °C, 1 h. Flash 
chromatographical purification on silica (n-pentane/Et2O 40:1) gave a colorless oil (363 mg, 
83%). 
1H-NMR (300 MHz, CDCl3) δ: 8.0 (s, 1 H), 7.9 (m, 2 H), 7.4 (m, 2 H), 1.5 (s, 9 H). 
13C-NMR (75 MHz, CDCl3) δ: 200.3, 142.1, 141.6, 139.2, 128.8, 127.1, 125.8, 124.8, 122.5, 
44.2, 28.2. 
IR (ATR) ν~  (cm-1): 2970, 2930, 2901, 1739, 1647, 1593, 1558, 1510, 1474, 1457, 1430, 
1394, 1366, 1274, 1217, 1144, 1126, 1072, 937, 898, 864, 842, 789, 758, 742, 723.   
MS (70 eV, EI) m/z (%): 218 (15) [M+], 161 8100), 89 (11), 43 (14).  
HRMS (EI): 218.0759  (calcd. 218.0765). 
 
4.7. Co-catalyzed aryl sulfonate/copper-exchange 
 
4.7.1. Starting Material Synthesis 
 
Synthesis of 3,5-dibromophenyl 4-methoxybenzenesulfonate: 
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The title compound was prepared following TP3 from 3,5-dibromophenol (5.04 g, 20 mmol), 
4-methoxybenzenesulfonyl chloride (4.96 g). 7.96 g (90%) of a brown solid were isolated. 
m.p.: 102.4 - 103 °C 
1H-NMR (300 MHz, CDCl3) δ (ppm): 7.8 (d, J = 9.2 Hz, 2 H), 7.6 (t, J = 1.7 Hz, 1 H), 7.1 
(m, 2 H), 7.0 (m, 2 H), 3.9 (s, 3 H). 
13C-NMR (75 MHz, CDCl3) δ (ppm): 164.6, 150.1, 132.9, 130.8, 125.9, 124.8, 122.9, 114.6, 
55.9. 
IR (ATR) ν~  (cm-1): 1593, 1566, 1497, 1417, 1378, 1268, 1200, 1192, 1185, 1170, 1095, 
1016, 912, 872, 858, 832, 805, 740, 712, 679, 667, 634.   
MS (70 eV, EI) m/z (%): 421 (12), 419 [M+] (6), 172, (24), 171 (100), 170 (60), 123 (31), 107 
(84), 92 (31), 77 (45), 64 (16). 
HRMS (EI): 419.8671 (calcd.: 419.8667). 
 
Synthesis of diethyl 5-{[(4-methoxyphenyl)sulfonyl]oxy}isophthalate (50a): 
 
 
 
The title compound was prepared following TP3 from diethyl 5-hydroxyisophthalate (4.77 g, 
20 mmol), 4-methoxybenzenesulfonyl chloride (4.96 g). 7.59 g (93%) of a colorless solid 
were isolated. 
m.p.: 85.3 - 86.0 °C 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.6 (t, J = 1.5 Hz, 1 H), 7.9 (d, J = 1.5 Hz, 2 H), 7.8 
(m, 2 H), 7.0 (m, 2 H), 4.4 (q, J = 7.2 Hz, 4 H), 3.9 (s, 3 H), 1.4 (t, J = 7.2 Hz, 6 H). 
13C-NMR (75 MHz, CDCl3) δ (ppm): 164.5, 164.4, 149.6, 132.6, 130.8, 129.0, 127.6, 126.2, 
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114.6, 61.7, 55.8, 14.2. 
IR (ATR) ν~  (cm-1): 1717, 1310, 1170, 1022, 953, 844, 821, 760, 748, 704. 
MS (70 eV, EI) m/z (%): 408 (8) [M+], 363 (15), 193 (15), 171 (100), 123 (14), 107 (27), 77 
(14). 
HRMS (EI): 408.0879 (calcd.: 408.0881). 
 
 
Synthesis of ethyl 3-cyano-5-{[(4-methoxyphenyl)sulfonyl]oxy}benzoate (50b): 
 
 
 
The title compound was prepared from 3,5-dibromophenyl 4-methoxybenzenesulfonate (8.44 
g, 10 mmol), iPrMgCl·LiCl, TsCN (1.81 g, 10 mmol) following TP 4 (Exchange time: 60 
min). The second Br/Mg-exchange was performed on the crude product according to TP 4 
(Exchange time: 60 min) using ethyl cyanoformate (991 mg, 10 mmol) as an electrophile 
furnishing (2.0 g, 56%) a colorless solid.  
m.p.: 90.1 - 90.8 °C  
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.2 (t, J = 1.4 Hz, 1 H), 7.9 (dd, J = 2.4, 1.5 Hz, 1 H), 
7.8 (m, 2 H), 7.5 (dd, J = 2.3, 1.4 Hz, 1 H), 7.0 (m, 2 H), 4.4 (q, J = 7.1 Hz, 2 H), 3.9 (s, 3 H), 
1.4 (t, J = 7.1 Hz, 3 H). 
13C-NMR (75 MHz, CDCl3) δ (ppm): 164.7, 163.3, 149.8, 133.7, 131.6, 130.8, 129.7, 128.1, 
125.6, 116.6, 114.8, 114.0, 62.2, 55.9, 14.2.  
IR (ATR) ν~  (cm-1): 1717, 1592, 1378, 1316, 1303, 1265, 1224, 1195, 1183, 1172, 1116, 
1093, 1011, 968, 894, 843, 807, 778, 769, 739, 678, 668, 626 . 
MS (70 eV, EI) m/z (%): 361 (2) [M+], 316 (5), 171 (100), 123 (10), 107 (23), 77 (12), 74 
(27), 59 (37), 45 (26). 
HRMS (EI): 361.0607 (calcd.: 361.0620). 
 
Synthesis of 3,5-dicyanophenyl 4-methoxybenzenesulfonate (50c): 
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The title compound was prepared from 3,5-dibromophenyl 4-methoxybenzenesulfonate (8.44 
g, 10 mmol), iPrMgCl·LiCl, TsCN (1.81 g, 10 mmol) following TP 4 (Exchange time: 60 
min). The second Br/Mg-exchange was performed on the crude product according to TP 4 
(Exchange time: 60 min) using TsCN (1.81 g, 10 mmol) as an electrophile furnishing (1.54 g, 
49%) as a colorless solid. 
m.p.: 98.8 - 100.2 °C 
1H-NMR (300 MHz, CDCl3) δ (ppm): 7.83 (t, J = 1.5 Hz, 1 H), 7.78 (m, 2 H), 7.56 (d, J = 
1.5 Hz, 2 H), 7.04 (m, 2 H), 3.94 (s, 3 H). 
13C-NMR (75 MHz, CDCl3) δ (ppm): 165.1, 150.1, 133.6, 130.8, 130.4, 125.1, 115.5, 115.4, 
114.9, 55.9. 
IR (ATR) ν~  (cm-1): 3071, 2942, 2910, 1575, 1498, 1272, 1169, 1135, 1093, 964, 749. 
MS (70 eV, EI) m/z (%): 314 (2) [M+], 171 (100), 107(38), 123 (19), 92 (17), 77 (24), 64 (10), 
44 (4). 
HRMS (EI): 314.0358 (calcd.: 314.0361). 
 
 
Synthesis of 3,5-bis(trifluoromethyl)phenyl 4-(dimethylamino)benzenesulfonate (50d): 
 
 
 
The title compound was prepared following TP3 from 3,5-bis(trifluoromethyl)phenol (2.30 g, 
10 mmol), 4-(dimethylamino)benzenesulfonyl chloride (2.20 g, 12 mmol). 3.3g (79%) of a 
colorless solid were isolated. 
m.p.: 151.0 - 153.4 °C 
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1H-NMR (300 MHz, CDCl3) δ (ppm): 7.74 (bs, 1 H), 7.59 (m, 2 H), 7.44 (bs, 2 H), 6.66 (m, 
2 H), 3.08 (s, 6 H). 
13C-NMR (75 MHz, CDCl3) δ (ppm): 154.2, 150.4,133.6, 133.2, 132.7, 130.5, 127.9, 124.3, 
123.6, 123.5, 120.7, 120.5, 120.5, 120.4, 120.4, 120.3, 118.2, 117.1, 110.9, 40.1. (observed 
complexity due to C-F splitting, definitive assignments have not been made).  
IR (ATR) ν~  (cm-1): 3079, 2973, 1594, 1585, 1498, 1354, 1170, 1093, 965, 749, 669. 
MS (70 eV, EI) m/z (%): 413 (30) [M+], 394 (12), 184 (100), 136 (79), 120 (63), 105 (14), 77 
(17), 41 (14). 
HRMS (EI): 413.0508 (calcd.: 413.0520). 
 
Synthesis of 3-cyano-5-formylphenyl 4-methoxybenzenesulfonate (50i): 
 
 
 
The title compound was prepared from 3,5-dibromophenyl 4-methoxybenzenesulfonate (8.44 
g, 10 mmol), iPrMgCl·LiCl, TsCN (1.8 g, 10 mmol) following TP 4 (Exchange time: 60 min). 
The second Br/Mg-exchange was performed on the crude product according to TP 4 
(Exchange time: 60 min) using DMF (10 mmol) as an electrophile furnishing (1.68 g, 53%) of 
a colorless solid.  
m.p.: 108.3 - 108.8 °C  
1H-NMR (300 MHz, CDCl3) δ (ppm): 10.0 (s, 1 H), 8.1 (m, 1 H), 7.8 (m, 4 H), 7.5 (dd, J = 
2.4, 1.4 Hz, 1 H), 7.0 (m, 1 H) 3.9 (s, 3 H).  
13C-NMR (75 MHz, CDCl3) δ (ppm): 188.4, 164.9, 150.4, 138.5, 131.2, 131.0, 130.8, 127.4, 
125.4, 116.3, 114.9, 55.9.  
IR (ATR) ν~  (cm-1): 1705, 1590, 1572, 1497, 1342, 1266, 1166, 1092, 966, 952, 839, 806, 
750, 719, 704, 670.    
MS (70 eV, EI) m/z (%): 317 (1) [M+], 171 (52), 140 (31), 108 (25), 74 (69), 65 (14), 59 
(100), 45 (75). 
HRMS (EI): 317.0355 (calcd.: 317.0358). 
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4.7.2. Aryl Sulfonate/Copper-Exchange 
 
Synthesis of diethyl 5-iodoisophthalate (52a): 
 
 
 
The title compound was prepared from 50a (408 mg, 1.0 mmol), iodine (508 mg, 2.0 mmol) 
following TP10. Column chromatographical purification on silica (n-pentane/Et2O 6:1) 
furnished a yellow solid (251 mg, 72%). 
m.p.: 75.2 - 75.8 °C 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.6 (t, J = 1.7 Hz, 1 H), 8.5 (d, J = 1.5 Hz, 2 H), 4.4 (q, 
J=7.2 Hz, 4 H), 1.4 (t, J=7.2 Hz, 6 H).  
13C-NMR (75 MHz, CDCl3) δ (ppm): 164.3, 142.3, 132.5, 129.8, 93.4, 61.7, 14.3. 
IR (ATR) ν~  (cm-1): 3083, 2984, 2903, 1710, 1290, 1231, 1142, 1103, 1021, 747, 714.   
MS (70 eV, EI) m/z (%): 347 (64) [M+], 319 (24), 312 (24), 302 (100), 291 (22), 274 (36), 
247 (22), 246 (16), 75 (10). 
HRMS (EI): 347.9853 (calcd.: 347.9858). 
 
Synthesis of ethyl 3-cyano-5-iodobenzoate (52b): 
 
 
 
The title compound was prepared from 50b (361 mg, 1.0 mmol), I2 (507 mg, 2.0 mmol) 
following TP10. Column chromatographical purification on silica (n-pentane/Et2O 9:1) 
furnished a yellow solid (196 mg, 65%). 
m.p.: 71.2 - 71.5 °C. 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.6 (t, J = 1.6 Hz, 1 H), 8.3 (t, J = 1.6 Hz, 1 H), 8.2 (t, 
J = 1.6 Hz, 1 H), 4.4 (q, J = 7.1 Hz, 2 H), 1.4 (t, J = 7.2 Hz, 3 H). 
13C-NMR (75 MHz, CDCl3) δ (ppm): 163.2, 144.0, 142.6, 132.3, 127.1, 116.3, 114.5, 93.6, 
62.2, 14.2. 
IR (ATR) ν~  (cm-1): 3084, 3075, 2980, 2236, 1726, 1561, 1431, 1393, 1368, 1279, 1255, 
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1191, 1156, 1128, 1106, 1020, 996, 939, 926, 890, 862, 809, 762, 722, 698, 667.   
MS (70 eV, EI) m/z (%): 301 (36) [M+], 272 (100), 255 (81), 227 (43), 207 (45), 115 (27), 
101 (51), 73 (48), 44 (47). 
HRMS (EI): 300.9600 (calcd.: 300.9589). 
 
Synthesis of diethyl 5-(prop-2-en-1-yl)isophthalate (52c): 
 
 
 
The title compound was prepared from 50a (408 mg, 1.0 mmol), allyl bromide (240 mg, 2.0 
mmol) following TP10. Column chromatographical purification on silica (n-pentane/Et2O 6:1) 
furnished a colorless oil (204 mg, 78%).  
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.4 (t, J = 1.7 Hz, 1 H), 8.0 (d, J = 1.7 Hz, 2 H), 5.9 
(m, 1 H), 5.0 (m, 2 H), 4.3 (q, J = 7.0 Hz, 4 H), 3.4 (d, J = 6.5 Hz, 2 H), 1.3 (t, J = 7.1 Hz, 6 
H). 
13C-NMR (75 MHz, CDCl3) δ (ppm): 165.7, 140.7, 136.1, 133.7, 130.9, 128.4, 116.8, 61.1, 
39.6, 14.2.  
IR (ATR) ν~  (cm-1): 3081, 2982, 2938, 2907, 1717, 1369, 1322, 1303, 1229, 1189, 1127, 
1105, 1096, 1024, 997, 920, 753, 717, 701.   
MS (70 eV, EI) m/z (%): 262 (49) [M+], 234 (15), 218 (15), 217 (100), 190 (12), 189 (47), 
117 (36), 115 (56), 105 (12), 77 (11). 
HRMS (EI): 262.1197 (calcd.: 262.1205). 
 
Synthesis of diethyl 5-(2,2-dimethylpropanoyl)isophthalate (52d): 
 
 
 
The title compound was prepared from 50a (408 mg, 1.0 mmol), pivaloyl chloride (240 mg, 
2.0 mmol) following TP10. Column chromatographical purification on silica (n-pentane/Et2O 
19:1) furnished a colorless solid (187 mg, 61%).  
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m.p.: 72 - 72.3 °C 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.8 (t, J = 1.6 Hz, 1 H), 8.5 (d, J = 1.7 Hz, 2 H), 4.4 (q, 
J = 7.1 Hz, 4 H), 1.4 (t, J = 7.1 Hz, 6 H), 1.35 (s, 9 H).  
13C-NMR (75 MHz, CDCl3) δ (ppm): 207.7, 165.2, 139.2, 132.6, 132.4, 131.0, 61.7, 44.3, 
27.8, 14.3.  
IR (ATR) ν~  (cm-1): 2976, 2934, 2908, 2876, 1726, 1717, 1672, 1474, 1434, 1396, 1367, 
1239, 1172, 1107, 1032, 1022, 1000, 880, 857, 733, 722, 607.  
MS (70 eV, EI) m/z (%): 306 (1) [M+], 250 (15), 249 (100), 222 (11), 221 (8), 194 (5), 57 (8). 
HRMS (EI): 306.1461 (calcd.: 306.1467). 
 
Synthesis of diethyl 5-(3-oxocyclohex-1-en-1-yl)isophthalate (52e): 
 
 
 
The title compound was prepared from 50a (408 mg, 1.0 mmol), 3-iodocyclohexenone (444 
mg, 2.0 mmol) following TP10. Column chromatographical purification on silica (n-
pentane/Et2O 1:1) furnished a colorless solid (202 mg, 64%). 
m.p.: 108 - 108.4 °C 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.7 (t, J = 1.6 Hz, 1 H), 8.4 (d, J = 1.5 Hz, 2 H), 6.5 (t, 
J = 1.5 Hz, 1 H), 4.4 (q, J = 7.1 Hz, 4 H), 2.8 (m, 2 H), 2.5 (m, 2 H), 2.2 (m, 2 H), 1.4 (t, J = 
7.2 Hz, 6 H).  
13C-NMR (75 MHz, CDCl3) δ (ppm): 199.5, 165.3, 157.6, 139.6, 131.6, 131.5, 131.0, 126.7, 
61.7, 37.2, 28.1, 22.7, 14.3.  
IR (ATR) ν~  (cm-1): 2981, 2922, 2877, 1713, 1672, 1646, 1613, 1450, 1434, 1369, 1332, 
1319, 1290, 1257, 1239, 1222, 1193, 1174, 1133, 1108, 1032, 1021, 964, 930, 920, 891, 861, 
751, 716, 690, 680.   
MS (70 eV, EI) m/z (%): 316 (32) [M+], 288 (25), 271 (27), 244 (10), 243 (70), 242 (100), 
215 (10), 197 (10). 
HRMS (EI): 316.1314 (calcd.: 316.1311). 
 
Synthesis of diethyl 5-[(1E)-3-ethoxy-3-oxoprop-1-en-1-yl]isophthalate (52f): 
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EtO2C CO2Et
CO2Et
 
 
The title compound was prepared from 50a (408 mg, 1.0 mmol), ethyl propiolate (196 mg, 2.0 
mmol) following TP10. Column chromatographical purification on silica (n-pentane/Et2O 9:1) 
furnished a yellow solid (195 mg, 61%). 
m.p.: 78.9 - 79.5 °C 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.7 (m, 1 H), 8.4 (d, J = 1.5 Hz, 2 H), 7.7 (d, J = 16.1 
Hz, 1 H), 6.6 (d, J = 16.1 Hz, 1 H), 4.4 (q, J = 7.1 Hz, 4 H), 4.3 (d, J = 7.1 Hz, 2 H), 1.4 (t, J = 
7.1 Hz, 6 H), 1.3 (t, J = 7.1 Hz, 3 H).   
13C-NMR (75 MHz, CDCl3) δ (ppm): 166.3, 165.2, 142.3, 130.7, 135.2, 134.4, 132.6, 131.7, 
120.7, 61.6, 60.8, 14.3.  
IR (ATR) ν~  (cm-1): 3072, 2984, 2941, 2906, 1716, 1708, 1643, 1442, 1368, 1332, 1309, 
1289, 1256, 1236, 1195, 1172, 1131, 1117, 1106, 1094, 1030, 998, 990, 967, 928, 917, 862, 
826, 755, 730, 717, 666.   
MS (70 eV, EI) m/z (%): 320 (47) [M+], 292 (11), 275 (100), 247 (24), 229 (52), 202 (14), 99 
(10), 85 (20), 71 (24), 57 (32), 43 (19).  
HRMS (EI): 320.1247 (calcd.: 320.1260). 
 
Synthesis of ethyl 3-cyano-5-(3-oxocyclohexyl)benzoate (52g) 
 
 
The title compound was prepared from 50b (361 mg, 1.0 mmol), cyclohexenone (194 mg, 2.0 
mmol), TMSCl (217 mg, 2.0 mmol) following TP10. Purification on silica (n-pentane/Et2O 
1:1) furnished a colorless oil (179 mg, 65%). 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.3 (t, J = 1.6 Hz, 1 H), 8.2 (t, J = 1.7 Hz, 1 H), 7.7 (t, 
J = 1.7 Hz, 1 H), 4.4 (q, J = 7.1 Hz, 2 H), 3.1 (s, 1 H), 2.7 – 2.4 (m, 4 H), 2.3 – 2.1 (m, 2 H), 
2.0 – 1.8 (m, 2 H), 1.4 (t, J = 7.0 Hz, 3 H).  
13C-NMR (75 MHz, CDCl3) δ (ppm): 209.1, 164.5, 146.2, 134.0, 132.3, 132.0, 131.6, 117.9, 
113.3, 61.9, 48.2, 44.1, 40.9, 32.4, 25.3, 14.3.  
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IR (ATR) ν~  (cm-1): 3079, 2939, 2234, 1720, 1668, 1596, 1447, 1369, 1307, 1296, 1247, 
1226, 1214, 1190, 1118, 1021, 891, 844, 767, 689.   
MS (70 eV, EI) m/z (%): 271 (32), 242 (100), 228 (41), 195 (44), 182 (22), 140 (17). 
HRMS (EI): 271.1205 (calcd.: 271.1208). 
 
Synthesis of ethyl 3-cyano-5-(methylthio)benzoate (52h): 
 
 
 
The title compound was prepared from ethyl 50b (361 mg, 1.0 mmol), S-methyl 
thiomethylsulfonate (252 mg, 2.0 mmol) following TP10. Column chromatographical 
purification on silica (n-pentane/Et2O 1:1) furnished a colorless solid (161 mg, 73%). 
m.p.: 77.3 - 77.9 °C 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.1 (m, 2 H), 7.6 (s, 1 H), 4.4 (q, J = 7.1 Hz, 2 H), 2.6 
(s, 3 H), 1.4 (t, J = 7.2 Hz, 3 H) . 
13C-NMR (75 MHz, CDCl3) δ (ppm): 164.4, 142.0, 132.2, 132.0, 130.7, 129.0, 117.7, 113.4, 
61.9, 15.3, 14.2. 
IR (ATR) ν~  (cm-1): 3076, 2984, 2232, 1720, 1572, 1434, 1370, 1282, 1188, 1158, 1133, 
1111, 1025, 951, 929, 906, 888, 868, 858, 766, 751, 672.   
MS (70 eV, EI) m/z (%): 221 (100) [M+], 207 (23), 193 (44), 177 (20), 176 (72), 149 (26), 
133 (18), 104 (12), 73 (15), 68 (10), 44 (20), 41 (12). 
HRMS (EI): 221.0502 (calcd.: 221.0510) 
 
Synthesis of ethyl 5-iodoisophthalonitrile (50i): 
 
 
 
The title compound was prepared from 50c (314 mg, 1.0 mmol), I2 (507 mg, 2.0 mmol) 
following TP10. Column chromatographical purification on silica (n-pentane/Et2O 9:1) 
furnished a colorless solid (163 mg, 63%). 
m.p.: 79.5 - 81.0 °C 
EXPERIMENTAL SECTION 
 164 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.20 (d, J = 1.4 Hz, 1 H), 7.90 (dd, J = 1.4, 1.4 Hz, 2 
H). 
13C-NMR (75 MHz, CDCl3) δ (ppm): 144.4, 134.2, 115.4, 115.1, 94.2. 
IR (ATR) ν~  (cm-1): 3069, 2945, 2911, 1571, 1498, 1268, 1150, 1138, 1097, 961, 758. 
MS (70 eV, EI) m/z (%): 254 (100) [M+], 127 (59), 100 (12), 75 (6), 52 (2), 50 (3), 44 (3). 
HRMS (EI): 253.9340 (calcd.:253.9341). 
 
Synthesis of [3,5-bis(trifluoromethyl)phenyl](phenyl)methanone (52j): 
 
F3C CF3
O Ph
 
 
The title compound was prepared from 50d (413 mg, 1.0 mmol), benzoyl chloride (281 mg, 
2.0 mmol) following TP10. Column chromatographical purification on silica (n-pentane/Et2O 
50:1) furnished a colorless solid (194 mg, 61%). 
m.p.: 109.0 - 110.8 °C 
1H-NMR (300 MHz, CDCl3) δ (ppm): 8.23 (bs, 2 H), 8.09 (bs, 1 H), 7.78 (m, 2 H), 7.67 (dt, 
J = 6.6, 1.5 Hz, 1 H), 7.54 (m, 2 H). 
13C-NMR (150 MHz, CDCl3) δ (ppm): 193.6, 139.4, 135.9, 133.6, 132.3, 132.2, 131.9, 
131.70, 130.3, 130.2, 130.0, 129.9, 129.8, 129.5, 128.9, 128.8, 128.6, 125.9, 125.6, 125.6, 
125.6, 123.8, 121.9, 121.7 (observed complexity due to C-F splitting, definitive assignments 
have not been made).  
IR (ATR) ν~  (cm-1): 3064, 3016, 2970, 1670, 1598, 1375, 1274, 1257, 1217, 1274, 1108, 
1079, 908, 797, 680.  
MS (70 eV, EI) m/z (%): 318 (21) [M+], 241 (12), 213 (19), 163 (8), 105 (100), 77 (42), 51 
(17). 
HRMS (EI): 318.0480 (calcd.: 318.0479). 
 
Synthesis of  ethyl 2-(3,5-bis(trifluoromethyl)benzyl)acrylate (52k): 
 
F3C CF3
CO2Et
 
 
EXPERIMENTAL SECTION 
 165 
The title compound was prepared from 50d (413 mg, 1.0 mmol), ethyl 2-
(bromomethyl)acrylate (384 mg, 2.0 mmol) following TP10. Column chromatographical 
purification on silica (n-pentane/Et2O 50:1) furnished a colorless oil (209 mg, 71%). 
1H-NMR (300 MHz, CDCl3) δ (ppm): 7.72 (bs, 1 H), 7.67 (bs, 2 H), 6.33 (bs, 1 H), 5.60 (m, 
1 H), 4.17 (q, J = 7.3 Hz, 2 H), 3.75 (s, 2 H), 1.24 (t, J = 7.3 Hz, 3 H). 
13C-NMR (75 MHz, CDCl3) δ (ppm): 166.1, 141.5, 138.7, 132.3, 131.8, 131.4, 131.0, 129.2, 
129.2, 129.1, 129.1, 129.1, 129.1, 129.1, 129.0, 129.0, 129.0, 127.4, 127.2, 125.1, 121.5, 
120.6, 120.5, 120.4, 120.4, 117.9, 61.1, 38, 21.6, 14.0 (observed complexity due to C-F 
splitting, definitive assignments have not been made).  
IR (ATR) ν~  (cm-1): 2960, 2935, 2870, 1714, 1620, 1525, 1481, 1446, 1403, 1403, 1317, 
1278, 1253, 1173, 1278, 1253, 1173, 1136, 1057, 1024, 755,  
MS (70 eV, EI) m/z (%):  326 (38) [M+], 247 (48), 226 (54), 183 (41), 164 (24), 115 (23), 57 
(30), 43 (100)  
HRMS (EI): 326.0732 (calcd.: 326.0742). 
 
Synthesis of 3-formyl-5-(methylthio)benzonitrile (52p): 
 
 
 
The title compound was prepared from 50i (317 mg, 1.0 mmol), S-methyl thiomethylsulfonate 
(252 mg, 2.0 mmol) following TP10. Column chromatographical purification on silica (n-
pentane/Et2O 9:1) furnished a colorless solid (120 mg, 68%). 
m.p.: 139.2 - 139.7 °C 
1H-NMR (300 MHz, CDCl3) δ (ppm): 10.0 (s, 1 H), 7.9 (m, 2 H), 7.7 (m, 1 H), 2.6 (s, 3 H). 
13C-NMR (100 MHz, CDCl3) δ (ppm): 189.6, 143.2, 137.0, 134.9, 133.5, 129.6, 129.1, 114.2, 
15.2.  
IR (ATR) ν~  (cm-1): 3063, 2925, 2856, 2234, 1699, 1576, 1438, 1429, 1403, 1385, 1300, 
1267, 1243, 1195, 1146, 1136, 1127, 1057, 1012, 993, 981, 973, 954, 889, 874, 852, 830, 770, 
728, 722, 695, 671, 624, 617, 602.   
MS (70 eV, EI) m/z (%): 177 (100) [M+], 176 (65), 133 (10), 104 (17), 69 (8), 45 (9).  
HRMS (EI): 177.0239 (calcd.: 177.0248). 
 
Synthesis of 3-(2,2-dimethylpropanoyl)-5-formylbenzonitrile (52q): 
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The title compound was prepared from 50i (317 mg, 1.0 mmol), pivaloyl chloride (240 mg, 
2.0 mmol) following TP10. Column chromatographical purification on silica (n-pentane/Et2O 
2:1) furnished a colorless solid (129 mg, 60%). 
m.p.: 42.2 - 42.8 °C 
1H-NMR (300 MHz, CDCl3) δ (ppm): 10.1 (s, 1 H), 8.4 (t, J = 1.5 Hz, 1 H), 8.3 (t, J = 1.5 Hz, 
1 H), 8.2 (t, J = 1.5 Hz, 1 H), 1.4 (s, 9 H).  
13C-NMR (75 MHz, CDCl3) δ (ppm): 205.8, 189.1, 140.4, 136.8, 136.2, 134.5, 132.1, 116.9, 
114.0, 44.5, 27.7. 
IR (ATR) ν~  (cm-1): 2982, 2935, 2853, 2236, 1729, 1701, 1676, 1585, 1476, 1462, 1446, 
1401, 1380, 1372, 1291, 1266, 1240, 1150, 1132, 1052, 1031, 1012, 1002, 948, 931, 896, 848, 
787, 762, 704, 688, 674, 622, 607.   
MS (70 eV, EI) m/z (%): 215 (1) [M+], 187 (12), 158 (10), 131 (6), 102 (7), 57 (100), 40 (30). 
HRMS (EI): 215.0939 (calcd.: 215.0946). 
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5.1. Data of the X-rayAnalysis: 
 
3-Hydroxy-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide (Talnetant; 25) 
 
Empirical formula  C25 H22 N2 O2 
Formula weight  382.454 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Orthorhombic 
Space group  P212121 
Unit cell dimensions a = 7.3472(3) Å α= 90°. 
 b = 9.8722(4) Å β= 90°. 
 c = 26.8795(10) Å γ = 90°. 
Volume 1949.65(13) Å3 
Z 4 
Density (calculated) 1.30298(9) Mg/m3 
Absorption coefficient 0.083 mm-1 
F(000) 808 
Crystal size 0.44 x 0.33 x 0.24 mm3 
Theta range for data collection 4.32 to 26.35°. 
N
OH
OHN
EtPh
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Index ranges -9<=h<=7, -7<=k<=12, -33<=l<=32 
Reflections collected 8157 
Independent reflections 2285 [R(int) = 0.0283] 
Completeness to theta = 26.35° 99.1 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.98000 and 0.95671 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 2285 / 0 / 271 
Goodness-of-fit on F2 0.932 
Final R indices [I>2sigma(I)] R1 = 0.0297, wR2 = 0.0597 
R indices (all data) R1 = 0.0413, wR2 = 0.0619 
Absolute structure parameter ? 
Largest diff. peak and hole 0.135 and -0.156 e.Å-3 
 
CCDC 766951 contains the supplementary crystallographic data for this compound. This data 
has been deposited in the Cambridge Crystallographic Data Centre and can be obtained free 
of charge via the internet: www.ccdc.cam.ac.uk/data_request/cif  
APPENDIX 
 170 
Ethyl 3-{[bis(dimethylamino)phosphoryl]oxy}-2-phenylquinoline-4-carboxylate (31a) 
 
 
Empirical formula  C22 H26 N3 O4 P 
Formula weight  427.433 
Temperature  200(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/c 
Unit cell dimensions a = 13.619(3) Å α= 90°. 
 b = 11.209(2) Å β= 94.89(3)°. 
 c = 14.083(3) Å γ = 90°. 
Volume 2142.0(7) Å3 
Z 4 
Density (calculated) 1.3255(4) Mg/m3 
Absorption coefficient 0.162 mm-1 
F(000) 904 
Crystal size 0.19 x 0.15 x 0.06 mm3 
Theta range for data collection 3.15 to 27.10°. 
Index ranges -17<=h<=17, -14<=k<=13, -18<=l<=18 
Reflections collected 15784 
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Independent reflections 4700 [R(int) = 0.0482] 
Completeness to theta = 27.10° 99.5 %  
Absorption correction None 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4700 / 0 / 276 
Goodness-of-fit on F2 1.026 
Final R indices [I>2sigma(I)] R1 = 0.0438, wR2 = 0.1020 
R indices (all data) R1 = 0.0737, wR2 = 0.1153 
Absolute structure parameter ? 
Largest diff. peak and hole 0.202 and -0.425 e.Å-3 
 
CCDC 766953 contains the supplementary crystallographic data for this compound. This data 
has been deposited in the Cambridge Crystallographic Data Centre and can be obtained free 
of charge via the internet: www.ccdc.cam.ac.uk/data_request/cif  
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4-(3-{[bis(dimethylamino)phosphoryl]oxy}pyridin-4-yl)phenyl 
trifluoromethanesulfonate (29b): 
 
 
Empirical formula  C16 H19 F3 N3 O5 P S 
Formula weight  453.374 
Temperature  173(2) K 
Wavelength  0.71073 Å 
Crystal system  Monoclinic 
Space group  P21/c 
Unit cell dimensions a = 10.2499(4) Å α= 90°. 
 b = 10.0927(4) Å β= 98.197(4)°. 
 c = 19.7258(8) Å γ = 90°. 
Volume 2019.77(14) Å3 
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Z 4 
Density (calculated) 1.49097(10) Mg/m3 
Absorption coefficient 0.300 mm-1 
F(000) 936 
Crystal size 0.31 x 0.29 x 0.27 mm3 
Theta range for data collection 4.26 to 26.34°. 
Index ranges -12<=h<=8, -12<=k<=11, -24<=l<=21 
Reflections collected 8084 
Independent reflections 4075 [R(int) = 0.0241] 
Completeness to theta = 26.34° 99.2 %  
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.92200 and 0.90136 
Refinement method Full-matrix least-squares on F2 
Data / restraints / parameters 4075 / 0 / 266 
Goodness-of-fit on F2 0.911 
Final R indices [I>2sigma(I)] R1 = 0.0359, wR2 = 0.0830 
R indices (all data) R1 = 0.0574, wR2 = 0.0880 
Absolute structure parameter ? 
Largest diff. peak and hole 0.274 and -0.366 e.Å-3 
 
CCDC 766952  contains the supplementary crystallographic data for this compound. This data 
has been deposited in the Cambridge Crystallographic Data Centre and can be obtained free 
of charge via the internet: www.ccdc.cam.ac.uk/data_request/cif  
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